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 Abstract 
Despite the privileged position of Hamilton’s barbiturate binding system in supramolecular 
chemistry, this motif has never been used in generating interlocked structures, such as 
rotaxanes or catenanes. This thesis demonstrates the feasibility of such structures. A series of 
Hamilton-like receptors has been synthesised. Their conversion from “open” to “closed” 
forms by metathesis and their binding with barbital was studied, demonstrating the 
importance of the macrocycle size. Barbiturates disubstituted with flexible chains terminated 
either by reacting groups (anthracenes, olefins) or stoppers (trityl) were also synthesised. The 
fluorescence properties of anthracene-tagged barbiturates and their kinetics of intramolecular 
anthracene photodimerisation and thermal return were studied, demonstrating remarkable 
differences depending on the chain length. Binding studies of these barbiturates with the 
receptors were then undertaken, revealing smaller binding constants compared with barbital. 
A series of ring-closing experiments involving the barbiturate complexes was then 
undertaken, either by anthracene photodimerisation or olefin metathesis. In one metathesis 
experiment, indirect evidence for the formation of a low amount of catenane was obtained by 
mass spectrometry, where the smallest ring is formed by a chain of only 19 carbon atoms, 
which is unprecedented. Finally, different synthetic pathways for the synthesis of barbiturates 
substituted with large rigid substituents were investigated. Models of their complexes with the 
receptors and IR studies are presented that suggest that their structure would facilitate the 
formation of interlocked complexes. 
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Abbreviations, units and symbols 
Unless otherwise stated, the units and prefixes used in this thesis are SI units. Other units are 
indicated in the following table. 
A Absorption (dimensionless). 
AU Arbitrary unit. 
cal Calorie (1 cal = 4.1868 J). 
br. In NMR spectra: broad peak (for example: br. s: broad singlet). 
d In NMR spectra: doublet. 
ddt In NMR spectra: doublet of doublet of triplets. 
δ( ) In IR spectra: deformation band. 
δ Chemical shift (in ppm) in NMR spectra. 
∆G° Standard molar free enthalpy of complexation (in kcal.mol-1). 
∆H° Standard molar enthalpy of complexation (in kcal.mol-1). 
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene. 
DCM Dichloromethane. 
DMF Dimethylformamide. 
DMSO Dimethyl sulfoxide. 
DMSO-d6 Deuteriated dimethyl sulfoxide. 
∆S° Standard molar entropy of complexation (in cal.mol-1.K-1). 
ε Molar extinction coefficient. 
EI Electronic ionisation mass spectrometry. 
ES Electrospray mass spectrometry. 
ES+ Electrospray, positive ions mode. 
ES- Electrospray, negative ions mode. 
exp( ) Exponential. 
Φ Quantum yield (dimensionless). 
FTIR Fourier transform infrared spectrometry. 
hh head to head (anthracene dimer). 
HSAB Hard and Soft Acids and Bases theory. 
ht head to tail (anthracene dimer). 
IF Intensity of fluorescence (in AU). 
IR Infrared spectrometry; infrared spectrum. 
J Coupling constant (in Hz). 
K Binding constant (dimensionless). 
k Rate constant (in s-1). 
l Optical path (in cm). 
L Litter (1 L = 10-3 m3). 
λ Wavelength (in nm). 
λem. Wavelength of emission (in nm). 
λexc. Wavelength of excitation (in nm). 
log( ) Decimal logarithm. 
ln( ) Natural logarithm. 
m In NMR spectra: multiplet. In IR spectra: medium band. 
M Molar (1 M = 1 mol.L-1). 
MALDI Matrix assisted laser desorption ionisation mass spectrometry. 
MS Mass spectrometry. 
Me Methyl. 
ν Wave number (in cm-1). 
ν( ) In IR spectra: vibration band. 
NA Avogadro constant (NA = 6.02214179(30) µ 1023 mol-1). 
NMR Nuclear magnetic resonance spectrometry; NMR spectrum. 
P Photonic flux. 
pKa pKa = - log(Ka) where Ka is the acid dissociation constant. 
ppm Part per million. 
q In NMR spectra: quadruplet. 
quint. In NMR spectra: quintuplet. 
R Molar gas constant (R = 8.314472(15) J.mol-1.K-1). 
rt. Room temperature. 
s In NMR spectra: singlet. In IR spectra: strong band. 
t In NMR spectra: triplet. 
THF Tetrahydrofuran. 
UV-Vis UV-Visible spectrometry; electronic absorption. 
w In IR spectra: weak band. 
(C) Activity of chemical species C in solution (dimensionless). 
(C) = [C] / C0 where C0 = 1 M. 
[C] Concentration of chemical species C (in M). 
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1) INTRODUCTION 
1.1) Background 
1.1.1) Supramolecular and Dynamic Covalent Chemistries 
1.1.1.1) Introduction to the field 
 According to The Concise Oxford Dictionary, 1 the first meaning of “chemistry” is 
“the branch of science concerned with the properties and interactions of the substances of 
which matter is composed”. The second is “the chemical properties of a substance or body”, 
and the third is “the emotional or psychological interaction between two people, especially 
when experienced as a powerful mutual attraction”. Even if this last metaphorical meaning is 
very far from the subject of this thesis, it is interesting to notice that even in this common 
meaning, chemistry deals with interaction and especially attraction. Therefore, it can seem 
surprising that “classical” organic chemistry, as it has developed since the ninetieth century, 
has been mainly concerned with only one type of interaction: the covalent bond. By contrast 
with this molecular chemistry, supramolecular chemistry2 is concerned with the synthesis and 
the study of supermolecules, which can be defined as entities resulting from the association of 
at least two chemical species (molecules or ions) held together by intermolecular bonds 
weaker than covalent. 
 This thesis is written in the context of supramolecular chemistry. This concept started 
to emerge as a new field of study in the late 1960’s, and was acknowledged for the wider 
audience by the Nobel Prize awarded in 1987 to three of its pioneers, Donald J. Cram, J.-M. 
Lehn and Charles J. Pedersen, “for their development and use of molecules with structure-
specific interactions of high selectivity, awarded for syntheses of molecules that mimic 
important biological processes”. 3  Indeed some of the most important concepts of 
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supramolecular chemistry come from biochemistry. Many biological processes involve the 
recognition and fixation of a guest molecule or substrate by a host or receptor: The 
recognition of antigens by antibodies is the basis of the immune system, and the catalysis of 
biological reactions by enzymes depends on the complexation and stabilization of transition 
states in the enzyme’s active site.4  For this reason, supramolecular chemistry has sometimes 
been described as host-guest chemistry. The molecular recognition of a guest molecule by a 
host implies a complementarity between the host and the guest, which is both a shape or steric 
complementarity (illustrated by Emil Fischer5 as “lock and key”) and a complementarity of 
interaction, in the sense that functional groups that will interact together have to be facing 
each other. 
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Scheme 1.1. An exemple of self-assembly: barbital and 2,4,6-diamino-5-butyl-pyrimidine 
forming supramolecular ribbons or supramolecular macrocycles.6a 
 The spontaneous recognition of molecules in solution by the formation of reversible 
bonds can be used strategically to access complex molecular and supramolecular structures. 
The terms pre-organisation and template effect come into play when it is the structure and 
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binding properties of one of the molecules or ions forming the supermolecule that determine 
its overall geometry. When the molecular recognition and assembly tends to form a complex 
structure by itself, the process is described as self-assembly. When self-assembly leads to the 
apparition of a new entity which involves several self-assembly processes, then it is possible 
to describe it as self-organisation. This is illustrated by the self assembly of barbital and 
triaminopyrimidine derivatives (Scheme 1.1).6a 
The bonds used in supramolecular chemistry are weaker than typical covalent bonds 
and are formed reversibly, which implies that their formation remains under thermodynamic 
control. This is another difference compared to classical “synthetic” chemistry, where 
covalent bonds are usually formed under kinetic control, which makes their formation 
practically irreversible. This is because the aim of synthetic chemistry is to maximise the yield 
of reaction in a definite direction as a purpose for synthesis, but there are many reactions well 
known in organic chemistry that form covalent bonds under thermodynamic control. The 
emergence of supramolecular chemistry, and its ability to form complex supramolecular 
architectures via molecular recognition, pre-formation and self-assembly has revived the 
interest in a branch of chemistry where covalent bonds are formed, broken and re-arranged 
under thermodynamic equilibrium control: this branch is called dynamic covalent chemistry.7 
 
Figure 1.1. A supramolecular device where the input is a guest species. 
Signaling 
unit 
Binding 
site 
Receptor 
Substrate 
Complex 
Signal 
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Another field that has been revived by the development of supramolecular and 
dynamic covalent chemistries is the synthesis, study and use of molecular and supramolecular 
devices (see Figure 1.1). They can be defined as molecular or supramolecular systems whose 
physicochemical properties are reversibly changed or altered by an external input. This input 
can be light (photochemical input), applied potential (electrochemical input) or the binding of 
a guest species (chemical input), and the physicochemical property that is affected can also be 
the photochemical or electrochemical properties of the device or its binding affinities, but it 
can also be its shape or position in space: in this case the input gives rise to chemical motion. 
Depending on the function that they perform, these devices can also be designed as sensors, 
switches or molecular machines. It has to be noted that such systems can be considered as 
devices that are able to receive and/or transfer information beyond their molecular scale, or in 
other words that they are dealing with signals. 
1.1.1.2) Interactions 
 The definition of supramolecular chemistry given above makes it necessary to explain 
the different kinds of interactions used in “covalent” and supramolecular chemistry. The first 
thing to note is that they are all a different expression of the same fundamental interaction, the 
electromagnetic interaction between electrically charged particles, which at the scale of 
chemistry are the nuclei of atoms and their electronic clouds. 
 Covalent bonds are bonds between atoms characterized by the sharing of electron 
pairs. It is possible to describe these bonds with the theory of molecular orbitals. Covalent 
bonds are strong, with an energy ranging between 150 and 1000 kJ.mol-1. Another interaction 
approximately as strong as covalent bond is the ionic bond, encountered in ionic solids, the 
classical example being sodium chloride. In solids, ionic bonds are usually not localised 
between two precise atoms but give rise to lattice structures. It is the electrostatic interaction 
between charged species that defines the ionic bond.  
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If molecules, in contrast to ions, have a global electric charge of zero, the difference of 
electronegativity between atoms, and the effects of exterior electric and magnetic field on the 
shape of the electronic cloud, give rise to a distribution of the electric charge in a molecule. It 
affects the nature of the bonds in the molecule, which shift from the pure covalent bond to 
ionic bond when the difference of electronegativity of the atoms gets higher, as the sharing of 
electron pair becomes less important compared to the electrostatic interaction between the 
partly charged atoms. Some bonds can be described as having both ionic and covalent 
character: Polar covalent bonds are covalent bonds between atoms of different 
electronegativities, which confers them some ionic character. Dative bonds, also known as 
coordinate covalent bonds, created between a metal ion and a ligand, are encountered in 
coordination chemistry. As covalent bonds, they can in fact be described in terms of 
molecular orbitals. 
These different kinds of covalent bonds are what define molecules or ions as separate 
species, therefore their creation and breaking belong to the domain of classical chemistry, not 
supramolecular. Ionic bonds, on the contrary, are already supramolecular in nature in the 
sense that they act beyond the limit of the separate species they involve, but their strong 
energies, poor localisation and absence of selectivity puts them in a different category than 
other supramolecular bonds.  
 The distribution of charges inside neutral molecules also gives rise to intramolecular 
interactions, that are the specific domain of supramolecular chemistry. As for the ionic bond, 
they can be described as electrostatic interactions between the charge distributions, often 
simplified as dipoles by considering the dipole moment of the molecules. There is a 
distinction to be made between permanent dipoles, that is molecules that possess a permanent 
dipole moment because of the difference of electronegativity of their constituting atoms, and 
instantaneous dipoles, which appear by induction even in practically non-polar molecules 
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because of their surrounding electromagnetic field. However the interactions between non-
permanent dipoles (sometimes referred to as repulsion, induction and dispersion interactions, 
or Van der Waals interactions) are much weaker than electrostatic interactions between 
permanent distributions of charges, which are usually sufficient to quantify intermolecular 
interactions.8 
X H Y
~ 1.1 Å ~ 1.6 to 2 Å
 
Figure 1.2. General description of a hydrogen bond 
One of the most frequently employed interactions is the hydrogen bond. As 
represented in Figure 1.2, it is described as a bond involving a hydrogen atom bonded 
covalently to a relatively electronegative atom X, and another electronegative atom Y of the 
same or another molecule, bearing a lone pair, and in the direction of the X-H bond. Also as 
they are usually considered as a particular kind of electrostatic interaction between dipoles, it 
has been demonstrated that they are better described as partly covalent.9 Hydrogen bonds are 
involved in many biological supramolecular systems; in particular, they play a major role in 
determining the 3D structure of proteins and nucleic acids. Supramolecular assemblies based 
on H-bonds often have a well-defined 3D structure, and this geometric precision makes H-
bonding useful for controlling reactivity and stereoselectivity in a reversible manner.10 
1.1.1.3) On the thermodynamics of binding 
 Some concepts coming from thermodynamics will be used later in this thesis; in order 
to introduce them now, a simple equilibrium will be considered: 
A + B  C 
The direction in which this equilibrium will evolve is determined by the value of the 
standard molar free enthalpy of the equilibrium, noted ∆G°: spontaneous chemical reactions 
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have a negative ∆G°. But the value of ∆G° also indicates where the reaction is going to stop: 
it can be demonstrated,11 by considering the chemical potential of each species involved in the 
equilibrium, that the following equation will be verified at equilibrium: 
∆° = −. . 	
  .  .
°. .  
where γi is the activity coefficient of the species i, Ci its concentration and C° the standard 
concentration. If the standard concentration is 1 M, and if the concentrations are small enough 
to have all γi = 1, then the equation above can be re-written with the concentrations (i) of the 
species i, expressed in M, but dimensionless (as the activity): 
∆° = −. . 	
  ()(). () 
We can now introduce the binding constant K: 
 =  ∆°.  
This leads immediately to the following equation: 
 ()(). () =  
 This last equation indicates that at a given temperature, and whatever the quantity of 
starting materials are, the quotient of reaction will be equal to the binding constant at 
equilibrium. It has to be noted that this last equation can also be obtained by kinetic 
considerations: if we can define a speed of complexation kC and a speed of dissociation kD, 
then it can be demonstrated that the expression of the concentrations will tend for an infinite 
time to a limit where the equation above is verified, provided that K = kC / kD. So if these 
speeds are fast enough, we can consider that the limit is reached in the time of the experiment 
and the reaction or binding is said to be under thermodynamic control. Nearly all the non-
covalent binding equilibria encountered in supramolecular chemistry and biochemistry are 
under thermodynamic control. By contrast, reactions that involve the creation or breaking or 
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sigma bonds are usually not under thermodynamic control, and when they are the 
equilibration processes are usually much slower because of the slower kinetics associated 
with dynamic covalent bond formation. For this reason, most of the reactions encountered in 
dynamic covalent chemistry require a catalyst to reach equilibrium in a reasonable time 
scale.7 
 The binding constant K can be evaluated by any method allowing to measure the 
concentration of all species A, B and C in solution. It is theoretically dimensionless but often 
expressed with the dimensions implied by its calculation from concentrations (in L.mol-1 or 
M-1 for a 1:1 binding), or expressed as its decimal logarithm log(K). Using the following 
reaction, we can see that ∆G° is proportional to log(K) at a given temperature T: 
∆G° = -R.T.ln(K) = -R.T.ln(10).log(K) 
For reactions or binding in solution at atmospheric pressure, ∆G° and K will vary with 
the temperature. The definition of G as G = H - T.S leads immediately to the following 
equation: 
∆G° = ∆H° - T.∆S° 
where ∆H° is the standard molar enthalpy of the equilibrium, or enthalpic term of ∆G°, and 
∆S° its standard molar entropy, and - T.∆S° the entropic term of ∆G°. Both ∆H° and ∆S° vary 
with temperature: 
∆°() =  ∆° !"# + % ∆&°(). '

()*
 
∆+°() =  ∆+° !"# +  % ∆&°() . '

()*
 
where ∆CP° is the standard molar heat capacity at constant pressure.12 It is reasonable to 
consider that ∆CP° is independant of temperature in a given limited range. Then if we 
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integrate the equations above and consider that T - Tref ≪ Tref we obtain the following 
expression for ∆G°(T) where all terms containing ∆CP° have disappeared: 
∆G°(T) ≃ ∆H°(Tref) - T.∆S°(Tref) 
This can give an idea of the dependance of ∆G° with temperature, and allows us to 
evaluate ∆H°(Tref) and by difference ∆S°(Tref) from a set of measures of ∆G° at different 
temperatures through what is often referred to as a Van’t Hoff plot. However, this method 
requires a large number of titrations in a limited range of temperature, it can often give results 
with a poor precision. ∆H° measures the exothermicity of the reaction or binding, whereas ∆S° 
measures the amount of disorder generated by the reaction. For a binding equilibrium, which 
obviously implies an increase of order, ∆S° is very often negative. In this case, as ∆G° has to 
be negative, it implies that ∆Η° is also negative if the binding is efficient. ∆Η° can be 
measured by measuring the heat change (a method called calorimetry), which gives a direct 
measure of ∆Η° provided that the advancement of the reaction under the measurement 
conditions is known. The measure of the heat change during a titration at a given temperature 
is called isothermal titration calorimetry (ITC) and has become an established method to 
measure biological interactions in the last 15 years.13 ∆S°  cannot be measured directly, so it is 
evaluated by difference, using the equation ∆S° = (∆G° - ∆H°) / T. 
 It has been observed that many supramolecular systems present a phenomenon known 
as entropy-enthalpy compensation:14 In the formation of complexes of similar guests binding 
to similar receptors, it can be observed that the individual entropic and enthalpic terms in the 
expression of the free enthalpy vary from one complex to another in a compensatory way, so 
that large variations of ∆H° and ∆S° are often associated with smaller variations of ∆G°. For 
this reason, the interpretation of variations of binding affinity in terms of ∆H° and ∆S° is often 
difficult and some models consider directly the effects of different factors as terms of free 
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enthalpy.8 Moreover, a plot of ∆H° vs. ∆S° often shows that the plots corresponding to each 
complex are often roughly aligned, as if there was a linear relationship between ∆H° and ∆S°, 
where the slope can be defined as the compensation temperature TC: 
∆H° = α + TC.∆S° 
Both the fact in itself and its interpretation are subject to important controversies. It 
has been argued that this may be a consequence of the narrow range of ∆G° that can be 
measured experimentally compared to the wide range of ∆H°, leading to an illusion of relative 
constancy of ∆G° due to this small free energy window, which reflects into an artificial linear 
relationship between ∆H° and ∆S°.12 However this does not explain why for many series of 
complexes ∆G°  actually remains in the accessible free energy window.  It was also proved 
that the experimental errors induced by the calculation of ∆S° by difference between ∆H° and 
∆G° could lead to an artificial linear relationship between ∆H° and ∆S°, and a statistical test 
on the value of TC has been developed to reject these cases:14b if the temperature of measure T 
verifies the following relationship where σ is the standard deviation on the value of TC 
obtained from the model, then the compensation observed is not distinguishable from an 
artificial relationship: 
TC - 2.σ < T < TC + 2.σ 
Applying this test shows that in some cases, such a relationship between ∆H° and ∆S° 
is genuine in the sense that it cannot be due to the experimental error, but that very frequently 
the series of measures reported in the literature as presenting entropy-enthalpy compensation 
fail this test. However even in the rejected cases, it cannot be assumed that no relationship is 
present, as the value of the compensation temperature TC may be close to the measurement 
temperature. A qualitative explanation for this phenomenon is that when the bonds created 
upon complexation are stronger (which is reflected in ∆H°), the freedom of motion is 
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restrained (which is reflected in ∆S°), and on the contrary if the bonds created upon 
complexation are weaker or less numerous, then the freedom of motion is relatively bigger. 
Some models, both at a very general and theoretical level15a and on specific complexes15b 
suggest that this may give a correct explanation for the entropy-enthalpy compensation. 
1.1.1.4) Olefin metathesis and its role in this field 
R1 R2
R4R3 R2R1
R1 R2
R1R2
R1 R2catalyst
+ +
R4R3
R3 R4
R3R4
R3 R4
+ +
R1 R2
R3R4
 
Scheme 1.2. General case of metathesis. 
This thesis makes use of a particular reaction, olefin metathesis, which therefore needs 
to be introduced. This reaction has become one of the most important reactions in many fields 
of organic chemistry, including synthesis, polymer science and supramolecular and dynamic 
chemistries, a success that has been acknowledged by the Nobel Prize awarded to Y. Chauvin, 
R. R. Schrock and R. H. Grubbs in 2005. The name of this reaction comes from Greek 
metathesis, which means transposition or exchange. In this reaction, two olefins will formally 
exchange their carbenes. It is a catalytic equilibrium and often not very selective, so in the 
general case an olefin in the presence of a metathesis catalyst would lead to a complex 
mixture as illustrated on Scheme 1.2. 
R R
R
R R
+ +
catalyst
2
 
Scheme 1.3. Homodimerisation by metathesis of a terminal alkene. 
 Depending on the nature of the substituents of the olefin and the context of this 
reaction, it can become a very interesting tool for synthesis. A classical application is 
illustrated in Scheme 1.3: When the starting material is a terminal alkene, then one of the by-
products is ethylene which will be eliminated from the reacting mixture by evaporation, 
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displacing the equilibrium in the direction of the coupling product, which will be obtained as 
a mixture of cis and trans isomers. The same reaction can occur on a molecule with two 
terminal olefins, which will lead, depending on the concentration and on steric considerations, 
either to polymerisation or ring closure metathesis (RCM). Another classical application is 
the opening of a cyclic olefin leading to polymerisation (ring opening polymerisation, 
ROMP). 
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Scheme 1.4. Chauvin’s mechanism for olefin metathesis. 
The first metathesis reactions reported were observed with simple catalysts such as 
molybdenum metal, or oxide, or [Mo(CO)6] on alumina WCl6/AlEt2Cl and the mechanism 
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was not known.16 It was Yves Chauvin who proposed for the first time in 1974 a mechanism17 
(see Scheme 1.4) for this reaction involving metallocarbenes as catalytic species and 
metallacyclobutane intermediates. This mechanism is now considered as the main mechanism 
for all olefin metathesis reactions. Many other organometallic reactions that involve square 
intermediates comprising a metal atom have been discovered, and new catalysts for this 
reaction have been developed that wouldn’t have been conceived without this mechanism.18 
The two main families of catalysts used today derive from the works of Schrock 19  and 
Grubbs20. Some of these catalysts are represented on Figure 1.3. 
Ru
Cl
Cl
PCy3
PCy3
Cy : cyclohexyl
Grubbs
1st generation
Ru
Cl
Cl
PCy3
NN
Grubbs
2nd generation
Ru
Cl
Cl
PCy3
Ru
Cl
Cl
NN
O O
Grubbs-Hoveyda
1st generation
Grubbs-Hoveyda
2nd generation
M
N
RO
RO
Ar
Schrock's
catalysts
M = Mo or W
R & Ar: bulky substituents
 
Figure 1.3. Some catalysts for metathesis. 
As it is a reaction under thermodynamic control, it falls into the category of reactions 
that can be studied in the context of dynamic covalent chemistry. The ring closure metathesis 
for macrocycles, in particular, has been applied several times to the synthesis of interlocked 
 structures both as a synthetic 
dynamic covalent chemistry22f
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parts are not irreversibly linked. It is the presence of bulky stoppers at both ends of the axle in 
rotaxanes or the topology of catenanes that forces the two parts to remain linked. 
Concepts borrowed from the field of mathematics called topology are often used in 
order to describe interlocked structures. For example, two molecules or supermolecules that 
have the same crude formula, but cannot be represented by the same graph, are called 
topological isomers, and if one of these isomers cannot be represented by a planar graph, this 
isomer is an interlocked structure. However, it is important to note that the concepts borrowed 
from topology are not sufficient to define interlocked structures in chemistry: in mathematics, 
two objects have the same topology if there is a continuous transformation from one to the 
other, which transformation has a continuous inverse. With actual chemical structures, which 
are not conceptual mathematical objects but actual material ones, such transformations are not 
always possible because the covalent bonds cannot be stretched infinitely. It is because the 
transformation of a rotaxane to two separated components is impossible using only possible 
chemical motion and without breaking any bond, that rotaxanes belong to the field of 
interlocked structures. 
The synthesis of interlocked structures is only possible with macrocycles which have 
an inner diameter large enough to accommodate the thinner part of the molecular fragment 
that will be interlocked. Most of the time, this means that the inner diameter of the 
macrocycle should be large enough to accommodate an alkyl chain. In the case of an alkyl 
chain threaded inside an cycloalkane ring, different models indicate that the smallest ring size 
possible is between 18 and 22 CH2.23, 24 Experimentally, rotaxanes of this type have been 
detected with rings as small as 21 CH2.25 More recently, high-yielding syntheses of rotaxanes 
with a 21-membered ring have been described where the macrocycle is of crown or benzo-
crown ether type.26 Indirect evidence have also been provided for the threading of an alkyl 
chain in a 20-membered ring.27 It has also been postulated23 that the size of the smallest ring 
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that can be used for making interlocked structures is likely to depend on the strategy used to 
obtain this structure, and that rotaxanes and catenanes with small ring sizes should be more 
easily obtained using ring-closing reactions rather than threading. 
1.1.2.2) Brief history of interlocked structures 
  The possibility of the existence of interlocked structures was admitted in informal 
discussions and seminars but only rarely mentioned in the literature,24 but the first time the 
presence of a catenane was demonstrated, as well as the first occurrence of the word 
“catenane” in the literature, was is an article by E. Wasserman and M. Hill in the Journal of 
the American Chemical Society in 1960.28a Although Wasserman recognised two years later 
that his yield was overestimated,28b this article kindled the interest in these species and the 
exploration of what was called at this time chemical topology.24 However the way these 
interlocked structures were obtained, which is now referred to as the statistical approach, was 
rather inefficient: the catenanes were obtained as byproducts in polymerisation reactions. This 
statistical approach to catenanes and rotaxanes have been the basis of the first works studying 
these new compounds, in particular by G. Schill.23,25 
The first review on chemical topology cited above24 also mentioned some ideas of 
strategies to direct the synthesis of catenanes instead of obtaining them statistically. These 
proposed strategies all involved a temporary binding of the future parts of the catenane, which 
at this time (prior to the development of supramolecular chemistry) meant implicitly covalent 
binding. This kind of “covalent strategy” was applied successfully as early as 1964 by G. 
Schill and A. Lüttringhaus, 29  using a phenyl ring as a central core to which the future 
components of the second ring were successively attached, displaced inside the first ring, 
cyclised and cleaved to yield a catenane (Scheme 1.4). 
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Scheme 1.4. Catenanes obtained by covalent strategy.29 
It was also in the 60’s that the first naturally occurring interlocked structures were 
discovered, with the first observation of catenated DNA.30a It was discovered later that these 
structures were associated with different stages in the replication of DNA, and that catenation 
and decatenation of DNA was catalysed by a family of enzymes known as DNA 
topoisomerases.30b 
The development of supramolecular chemistry in the 1980’s and 1990’s offered new 
possibilities to make interlocked structures: instead of using temporary bonds that have to be 
cleaved, bonds weaker than covalent were used to pre-form the future interlocked structure 
before cyclisation or stoppering. There are now numerous examples of such an approach, but 
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two research teams have dominated this field of research during this period, those of J.-P. 
Sauvage21,31 and of J. F. Stoddart.32 
The work of J.-P. Sauvage used the template effect of copper I ions in the pre-
formation of a complex with two 2,9-disubsitituted 1,10-phenanthrolines. By using a classical 
ring-closing reaction, he was able to obtain an interesting interlocked structure that he called a 
catenate (see Scheme 1.5): it is a complex with a metallic ion, where the ligand (a catenand) 
has the topology of a catenane once it is demetalated.31 Using the same template effect of 
copper with phenanthroline-based ligands, many interlocked structures with different 
topologies were obtained, such as [3]-catenanes,31 doubly interlocked [2]-catenanes,32a 
rotaxanes,32a molecular knots,32a,21a handcuff-like supermolecules, etc.21b 
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Scheme 1.5. Copper-based catenates designed by J.-P. Sauvage and C. Dietrich-Buchecker.31 
The work of the Stoddart group32 evolved from the study of the binding of an organic 
cation, diquat, by benzo-crown ethers in sandwich-like charge-transfer complex, 33  to 
pseudorotaxanes and then naturally to interlocked structures. In a series of 60 articles called 
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molecular meccano and published between 199232d and 2000,32e this team developed a range 
of simple building blocks that constituted a molecular meccano kit, aimed to be used in the 
construction of supramolecular devices and machines using the possibilities offered by 
mechanical bond. It is important to notice that the intention to develop molecular devices 
from interlocked structures was already mentioned in his first article of the molecular 
meccano series.32d 
Interlocked structures were seen for thirty years as pure academic curiosity, and the 
interest of their synthesis was mainly aesthetical, as can be clearly seen by reading the review 
of Sauvage31 cited above. By comparison, the review of Stoddart,32a if it also insists on this 
beauty of interlocked structures, mentioned already “the potential applications that might be 
addressed by incorporating the aspect of entanglement into chemical systems” and evokes in 
its conclusion “the possibility of constructing molecular computers” by using “”devices” at 
the molecular scale”. The work of Stoddart’s group and a few others opened the way to the 
conception of dynamic, informed systems containing mechanical bonds in the last two 
decades. 
The conception of dynamic interlocked systems has developed from two ideas: 
controlling the rotational and translational motion of mechanically bonded molecules, and 
making the formation of this mechanical bond itself reversible. The study of molecular 
motion in catenanes was initiated by the Stoddart group, as illustrated with the molecular 
shuttle34 of Scheme 1.6. Leigh’s group, who previously entered in the world of catenanes with 
what was probably the first high-yielding serendipitous synthesis of a catenane,35a,b have also 
designed and studied molecular devices presenting the possibility of directed motion inside 
catenanes35b-e and rotaxanes.22h ,35f,g 
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Scheme 1.6. Stoddart’s electrochemically and chemically driven molecular shuttle.34 
Fujita’s name, although he was not the first to obtain a catenane under thermodynamic 
control,22a remains associated with what he first called magic ring catenanes,22b-e as the 
interlocking of separate rings may remind one of the conjurors trick of interlocking “magic” 
rings. These first examples used the reversible formation of weak metal-ligand bonds. Other 
magic ring catenanes and rotaxanes were subsequently developed by the Leigh group using 
olefin metathesis.22f-h It was also by using ring-closure reactions under thermodynamic 
control that the Stoddart group finally synthesised Borromean rings (see Scheme 1.7).36 
 
Introduction 
21 
 
 
Scheme 1.7. Stoddart’s dynamic synthesis of Borromean rings.36 
The future of research in interlocked structures will probably involve more practical 
applications. A few recent results show how the particular molecular-scale properties of 
interlocked structures can be used for applications at a macroscopic level. The first will be an 
example, given by Leigh’s group, of how molecular machines based on rotaxanes can be used 
for macroscopic transport. 37  By attaching specially designed photochemically driven 
rotaxane-based molecular shuttles to a surface, it was shown that upon irradiation of these 
rotaxanes, the surface tension was changed, which was then used to move a droplet of 
iodomethane on the surface. The second example is the concept of mechanised nanoparticles 
by Stoddart’s group. 38  Pseudorotaxanes and bistable rotaxanes can be used as actual 
nanovalves allowing the controlled release of molecules imprisoned in hollow nanoparticles 
equipped with these valves. Obviously, one of the possible applications of this technology is 
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in drug delivery. The last example is also given by Stoddart’s group39a and uses molecular 
shuttles in the concept of a 160 kilobit molecular electronic memory. This is probably one of 
the most promising application of rotaxanes as it may give in the future an alternative to 
silicon electronics. Other work carried out today in the field of rotaxanes are clearly aimed at 
being used for the establishment of alternative “bottom-up” technologies in the field of 
computing.39b 
1.1.3) Fluorescence and photochemistry 
1.1.3.1) Overview of fluorescence and photochemistry40 
 The work in this thesis makes it necessary to introduce the notions of fluorescence, 
photochemistry and in particular the photochemical and fluorescence properties of anthracene 
derivatives. Photochemistry is the study of the changes in matter induced by light. In a more 
general perspective, it is the study of the interaction of light with matter. In modern physics, 
light is understood as a flux of elementary particles, photons, which are the force carriers of 
the electromagnetic interaction. As a result, photochemical processes can be understood at the 
molecular level using quantum physics. The absorption of a UV photon by a molecule leads 
to an electronic transition, as one of the electrons of the molecule will be promoted from its 
occupied orbital to an unoccupied orbital of higher energy. As a consequence, the overall 
energy of the molecule will be higher: it is said to be in an excited state. It is for this reason 
that the UV-Vis spectrum of a molecule is sometimes referred to as electronic absorption 
spectrum, in contrast with IR spectrum which corresponds to vibrational spectrum. 
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Figure 1.6. Perrin-Jablonski diagram. 
The different processes that excited states can follow without chemical transformation 
are illustrated in Figure 1.6, which is an example of Perrin-Jablonski diagram. When an 
electron is promoted from the ground state to a higher energy level, its spin remains generally 
unchanged. A state where the total spin number is zero is called a singlet state, and as for 
most molecules the ground state is a singlet state (S0), therefore the excited state formed 
initially by photon absorption is also a singlet state (S1). On the diagram in Figure 1.6 they 
are represented by bold lines, whereas the fine lines above them represent the different 
vibrational states of these electronic states. A molecule in the singlet excited state can relax, 
which means go back to the ground state, by emitting a photon: this phenomenon gives rise to 
fluorescence emission. It can also relax without light emission: in this case, it will first 
undergo an internal conversion (IC) to a higher vibrational state of the ground state followed 
by a vibrational relaxation. But it can also be converted to a state where the spin of the 
electron has changed: this process is called intersystem crossing (ISC) and gives rise to a new 
excited state which is called triplet state (T1). It can relax either by another intersystem 
crossing followed by vibrational relaxation, or less frequently by emission of a photon, which 
in this case is called phosphorescence. 
Apart from these intrinsic relaxation processes, there are other processes40 that an 
excited state can undergo that can happen in the presence of another molecule. It can also 
transfer its charge through either intra- or inter-molecular proton or electron transfer. This last 
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case, known as photoinduced electron transfer (PET), has a role in natural photosynthesis and 
is used in applications using solar energy such as photocells. It can also transfer the energy of 
its excited state to another molecule, either by emission and reabsorption of a photon, which is 
known as radiative energy transfer, or without emission of a photon, a process known as non-
radiative energy transfer, which can occur either through dipole-dipole interaction (which can 
allow to determine the distance between donor and acceptor) or, at close distance only, 
through recovery of molecular orbitals of the donor and acceptor. It has to be noted that this 
last mechanism is the only one that can happen when the excited state that transfers its energy 
is a triplet state. And finally, the molecules in the excited state can be involved in chemical 
transformations. Such chemical reactions that follow the absorption of a photon are called 
photochemical reactions.  
As the molecules in the excited state are highly reactive and/or have a tendency to go 
back to the ground state, the excited states are usually short lived. In the simpler cases, for an 
impulsional irradiation and when there is no equilibrium between different excited states, it is 
possible to define this lifetime. In the case described in the Perrin-Jablonski diagram of 
Figure 1.6, the singlet excited state S1 can relax either by fluorescence, with a rate constant 
kF, or by internal conversion with a rate constant knr, or by intersystem crossing with a rate 
constant kISC. A rate constant for non-radiative relaxation can be defined as knr = kIC + kISC. If 
the concentration of the molecule in this excited state is noted (M*), then it will follow this 
equation as in classical kinetics: 
− '(,∗)'. = (/0 + /1!). (,∗) 
The integration of this equation leads to: 
(,∗) = (,∗)2. 34 
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In this equation, (M*)0 is the initial concentration of this excited state after the 
impulsional excitation, and τ is the lifetime of this excited state, given by the following 
equation: 
5 = 1/0 + /1!  
The fluorescence intensity iF(t) is then given by the following equation: 
70(.) = /0 . (,∗) = /0 . (,∗)2. 34 
 For this reason, it is possible to evaluate the lifetime of the excited state by fitting the 
fluorescence decay with a monoexponential model. In a more general case, the fluorescence 
decay at a given wavelength can be a sum of exponential terms with as many terms as 
different excited states in equilibrium that emit fluorescence at this wavelength, and the 
expression of the lifetime can contain terms other than rate constants of radiative or non-
radiative relaxations, such as rate constants of photochemical reactions. 
The quantum yield of a process (fluorescence, photochemical reaction...) is defined as 
the fraction of molecules in the excited state that follow this process. For example, in the 
simple case described above the quantum yield of fluorescence ΦF, which measures the 
efficiency of the fluorescence as relaxation process, is given by the following equation: 
80 = /0/0 + /1! = /0 . 5 
 In the general case, it is given by the following equation: 
80 = 1(,∗)2 % 70(.). '.
9
2
 
 However, it is usually measured by calculating the integral of the whole emission 
spectrum at a wavelength of excitation λexc and comparing it to a known compound, according 
to the following formula:41 
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Where ΦF,M is the quantum yield of fluorescence of the compound M, IM the integral of the 
fluorescence signal of the solution of M between λexc and +∞, AM is its absorbance at λexc, and 
ns,M is the refractive index of the solvent used for making the solution of M. 
1.1.3.2) Interface with supramolecular chemistry 
 As suggested above in the definition of supramolecular devices, a change in the 
fluorescence or photochemical properties of a molecule or supermolecule upon a specific 
input can be considered as a signal. For example, a molecule whose fluorescence spectrum is 
changed upon binding to a specific guest can be defined as a fluorescent sensor for this guest 
species. This is illustrated with anthracene-tagged azacrown ethers (Scheme 1.8) .42 
O
O
N
O
O
O
fluorescence off
(PET from the N)
O
O
N
O
O
O
fluorescence on
Na
O
O
N
O
O
O
H
Na
H
 
Scheme 1.8. Anthracene-tagged azacrown ether as fluorescent sensor. The fluorescence of the 
anthracene is quenched by electron transfer from the nitrogen when no guest is bound, but 
switched on by the binding of an alkali metal cation42a,b or a proton.42c  
The input itself can also be irradiation: molecules which see their binding affinities to 
a specific guest reversibly modified upon irradiation can be defined as photochromic switched 
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receptors. This is illustrated with a spirobenzopyran derivative used to transport ion pairs 
across membranes (Scheme 1.9). 43 
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Scheme 1.9. A photochromic transporter.43 Upon irradiation in UV of the source phase, the 
spirobenzopyran is opened and its binding affinity with lithium cation is switched on, whereas 
upon irradiation in visible light of the receiving phase, the binding with lithium is switched 
off and the ion pair released in the receiving phase. 
Some other examples of such photochemical devices and others are given above in the 
short review on interlocked structures, and others will be given below in the review on 
“Hamilton-like” receptors. 
1.1.3.3) Photochemical properties of anthracene derivatives 
The second excited singlet state (S2) of anthracene is situated at an energy difference 
of 114 kcal.mol-1 above the electronic ground state (S0), which corresponds to an intense 
absorption band near 254 nm in its UV-visible spectrum (band labelled S0→S2 in 
Figure 1.7).44b Despite its very high absorption coefficient (close to 200 000 M-1.cm-1) this 
band is not usually used in photochemical experiments because this region of the UV 
spectrum normally also contains absorption bands of the photoproducts, whose excitation is 
undesirable.44b The first excited singlet state, (S1) lies at 76 kcal.mol-1 above S0, corresponds 
to a series of vibrationally spaced bands below 380 nm (bands labelled S0→S1 in 
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Figure 1.7).44b Its absorption coefficient is much weaker, close to 9 000 M-1.cm-1, but this part 
of the spectrum is characteristic of anthracene and it is usually at a wavelength corresponding 
to one of these bands that anthracene derivatives are irradiated in photochemical 
experiments.44b In anthracene derivatives, the substituents will affect the level of these energy 
levels. For example, with an electron donating group such as -OR, the absorption band will be 
displaced to higher wavelength and the different bands will be broader and less structured. 
 
Figure 1.7. UV-visible spectrum of anthracene, 2.9 µ 10-5 M in ethanol, at room temperature. 
When a solution of anthracene is irradiated in one of these bands around 350 nm, the 
excited state S1 is obtained. Fluorescence is then observed, with a quantum yield close to 0.3 
(0.27 in ethanol at room temperature).44a The second triplet state (T2) of anthracene lies at 
74 kcal.mol-1 above S0 (2 kcal.mol-1 below S1), and the lowest triplet state (T1) at 42 kcal.mol-1 
above S0.44b The proximity of S1 and T2 means that intersystem crossing from the S1 state to 
T2 is efficient, with a quantum yield of 0.7.44b Furthermore, for many other substituted 
anthracenes it has been established that the sum of quantum yields of fluorescence and of 
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intersystem crossing to the triplet state is close to 1.44b Thus, for many anthracene derivatives, 
the main deactivation process is intersystem crossing and not internal conversion. 
In concentrated solutions of anthracene derivatives, or in solutions of molecules or 
complexes containing two anthracene units, an anthracene in its excited state can come in 
close contact to another anthracene in its ground state, which can give rise to an excimer.40 It 
is a 1:1 complex of two anthracene units, stable in the excited state but not in the ground state. 
It also emits fluorescence, also at higher wavelength (close to 550 nm in a bis-9-anthracene)45a 
than monomeric anthracene (which emits around 430 nm in the same molecule), and with a 
featureless band. It has been shown that the excited state that gives rise to excimer when 
binding to a ground-state anthracene is the S1 singlet state.46b The geometry of this excimer in 
intermolecular formation is a slightly staggered sandwich configuration, but it has been shown 
that when the excimer is formed intramolecularily, different orientations of the anthracene 
subunits can lead to different excimers.46b, 47 
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Scheme 1.10. Photodimerisation of 9-substituted anthracenes. 
As well as excimers, that return to the ground state in a similar way to other excited 
states, anthracene is known to form photodimers, as illustrated on Scheme 1.10.46 It has been 
demonstrated that as for excimer formation, it is the S1 state which is involved in this 
photoreaction.45 There are also good evidences that the photodimer forms from the excimer 
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rather than in competition with it.45 The photodimer can then be reverted to the anthracene 
monomer either by irradiation (typically at 270 nm) or by heating.45 Different substituents on 
the anthracene can lead to different dimers; when the anthracene is substituted on the 9 
position, then two different dimers can theoretically be formed, the head to head dimer (hh) 
and the head to tail dimer (ht).45 These two dimers however have usually very different 
thermal stabilities; with intermolecular dimers, the half-life of ht dimers are usually between a 
few years and thousands of years, whereas the half-life of hh dimers are usually expressed in 
hours.45 However these times of thermal return are usually much more varied in 
intramolecular dimers and can be affected by other chemicals.45 
Anthracenes can also be involved in other photoreactions that will not be mentioned 
here,44b but it has to be mentioned that they are often oxidised to anthraquinone in non-
degased solutions or even in air when not kept in the dark. This is in fact the result of a 
photochemical reaction of the triplet state of anthracene with singlet oxygen, that leads to an 
endoperoxide which later decomposes partly to anthraquinone.44c 
Because of these interesting fluorescence and photochemical properties, anthracene 
groups have been used in the conception of different kinds of supramolecular devices. A few 
examples of theses applications can be given. Anthracene has been used as signalling unit in 
fluorescence probes, for example in the conception of DNA probes48 in order to detect SNPs.* 
On the other hand, anthracene dimerisation has been used to design photocrown ethers45 and 
other cryptands and coronands.49 It has also been used in the synthesis of polyrotaxanes.50 
And as will be explained later, it has also been used in photoswitchable artificial receptors for 
barbiturates (cf. Scheme 1.13).51 
                                                 
*
 SNPs stands for “single-nucleotide polymorphisms”, which designs a variation of a single 
nucleotide in a DNA sequence. 
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1.1.4) Hydrogen-bonded receptors for Barbiturates 
1.1.4.1) Receptors in supramolecular chemistry2 
 A receptor can be defined as a molecule that can selectively bind to an ionic or 
molecular substrate by the mean of diverse intermolecular interactions, leading to the 
assembly of at least two species, a supermolecule. This concept is central in supramolecular 
chemistry and a complete overview of the different kinds of receptors would be out of the 
scope of this thesis. 
Supramolecular chemistry emerged from the study of the selective fixation of alkali 
and alkaline earth metal cations. Crown ethers and cryptates were studied for their ability to 
bind these positively charged, spherical substrates by electrostatic interactions and to select 
them by their size. The binding of spherical anions was later performed in a similar way by 
using polyammonium macrocycles and polymacrocycles. But the binding of non-spherical 
substrates required to develop shape-specific receptors. Hydrogen bonds, with their 
particularity of being directional, became an interesting choice. Their use also made possible 
the binding of neutral molecules by multiple hydrogen bonds. One of the most classical 
receptors for neutral molecules is A. D. Hamilton’s receptor for barbiturates,52 which will be 
described here. 
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1.1.4.2) Barbiturates 
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Figure 1.8. Examples of barbiturates and parent molecules. 
 Barbituric acid was first named by Adolf von Baeyer in 1863 and synthesised in 1864 
by condensation of urea and diethyl malonate.53 Its oxidised parent alloxan was known since 
1818, when it was obtained by oxidation of the natural uric acid using nitric acid.54 Also 
barbituric acid on its own has no effect on the central nervous system, Emil Fischer and 
Joseph von Mering discovered in 190355 that 5,5-diethylbarbiturate (also known as veronal, 
its first commercial name, or barbital as it will be called in this thesis) was a very powerful 
central nervous system depressant. This drug, as well as other barbiturates, was then used for 
applications ranging from mild sedation to anaesthesia, but they were also used as anxiolytics, 
hypnotics and as anticonvulsants. The story of barbiturates from this point is the story of 
psychotropic drug use... and abuse. Also most of their medical use belongs to history as they 
have been replaced by benzodiazepines, they are still drugs of abuse, and most infamously 
used in lethal injections. 
Besides this use, following the publication by A. D. Hamilton of the first synthesis and 
binding studies of a series of new artificial receptor for barbital,52 the synthesis of barbiturates 
has seen a revival for their applications in supramolecular chemistry. 
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 There are different ways to synthesise C-substituted or disubstituted barbiturates 
described in the literature. Also some of the more reactive alkyl halides react directly with 
barbituric acid,56 most do not, and the classical method derives from the historical synthesis of 
barbituric acid53b as it consists in synthesising first a substituted malonate, which is then 
reacted with urea to form the barbiturate (see Scheme 1.11).57 The conditions of this reaction 
were historically using sodium ethoxide in ethanol,57a-c but since then it has been proved that 
the reaction was faster and gave better yields in DMSO, because the side reaction of 
decarbethoxylation57d was either less important or avoided depending on the base used 
(alkoxide or hydroxide). However, side reactions such as saponification and decarboxylation 
could still take place when using these bases.57e The modern syntheses of barbiturates are now 
often performed in DMSO using sodium hydride as a base.57f 
EtO
O
OEt
O
base
R X 2 eq
EtO
O
OEt
O
R R
urea
base
HN NH
O
O O
R R  
Scheme 1.11. Synthesis of disubstituted barbiturates by the classical method, only efficient 
when RX is an alkyl halide. 
There are some drawbacks to this strategy: first introduction on the malonate of 
another substituent than an alkyl, for example an aryl group, can usually not be done by 
nucleophilic substitution. The introduction of aryl groups on the malonate was made possible 
using Friedel-Crafts reactions from diethyl ketomalonate,58a but it was then observed that the 
yields of cyclisation with urea of malonates with bulky substituents were often low,58b 
supposedly because of the side reactions mentioned above.57d The direct introduction of the 
aryl substituents by Friedel-Crafts reaction on alloxan was attempted as early as 1935,58c-d and 
greatly improved in 1999,58e but due to the poor physiological effects of diaryl barbiturates 
compared to their alkyl parents, the synthesis of diarylbarbituric acids remained a rare 
curiosity. This thesis will show that they may have another unexpected practical interest. 
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Some other ways to obtain C-substituted barbituric acids have also been developed, 
that start from barbituric acid. To mention only two, diarylbarbituric acids were also obtained 
by reacting barbituric acid with different aryllead triacetates,59a and dialkyl barbituric acids 
where also obtained by reductive C-alkylation using aldehydes and ketones in the presence of 
platinum and palladium catalysts.59b  
1.1.4.3) Hamilton's receptors 
  Hamilton’s receptors mentioned above52 bind barbital and other barbituric acids by 
forming six complementary H-bonds (see Figure 1.9). Because of the complementarity of 
their structure with the structure of barbituric acids, the binding constants obtained in these 
systems were remarkably high (see Table 1.1) by comparison to other H-bonded systems. 
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Figure 1.9. Hamilton’s receptors complexes with barbital.52 
Table 1.1. Binding constants of Hamilton’s receptors with barbital at 25°C.52 
log(K)  (I)  (II)  (III)  
CDCl3  4.3  6.1   
CH2Cl2   5.8  5.4  
This soon became a classical example of H-bonded receptor to bind neutral molecules, 
as this binding motif was used in many other works. Hamilton’s receptors and all receptors or 
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molecular devices derived from them can be described as consisting of two parts bond 
together: 
• The upper part is a central “bridge” consisting of an aromatic centre, most frequently a 
benzene ring, substituted by two 2,6-diamidopyridine units. The two diamidopyridine 
units are there to form the 6 H-bonds with the barbiturate and the primary role of the 
aromatic centre is to be a spacer between those two units, so this part can be designed 
as the binding motif of the receptors, and is what defines them as Hamilton-like 
receptors. It has to be noted that the aromatic centre of this “bridge” can be different 
from the classical 1,3-substituted benzene of Hamilton’s original receptor: it can bear 
some groups to improve its solubility, or to confer to it a specific functionality that 
would be switched on upon binding. 
• Attached to the two terminal nitrogen atoms of this bridge, we can have either a 
closing loop, or pendant arms, possibly bearing other motifs. This lower part is 
typically what distinguishes two different receptors, modifies their binding affinity 
towards different barbiturates, the geometry and other properties of the complexes, 
and confer to these different receptors their functionalities for different applications. 
 
Figure 1.10. X-ray structure of the complex with barbital of one of Hamilton’s receptors.52b 
It has to be noted that each time crystal structures of the complexes formed with 
different versions of these receptors and barbiturates were obtained, the complexes were 
symmetrical when looked from above as illustrated in Figure 1.10, however the barbiturate 
was not exactly in the same medium plane than the two amidopyridine units but tilted with a 
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small angle, the oxygen of the central carbonyl of the barbiturate being in the medium plane 
and closer to the receptor, as shown in Figure 1.10. The value of this angle however was not 
the same with all receptors. 
Although they were developed to bind specifically barbiturates, these receptors, 
because they possess two donor-acceptor-donor sites, can bind other substrates through H-
bonds with some degree of complementarity. Of course cyanurates (derivatives of cyanuric 
acid, see  Figure 1.8) have the same complementarity as barbital with these receptors and will 
be bonded as strongly, but other substrates with less complementarity will be bonded, such as 
ureas or carboxylic acids. 
It has also to be noted that barbiturates are also involved in other types of 
complementary, H-bonded self-assembled superstructures, notably molecular films formed by 
self-assembly with triaminopyrimidine (as illustrated on Scheme 1.1)6a or melamine 
derivatives,6c which was the basis of many other works in supramolecular chemistry, in 
particular under the direction of J.-M. Lehn2 and G. M. Whitesides.60b,c 
1.1.4.4) Applications of Hamilton-like receptors 
Many supramolecular systems have been derived from Hamilton’s original barbiturate 
receptors. An overview of these systems involving Hamilton-like receptors can be made by 
reviewing the different characteristics and functions of these systems. 
The first applications developed with these receptors were in catalysis.61 Using his 
receptor for molecular recognition and stabilization of transition-state, Andrew Hamilton and 
his collaborators studied the catalysis of phosphoryl-transfer reactions.61a Following this idea 
of mimicking enzymatic mechanisms, reactions between derivatives of these receptors and 
barbiturates that were favored by the suitable prearrangement of the reagents upon binding 
were studied, in the case of thiolysis61b,c and decarboxylation of N-Carboxy-
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imidazolidinone.61d More recently, the synthesis of catalysts containing the Hamilton binding 
motif was envisaged.61e,f 
The next domain of application, also initiated by A. D. Hamilton and his collaborators, 
was to study the changes in fluorescence induced by binding. Energy transfer between 
receptors and barbiturates both tagged with different chromophores was studied, 62 a (see 
Scheme 1.10) and the first article describing fluorescent changes in these types of receptors 
not written by A. D. Hamilton was on the change upon complexation with different guests in 
the fluorescence spectrum of a receptor with two pyrenes attached on the lower part.62b It was 
later observed that Hamilton’s receptors were slightly fluorescent on their own, and this was 
used to design a fluorescent probe where the receptor was incorporated in mixed self-
assembled monolayers (SAMs) of alkanethiolates on gold.62c Other studies of binding 
luminescent ruthenium(II) tris(2,2’-bipyridine) tagged barbiturates have also been made and 
studied for electron transfer, such as the one given as an example in Figure 1.8.62d,e 
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Scheme 1.12. Energy transfer through Hamilton’s multichromophore complexes.62a 
Photoinduced electron transfer (PET) inside a Hamilton-like complex has also been 
studied and used by different groups.63 Barbiturates similar to the one in Figure 1.8 were used 
for this application with receptors tagged with another metal complex on the central aromatic 
bridge.63a Complexes with similar barbiturates and receptors tagged also on the bridge by a 
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methyl viologen group were used more recently to study the PET process itself inside the 
complex.63b Ultra-fast PET was also performed by the Bassani group between receptors 
bearing oligo(thienylene vinylene) groups attached to the arms and fullerene-tagged 
barbiturates.63c Another example of PET with a different fullerene-tagged barbiturate involves 
a central perylene bisimide bearing two Hamilton receptors.63d The PET from a porphyrin-
tagged receptor to a fullerene-tagged cyanurate has also been studied in a more recent article, 
showing that binding different metal ions in the porphyrin allowed to switch between energy 
and electron transfer.63e 
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Scheme 1.13. Photoswitched binding of barbital by anthracene-tagged receptors.51 
After fluorescence and PET, the next step was to use actual photochemical reactions 
inside complexes of this type. The first example51 of such device has been mentioned above in 
the paragraph about anthracene photodimerisation. It was developed in a collaboration 
between the Tucker group and the team of D. Bassani in Bordeaux, and involves a series of 
Hamilton-like open receptors terminated by anthracene groups, that can be reversibly closed 
using anthracene photodimerisation,46 leading to a change in the binding affinity with barbital 
(see Scheme 1.13). Another photochromic device based on Hamilton-like receptors is the 
recent conception of an “ultimate lock-and-key system in which the key unlocks the lock”,64 
that is a complex between a receptor where the closing part is a dithiane or trithane-based 
photolabile module which cleaves only in the presence of an external sensitizer, and a 
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barbiturate bearing this benzophenone sensitizer, so that upon irradiation of the complex the 
receptor closing part is cleaved. 
Another promising work with these receptors in the context of photochemistry is the 
complexation of merocyanine dyes by merocyanine-tagged Hamilton-like receptors, leading 
to the orientation of merocyanines in a head to tail fashion, as wanted for applications in 
nonlinear optics.65 
The idea of binding metallic cations in addition to the barbiturate with Hamilton-like 
systems is encountered in two different works.66 The first of these two articles66a describes a 
Hamilton-like receptor with two triethyleneglycol substituted arms that can bind both sodium 
and barbiturates, and that gives a better binding constant both for sodium and barbiturate 
when the barbiturates also bears a third triethyleneglycol arm to bind Na+ in a cryptate 
fashion. In a more recent article, 66b the binding of zinc (II) ions by the two bipyridine ligands 
covalently bond to a Hamilton-like receptor changes the conformation of its cavity and stops 
it to bind barbital: in this context, the Zn2+ ions are described as negative allosteric co-factors, 
again by analogy with biochemical systems. 
Also his contribution to the world of self-organised systems containing barbiturates 
and cyanurates was mainly based on the conception of molecular films,6 J.-M. Lehn and his 
coworkers have also used the Hamilton motif. The first of his articles to use a Hamilton-like 
receptor (in a competition experiment) are about the dynamic formation and selection of a 
receptor for barbiturates by self-organisation,67 in a dynamic covalent chemistry context. Also 
the receptor formed in this way does not fully belong to the family of Hamilton-like receptors, 
it also possesses two amidopyridine groups oriented towards the barbiturate and forming 4 
complementary H-bonds. The next article68 describes the conformational rearrangement of a 
receptor made by alternating 5 diamidopyridine motifs with 3 isophtalic bridges (which is 
basically the Hamilton motif repeated 3 times) in the presence of barbiturates and cyanurates. 
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The other contributions by this group all deal with supramolecular polymers69 made by self-
assembly of monomers bearing Hamilton-like receptors and/or cyanurate ends (see Scheme 
1.14). The properties of these polymers were studied and it was observed that some of the 
particular mechanical properties of these polymers could be explained by the stacking of the 
H-bonded planes. 
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Scheme 1.14. Supramolecular polymers with cyanurates and H-bonded receptors. 
This last phenomenon had already been used to make gelators70 based on Hamilton’s 
receptors substituted by cholesterol, whose gelation ability changed depending on the solvent 
and upon binding of barbital or other guests. In the same article, it was observed that 
Hamilton-like receptors have a tendency to self-associate by H-bonds, especially in aliphatic 
solvents, often leading to poor solubility. This problem was also encountered by another team 
working on dissolving Hamilton’s receptors in PVC for building extraction devices for 
barbiturates.71a In another article, Hamilton’s receptors were bound to polystyrene in order to 
selectively extract barbituric acid tagged compounds by chromatography.71b 
Another contribution of the Tucker group to the world of Hamilton-like receptors was 
to design receptors where the bridging isophtalic acid was replaced by ferrocene-1,1’ or 
ferrocene-1,3-dicarboxylic acid, in order to perform electrochemical sensing72 (see Scheme 
1.15). This structure was also encountered in another article61e that was already mentioned in 
the applications to catalysis. 
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Scheme 1.15. Electrochemical sensors for barbiturates. 
Chiral versions of the Hamilton’s receptor have also been designed. 73  Receptors 
containing a (R)-BINOL or a modified deoxycholate moiety in the closing part of the receptor 
have been synthesised and used for making asymmetric 1,3-dipolar cycloadditions on achiral 
barbiturate-cinnamic acid conjugates,73a however the enantioselectivities of these reactions 
were quite low, and this was attributed to the fact that barbiturates are not bound in the same 
medium plane than the receptor, so the reacting part of the barbiturate can be far away from 
the chiral moiety of the receptor. Similar receptors also closed by a (R)-BINOL but too small 
to bind barbiturates were used for their versatile H-bonding affinities with many different 
substrates as chiral solvating agents (shift reagents) for chiral discrimination in 1H NMR.73b-e 
Hamilton’s recognition motif has also been attached to polymers, in order to confer it 
binding properties with barbiturate-tagged products.74 It was then applied to bind barbiturate-
tagged nanoparticles to a surface.74c,d Another application in the domain of polymer science 
was the synthesis of polymers tagged with thymine- and cyanurate-, as well as diamino-
pyridine (receptor for thymine) and Hamilton-like receptors (for cyanurates) groups, in order  
to investigate the concept of self-sorting in polymers.74e 
Finally, the Hamilton motif has been used in the conception of dendrimers.75 In the 
first of these articles,75a the Hamilton motif was attached to pre-synthesised amine-terminated 
dendrimers, leading to large dendrimers with 4 to 32 binding sites for barbiturates, then the 
fluorescence properties of these multivalent receptors and their complexes with different 
barbiturates were studied. The six other articles75b-g are all made by A. Hirsch’s group, and all 
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concern supramolecular dendrimers obtained by binding cyanurates tagged with different 
functionalities to a core containing 3 to 6 times the Hamilton motif, as illustrated in Scheme 
1.16. 
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Scheme 1.16. Dendrimers based on Hamilton-like receptors.75b 
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1.2) Introduction to this project 
1.2.1) Initial description and aims of the project 
The project that this PhD thesis starts to explore derives from an observation of a 
property of Hamilton’s receptors and devices derived from them. There are several examples 
of directed synthesis of interlocked structures such as catenanes and rotaxane synthesis where 
the necessary pre-formation was made using hydrogen bonds,22f-h, 35, 76 but to the best of our 
knowledge the Hamilton motif, despite its privileged position in supramolecular chemistry as 
illustrated above, has never been used in generating such interlocked structures, also this idea 
has been evoked as an exercise in Eric Anslyn’s textbook “Modern Physical Organic 
Chemistry”.77 By considering existing crystal structures as the one of Figure 1.10, it was 
thought that using a 5,5’-disubstituted barbituric acid with suitably long appendages, the 1:1 
inclusion complexes formed with a macrocyclic Hamilton-like receptor would see the 
subtituents of the barbiturate protruding from front and back faces of the essentially planar 
receptor because of the geometry imposed by the unique sp3-carbon atom on the otherwise 
planar barbiturate guest. 
 
Scheme 1.17. Strategies for making interlocked structures. 
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This would be potentially conducive to the generation of mechanically-interlocked 
structures, such as catenanes via a ring-closing reaction between reacting groups at the 
extremities of the “arms” of the barbiturate, or rotaxanes by introducing stoppers instead. Or, 
if stoppers are already in place and prevent the formation of the rotaxane by threading 
through the Hamilton receptor, it was thought that another possibility was to use an open 
receptor and to use a ring closure reaction in order to form the rotaxane by clipping, or even to 
use the closed receptor in a magic ring approach. All these different strategies are illustrated 
in Scheme 1.17. 
Another idea which was soon introduced in this work was to use anthracene 
photodimerisation as a ring closure reaction. It had already been used successfully in a 
previous work made by Y. Molard in J. H. R. Tucker’s group that also involved Hamilton 
receptors, as already evoked (see Scheme 1.13).51 A work that was based on introducing 
anthracene groups at the extremities of a Hamilton-like receptor for performing the 
photocyclomerisation of the receptor by anthracene dimerisation, combined with the 
considerations above on the interesting geometry of these complexes, naturally invited to do 
the opposite, that is to introduce anthracene groups at the extremities of a barbiturate and 
perform the photocyclomerisation of the barbiturate, which would lead to a catenane and thus, 
would be a photocatenation. Making photocatenanes using anthracene photodimerisation was 
also envisaged by Dr. N. McClenaghan and his Master student C. Lincheneau in Bordeaux,78 
so a collaboration with this group started on this project. 
If the ring-closing reaction for the final formation of the catenane had to be anthracene 
dimerisation, then if another ring-closing reaction was to be used for the closure of the 
receptor it had to be of a different nature: the choice that was soon made was to use olefin 
metathesis, partly because it was already widely used in the synthesis of interlocked structures 
and as it is one of the simplest reaction that can be performed under thermodynamic control, 
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and partly because in a first time it was thought that the deformations and steric effects 
induced by the binding of a barbiturate in open Hamilton-like receptors terminated by a 
double bond would allow to control the reactivity and stereoselectivity of the ring-closing 
metathesis reaction. This was in fact a part of a larger project of attempting to obtain a form of 
supramolecular control of the reactivity and stereoselectivity in olefin metathesis. Also this 
will not be mentioned later in this thesis, some of the work that I have made during those four 
years and some of the work done by undergraduate students under my practical supervision in 
the laboratory was related to templated olefin metathesis.79 
This research project was started with the intention of filling a gap in the literature, 
that is the formation of interlocked structures derived from Hamilton's receptors. These have 
been suggested previously77 but in fact never synthesised. Providing a new way to obtain 
interlocked structures is always a significant development as there are still relatively few 
general templates to obtain these structures, which may have wide applications in different 
molecular machines in the near future with the development of nanotechnologies.32a,b,c 
Obtaining photocatenanes, that is catenanes resulting from a photochemical process, is 
another important new aim, and anthracene photodimerisation46 is an interesting candidate 
reaction for fulfilling this objective.78 Apart from interlocked structures, the Hamilton motif is 
presently widely used in many different applications.61-72 More experimental data and a 
description of the different aspects of this complexation phenomenon, on both geometric and 
thermodynamic grounds, will allow a better understanding for all future applications of 
similar receptors. 
1.2.2) Design of the molecules 
In order to achieve the aim of obtaining interlocked structures by using the techniques 
described in the above paragraph, the receptors and barbiturates described in Figure 1.11 
were envisaged. In this figure, the barbiturates are represented in their two possible 
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photocyclised forms, and the receptors are represented in their forms closed by metathesis, 
and complexed with barbital.  
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Figure 1.11. Structures envisaged for the barbiturates and receptors. 
Having a double bond in the closing part of the receptor will allow opening and 
closing of the receptors by metathesis. The dimension of the ring in these receptors is directly 
related to the number of CH2 units between the olefin and the C=O. The ring sizes of 
receptors 15 and 16 correspond approximately to the same ring size as A. D. Hamilton’s 
original receptors in terms of atom number (II and III in Figure 1.9).61 Receptor 14 would 
correspond to a smaller receptor. It was thought that it could be more rigid and may have a 
more clearly defined geometry which could yield more easily to interlocked structures. 
The dimension of the anthracene-terminated barbiturates can be related to the number 
of ethylene glycol units in the chain between the barbiturate and the anthracene. Barbiturate 
34 corresponds to a closed ring of 21 atoms, which is presently the smallest ring size for an 
interlocked structure obtained by threading, as discussed earlier.26 Barbiturate 35 is 
significantly larger and as will be discussed below, seems more adapted to the synthesis of 
interlocked structures. 
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As described below, the feasibility of forming interlocked structures is discussed on 
the basis of the relative dimensions of the closed rings, represented by the distances l and L, 
defined as the distance between the central atom of the barbiturate and respectively the first 
atom of the anthracene unit or the first atom of the double bond (see Figure 1.11). This 
distance was measured on molecular models obtained using the MM2 force field in the 
software Chem3D Pro.80 The results are presented in Table 1.2. 
Table 1.2. Dimensions of the rings described in Figure 1.1 according to Chem3D models. 
Receptor L (trans) L (cis) 
14 (n = 4) 5.3 Å 5.7 Å 
15 (n = 6) 7.8 Å 7.9 Å 
16 (n = 8) 9.9 Å 10.5 Å 
Guest l (hh) l (ht) 
34 (n = 3) 9.5 Å 7.8 Å 
35 (n = 4) 13.5 Å 11.1 Å 
If l > L, then cyclisation by dimerisation of the anthracene is more likely to occur 
beyond the receptor ring and the photocatenane will form more easily. According to these 
models, this will be the case for receptor 14 with both anthracene-terminated guests, for 
receptor 15 with both guests (but only if the hh dimer is formed with guest 34), and for 
receptor 16 with guest 35 only. If l d L, then photocyclomerisation will be hampered by the 
presence of the alkyl chain between the anthracene units, leading to slower kinetics or smaller 
yields of catenanes. According to these models, this will be the case for receptor 15 with the 
ht dimer of guest 34, and also probably with the cis form of receptor 16 with the ht dimer of 
35. If l ≪ L, then the anthracene dimer will not form unless it can form inside the receptor 
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ring, essentially leading perched complexes. The models above predict this situation for 
receptor 16 and guest 34. It has to be pointed out that even with l < L, catenanes can still be 
formed if cyclisation occurs on the side rather than at the opposite extremity of the receptor. 
Other receptors and guests have been designed and synthesised in this thesis. The 
rationale for their design and more sophisticated ab initio DFT calculation performed for 
several of these systems will be described in the corresponding chapters. 
1.2.3) Outline of the thesis 
 After this Chapter 1, the introduction to this thesis which reviewed the background of 
the domains touched by this thesis, Chapter 2, the first chapter of results and discussion of 
this thesis will be about the new Hamilton-like receptors designed for this project. In addition 
to their synthesis, this chapter will also study these receptors under different aspects: their 
ability to be opened or closed by olefin metathesis, and their binding properties with barbital 
which will be investigated by different methods, UV absorption, ITC and IR. 
 Chapter 3 will describe a first family of new barbiturates synthesised for this project, 
study their different properties, including fluorescence and photochemistry for the anthracene-
tagged barbiturates. 
 Chapter 4 will study the binding of the barbiturates described in chapter 3 to the 
receptors described in chapter 2, and will investigate the formation of catenanes or rotaxanes 
from these complexes, using olefin metathesis or anthracene photodimerisation. 
 The last chapter of results and discussion, Chapter 5, will introduce a second family of 
new barbiturates synthesised for this project, study their synthesis and the binding of one of 
them with the different receptors. 
 All the experimental results and procedures that are not directly needed for a 
comprehension and discussion of the results exposed in the other chapters but are necessary to 
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reproduce them experimentally are given in Chapter 6, experimental part of this thesis. 
Details of spectra and X-ray structures are given in Appendix. 
 In order to facilitate the reading, a chart of the most frequently mentioned molecules is 
folded at the last page of the thesis. 
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2) NEW RECEPTORS 
2.1) Synthesis 
2.1.1) Design and strategy 
 
Figure 2.1. Design of the new receptors and strategy. 
Three different kind of receptors for barbiturates containing the Hamilton1 motif were 
synthesised: 
• The first kind consists of open, uncyclised receptors substituted with alkyl chains 
terminated by free olefins. They can be obtained by substituting the central bridge 
with two equivalents of an acyl chloride bearing this olefin. 
• The second kind consists of cyclised receptors obtained by ring-closing metathesis of 
the receptors of the first kind. They can exist in two forms, cis or trans which may be 
formed in different quantities depending on the conditions of the metathesis and may 
be difficult to separate. 
New receptors 
59 
 
• The last kind consists of cyclised receptors bearing no double bond. They are formally 
a reduced version of the receptors of the second kind, but can be easily obtained by 
macrocyclisation using the central bridge and a diacyl chloride with a long alkyl chain. 
2.1.2) Precursors 
Br
n OH
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Scheme 2.1. Precursors of the “lower part” of the receptors. 
 For the synthesis of the “lower part” of the receptors (Scheme 2.1), the anhydride or 
the acyl chloride of the substituents were necessary. The pent-4-enoic anhydride (n = 2) and 
the 10-undecenoyl chloride (n = 8) are commercially available, but not the other acyl 
chlorides. Hept-6-enoic acid is commercially available, but not oct-7-enoic and non-8-enoic 
acids 1 and 2, which had to be synthesised from the corresponding bromides by forming a 
Grignard reagent and reacting it with solid CO2. They were obtained in moderate yields (32% 
and 38%). The acyl chlorides were obtained by adding an excess of oxalyl chloride and a few 
drops of DMF as a catalyst to a solution of the acid in DCM. The solvents and reagents in 
excess were then removed by evaporation to afford the products which were used without 
further purification for the next step. The diacyl chlorides used for the synthesis of the 
“reduced” receptors were obtained the same way.  
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Scheme 2.2. Synthesis of the “bridge”. 
 The “upper part” of the receptors was easily synthesised from the reaction of 
2,6-diaminopyridine 7, which in turn was made in quantitative yield from tert-butyl isophtalic 
acid. The “bridge” 8 was obtained in 85% yield after separation by flash chromatography on 
silica gel. 
2.1.3) Uncyclised olefin terminated receptors 
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Scheme 2.3. Synthesis of uncyclised olefin terminated receptors. 
 The “bridge” 8 was reacted with the acyl chlorides described above, using 
triethylamine as a base. The yields of these reactions (see Table 2.1 below) vary from low 
(7% for 11) to high (93% for 12). This variation is probably due to the varying purity of the 
acyl chloride used, as it is purified only by evaporation of the byproducts. 
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Table 2.1. Yields of uncyclised receptors. 
Receptor n Yield Using… 
9 2 23% 4-pentenoic anhydride 
10 4 56% 6-heptenoyl chloride (obtained from 6-heptenoic acid) 
11 5 7% 7-octenoyl chloride (3) synthesised in 2 steps from 7-bromohept-1-ene 
12 6 93% 8-nonenoyl chloride (4) synthesised in 2 steps from 8-bromooct-1-ene 
13 8 66% 10-undecenoyl chloride 
 
2.1.4) Ring-closing metathesis 
 The closing of these open receptors by metathesis had to be performed with a catalyst 
tolerant to the functional groups present in the receptors and barbiturates. The Grubbs’ 1st 
generation catalyst has been proven to be tolerant to reactants containing amide subunits,2 but 
the particular case of barbiturates (which are more acidic than other amides) was uncertain: in 
order to verify if Grubbs’ 1st generation catalyst was active in the presence of a barbiturate, 
the ring-closure metathesis of diallyl-diethyl-malonate in the presence of 1 equivalent of 
barbital was attempted (see Scheme 2.4). The NMR of the crude at the end of the reaction 
revealed that the reaction was complete, confirming that Grubbs’ 1st generation catalyst was 
tolerant to barbiturates. 
O
OO
OO
OO
O
Grubbs 1, 10%
1eq. barbital
DCM,
2h reflux
>95% by NMR
 
Scheme 2.4. Ring-closure metathesis of diallyl-diethyl-malonate in the presence of barbital. 
There are also very few examples of the use of this catalyst with compounds 
containing a pyridine subunit where the lone pair on the nitrogen is free to compete with the 
phosphine ligands binding to the ruthenium centre of the catalyst. Some examples were found 
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where the lone pair of a pyridine nitrogen was involved in coordination to a copper3  or 
platinum4 cation, but only few references were found where olefin metathesis was used for 
ring-closure metathesis with non-complexed pyridine subunit. 5 ,3b However in these two 
articles the nitrogen bearing a non-complexed lone pair could be considered as sterically 
protected. Consequently, it was uncertain whether cyclisation was possible with Grubbs’ 1st 
generation catalyst in the absence of the barbiturate guest. 
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Scheme 2.5. Synthesis of the “closed” receptors by metathesis. 
In order to verify whether the ring-closing metathesis reaction was going to work, a 
trial cyclisation was carried out, in the absence and in the presence of 1 equivalent of barbital. 
A small volume of solution of uncyclised receptors 9, 10, 12 or 13 or their 1:1 mixture with 
barbital, at a concentration of 3 mM, with 10 mol% of Grubbs’ 1st generation catalyst, was 
heated to reflux during 2 hours, then the solvent was evaporated and the reacting mixtures 
were then directly analysed by NMR and mass spectrometry. Figure 2.4 shows a region of the 
1H NMR spectrum for this experiment with 13 in the absence of barbital: the signals at 5.80 
(a) and 4.96 ppm (b & c) corresponding to the terminal olefin of the starting material have 
almost disappeared whereas a new ethylenic signal appears at 5.25 ppm. These changes are 
consistent with the formation of cyclised product 16 as the main product. However, it is 
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possible that small amounts of solid that did not dissolve in CDCl3 were polymeric or 
oligomeric material obtained by intermolecular metathesis. 
 
Figure 2.4. 1H NMR of the receptor with n = 8 in CDCl3 before and after metathesis, 
in the absence of barbital. 
By comparing the integration of this new signal with remaining signals of the 
uncyclised receptor in each experiment, it was possible to measure how much cyclised 
product was obtained if we assume that no polymerisation or oligomerisation occurred. 
Finally, for the actual synthesis of 14, 15 and 16 the cyclisation was made on a larger scale 
and the products were separated by flash chromatography and obtained as mixtures of cis and 
trans isomers (as shown by 13C NMR, vide infra). The results of these experiments are given 
in Table 2.2. 
  
4.60
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Table 2.2. Yield and product distribution of the cyclised receptors obtained by metathesis. 
n Starting uncy-
clised receptor 
Product Measured 
yield (NMR) 
Isolated yield after 
chromatography 
cis / trans in 
isolated product 
2 9 (no product) º0% (not isolated) (not applicable) 
4 10 
10 + barbital 
14 
14 + barbital 
>95% 
10% 
44% 68 / 32 
6 12 
12 + barbital 
15 
15 + barbital 
>85% 
>85% 
39% 79 / 21 
8 13 
13 + barbital 
16 
16 + barbital 
>95% 
>95% 
73% 66 / 34 
 When starting from 9, no cyclised product was obtained and only starting material was 
observed by 1H NMR. As no insoluble solids were observed, this could be a good evidence 
that there are no effective competing intermolecular processes. The ring can probably not 
form with n = 2 because the distance between the two double bonds, imposed by the large 
aromatic groups, remains too large for cyclisation, although molecular models obtained using 
the MM2 force field in the software Chem3D Pro6 suggest that the formation of this small 
ring is still possible. Another explanation for the difficulty of this reaction is that the  short 
distance between the C=O and the double bond may result in deactivation of the intermediate 
formed through the formation of a Ru-O coordinative bond (see Scheme 2.6). 
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Scheme 2.6. Possible deactivation of the Grubbs catalyst when reacting with 9. 
As the cyclisation did not work with 9 alone, it was not tried in the presence of barbital. For 
the larger compounds 10, 12 and 13, the corresponding cyclised receptors were formed, in 
high yield according to the 1H NMR spectra of the crude mixtures, but the isolated yields after 
chromatography were lower. It was interesting to note that when 1 equivalent of barbital was 
added to 10, the cyclisation by metathesis was hampered; only 10% of cyclised product was 
observed by metathesis, the origin of which probably comes from the unbound receptor which 
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is in equilibrium with the complex in solution. This result can be explained by steric reasons; 
presumably the bound guest prevents the two terminal double bonds from coming into close 
proximity. 
 The determination of the cis/trans ratios (Table 2.2) was estimated by 13C NMR since 
the 1H NMR spectra of these receptors did not show any evidence for a mixture of two 
isomers, also this was not the case for the 1H spectra of some of the complexes with 
barbiturates other than barbital where some evidence of this was observed (see Chapters 4 
and 5). In constrast, the 13C NMR spectra of these receptors clearly gave two distinct peaks of 
different intensity for many of the carbons. For each different carbon it was difficult to 
unambiguously determine which one belonged to the cis or the trans product, but the ratio 
between the smaller and the bigger peaks remained approximately constant for each carbon. 
However, according to a simulation using ChemNMR,7 the CH2 carbon closest to the double 
bond should appear at a different chemical shift depending on the configuration of the double 
bond: 27.3 ppm if the double bond is cis and 33.3 if it is trans. Indeed this is what was 
observed by NMR (cf. Chapter 6 for the detail of the spectra). Assuming that the ratio 
between the NMR signals of two carbons at the same position on each isomer of the molecule 
was proportional to the ratio of their concentrations, this average ratio was calculated as well 
as the standard deviation, which gave an uncertainty value close to 10%. We can conclude 
from this that the main product of these ring-closing metatheses is the cis isomer in each case. 
They were not separated and in the rest of this thesis they will be considered as one product, 
except when obviously an effect of the presence of two different isomers can be observed. 
In order to assess the order of magnitude of the fluorescence of these receptors, the 
fluorescence quantum yield of receptor 16 was measured by comparing the integral over all 
wavelengths of its emission spectrum for an excitation wavelength of 324 nm with the 
emission spectrum of an anthracene solution in the same conditions. The description of this 
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method is given in Chapter 6, as well as a figure showing the large difference  between the 
low intensity of the emission of receptor 16 compared to anthracene. An experimental 
fluorescence quantum yield of ΦF = 0.008 was obtained. The study showed that these 
receptors are only very weakly fluorescent, as is the case with most pyridine-containing 
compounds in non protic solvents where the relaxation process that dominates by far is 
intersystem crossing.8 
2.1.5) “Reduced” receptors 
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Scheme 2.7. Synthesis of “reduced” receptors. 
 Finally, the so-called “reduced” receptors were synthesised by macrocyclisation, 
through the simultaneous addition to the solvent of a solution of 8 containing two equivalents 
of triethylamine, and a solution of the diacyl chloride 5 or 6. The yields were only moderate 
(37% and 18% respectively for 17 and 18), as is often observed in macrocyclisation, where 
intermolecular reactions compete with the formation of the macrocycle. 
 In attempts to crystallise the complexes of these receptors with the barbiturate 39 (see 
Chapter 5), our colleagues N. McClenaghan, B. Kaufmann and J.-P. Desvergne from the 
University Bordeaux 1 (France) obtained good crystals of the receptors which allowed them 
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to determine the structures of these receptors in the solid state by X-ray diffraction. These 
structures are represented in Figure 2.5, and more details are given in Appendix 1. 
 
Figure 2.5. Structures of 17 (left) and 18 (right) in the solid state, as determined by XRD. 
 The structure of 18 is similar to Hamilton’s receptors;1 the “bridge” part is nearly 
planar with the two diamidopyridine subunits facing each other, making the binding motif 
nearly planar. However, 17 is not as planar and the two diamidopyridine units are separated 
by an angle of 35°, which makes it less complementary to the structure of barbituric acids. 
 
Figure 2.6. Crystal structure of 18 in the solid state along the 3 axes. 
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 The crystal structure of 18 (Figure 2.6) also shows that in the solid state, the receptors 
are H-bonded to each other and form large sheets (perpendicular to the c axis of the cell) with 
the alkyl chains and tert-butyl groups on the outside. Along with other observations made by 
NMR (the NH signals in the 1H NMR spectrum were found to change their chemical shift 
slightly depending on the concentration) and ITC (see below), this indicates that these 
receptors can probably aggregate to some extent in solution at high concentrations, a property 
that they share with other Hamilton-like receptors.9 
2.2) Binding studies with barbital 
2.2.1) Titrations followed by UV-vis spectrometry 
 
Figure 2.7. Variation of the corrected absorption spectra during the titration of 18 (2.5.10-5 M 
solution in DCM) with barbital (0 to 3 equiv.), at room temperature. 
The binding constant of each receptor with barbital was measured by UV absorption, 
by monitoring the change in the pyridine band of each receptor (around 300 nm) in the 
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presence of increasing amounts of barbital (see Chapter 6 for further information). Whereas 
for all the receptors the maximum of absorption of the pyridine was close to λmax = 298 nm, 
for the complexes with barbital it was close to λmax = 303 nm and εmax was (depending on the 
receptor) either slightly bigger or smaller at this new maximum. Therefore the shape of the 
band changes as more complex is formed in solution (see Figure 2.7). 
Table 2.3. log(K) for the formation of 1:1 complexes with barbital, obtained by UV titration 
in DCM at rt. 
Receptor n log(K) Margin of error 
10 4 4.70 0.02 
12 6 4.58 0.02 
13 8 4.66 0.04 
14 4 3.69 0.05 
15 6 5.09 0.03 
16 8 5.52 0.01 
17 4 3.99 0.05 
18 6 5.79 0.03 
The data were treated with the software Letagrop10 assuming that only 1:1 complexes 
could form, and the results are presented in Table 2.3. The errors are those given by the 
Letagrop software used to make the calculations from the UV data. 
We can see that the binding constants are approximately the same for all the 
uncyclised receptors 10, 12 and 13 (log(K) º 4.65 ± 0.09). For the closed receptors however, 
the binding constants are very different: they are lower than in the open form for the two 
smaller receptors 14 and 17 (even if this last value is not certain, see below), and higher for 
the larger receptors 15, 16 and 18. Having a higher binding constant in the closed form was 
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also found with Hamilton’s receptors1 and can be understood in terms of the macrocyclic 
effect.11a 
For the smaller receptors 14 and 17, the X-ray structure of 17 suggests an explanation. 
The short alkyl linker forces the binding motif to adopt a conformation which is not 
favourable to the formation of 6 complementary hydrogen bonds with barbital, and possibly 
even prevents it from adopting a conformation similar to that of the open receptors. In the 
case of receptor 17, it was difficult to obtain a good fit with this software for a 1:1 complex 
with the values of absorbance obtained. The result in Table 2.3 was obtained after removing 
the last spectrum obtained with 115 equivalents of barbital which was clearly not passing 
through the isosbestic point (see Chapter 6). Considering the X-ray structure, it was 
considered that the two amidopyridine units which are not facing each other could be 
considered as two separate binding sites. In which case, barbital may bind through only three 
H-bonds, occupying only one binding site, and leaving the other to eventally bind another 
barbital molecule and form a complex with two barbital molecules. A better fit was obtained 
when assuming that both a 1:1 and a 2:1 complex could form, but the error in each result was 
larger. The obtained results were: 
 17 + barbital    17∑barbital  log(K1)    =   4.2 ± 0.2 
 17 + 2.barbital   17∑(barbital)2  log(K2)    =   7.2 ± 0.3 
The binding constant for the binding of a second barbital to the first complex formed is: 
 17∑barbital + barbital  17∑(barbital)2  log(K2/K1) = 3.0 ± 0.5 
If the two binding sites were similar and independent, there would be a difference between K1 
and K2/K1 which would be explained only by statistical considerations. It can be easily 
demonstrated12 that for a statistical effect K2/K1 = K1/4. If we write (F) for concentration (in 
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mol.L-1) of free sites and (O) the activity of occupied sites, and if we note the receptor 17 as 
R, barbital as B, and the 1:1 and 2:1 complexes as R∏B and R∏B2 respectively, we would have: 
(F) = 2.(B) + (R∏B) 
(O) = (R∏B) + 2.(R∏B2) 
If the barbital could bind on both binding sites in a similar way, then it could be possible to 
define a binding constant K for this binding site, and we would have at equilibrium: 
 =
()
(). ()
 
By replacing (F) and (O) by their expressions as a function of the concentration of actual 
species, and then replacing (R∏B) and (R∏B2) by their expressions as a function of K1, K2, (R) 
and (B), this expression is obtained: 
 =
	 + 2. . ()
2 + 	. ()
 
As according to our starting hypothesis K is a constant, it should not depend on (R) which can 
be replaced by zero or any value. This leads to the conclusion: 
	 = 2.  

	
=

2
=
	
4
 
In our case, log(K1/4) = 3.6 and log(K2/K1) = 3.0 so we observe that K2/K1 < K1/4. Therefore, 
as could be reasonably expected for steric reasons, it is more difficult to bind the second 
molecule of barbital than the first. 
2.2.2) Titrations followed by ITC 
The binding of some of the receptors with barbital was also studied by ITC. The 
procedure followed is described in the experimental part (Chapter 6). The results of a first 
titration of receptor 18 with barbital using this method at 0.1 mM are shown in Figure 2.8. 
The negative slope is unexpected in a simple binding curve. However if these initial data 
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points are removed and if the initial concentration is corrected in order to obtain a calculated 
value of n = 1 at the equivalence, it is possible to obtain a good fit with the data and to obtain 
a calculated value for the binding constant and associated thermodynamic parameters: 
log(K) = 5.46 ± 0.03, ∆H° = -14.59 ± 0.13 kcal.mol-1, ∆S° = -24.0 ± 0.5 cal.mol-1.K-1.  
A repetition of the experiment using the same concentrations gave very similar results 
(with the same negative slope at the beginning, and similar calculated concentration / binding 
constant / thermodynamic parameters within a 5% margin of error). 
 
Figure 2.8. Titration of 18 by barbital at 0.1 mM: crude (left) and fitted after removing the 
first points (right). 
 By UV titration, the binding constant was evaluated as log(K) = 5.79. This is a 
different value but the order of magnitude remains the same. The negative slope observed at 
the beginning can be explained by an aggregation process.9 If we consider that a dimer of the 
receptor is forming at high concentrations in DCM, then this negative slope would correspond 
to the displacement of the dissociation equilibrium in the direction of the monomer induced 
by the dilution and the binding of barbital to the monomer (see Scheme 2.8, note that the 
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log(K) ≃ 5.0. The negative slope is no longer visible, as expected if this was really due to 
aggregation as explained above. 
Finally the  titrations were all made at an intermediate concentration (0.05 mM, see 
Figure 2.9) where the signal/noise ratio is reasonable and the negative slope in the first few 
data points is not seen. The results of these titrations are given in Table 2.4. 
Figure 2.9. Titration of 18 with barbital at 0.02 and 0.05 mM. 
Table 2.4. log(K), ∆H° and ∆S° of 1:1 complexation with barbital measured by ITC in 
dichloromethane at 25 °C (298 K). 
receptor n log(K) ∆H° / kcal.mol-1 ∆S° / cal.K-1.mol-1 
12 6 4.43 ± 0.02 
 
-17.0 ± 0.8 -37 ± 3 
16 8 4.85 ± 0.03 
 
-15.5 ± 0.4 -30 ± 1 
17 4 3.91 ± 0.03 
 
-8.0 ± 0.3 -8.9 ± 0.8 
18 6 5.33 ± 0.07 
 
-15.0 ± 0.2 -25.8 ± 0.8 
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The errors given in Table 2.4 are those given by the Origin software used to make the 
calculations from raw ITC data. The first observation that can be made is that the binding 
constants found with this method are of the same order of magnitude as those found by 
UV-Vis (Table 2.3), even if the values found by ITC are generally slightly smaller. This is 
likely to be an indirect consequence of the phenomenon of autoassociation of the receptors 
described above. For this reason, these values are probably less reliable than those found by 
UV-Vis titrations (Table 2.3), which were performed at a lower concentration where 
aggregation is less important. However, it can also be observed that when the log(K) of 
different complexes are compared to each other, similar trends are observed in the results 
obtained by ITC and UV-Vis titrations. Therefore, although there is a certain degree of 
uncertainty in these ITC results, it is still interesting to use the measured value of ∆H° and 
calculated ∆S° in order to explain these trends. 
It can be seen that the values of ∆H° and ∆S° obtained by ITC for the binding of 
barbital to the two “closed” receptors 16 and 18 are very similar. The comparison between the 
enthalpic and entropic terms differences between the two complexes reveal that the 
augmentation of the binding constant with barbital from 16 to 18 is explained by the entropic 
term: From 16 to 18, ∆(∆H°) = 0.5 ± 0.6 and ∆(-T.∆S°) = -1.3 ± 0.5 kcal.mol-1, so it is the 
bigger entropic term that determines the negative sign of ∆(∆G°) and makes the barbital bind 
more strongly to 18 than to 16. The same observation can be made between the open receptor 
12 and its closed, reduced formed 18: From 12 to 18, ∆(∆H°) = 2.0 ± 1.0 and 
∆(-T.∆S°) = -3.3 ± 1.1 kcal.mol-1, so once again it is the entropic term that determines the 
negative sign of ∆(∆G°) and makes the barbital bind more strongly to 18 than to 12. 
It is important to note that the observation of higher binding constants for closed 
“Hamilton-like” receptors compared with their open forms (i.e. the macrocyclic effect11a) does 
not result in a ready explanation for the enthalpic or entropic nature of this effect. Studies on 
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the binding of metallic cations by crown ethers have shown that this effect is often related to 
favourable enthalpic changes but that there are also cases where it is the entropic term that 
explains it.11b-c An enthalpic contribution to the macrocyclic effect can be understood if a non-
cyclic receptor has to adopt a conformation which is different from its own minimal energy 
conformation, a change that will add a positive term (unfavourable to binding) in the 
expression of ∆H°, whereas in the cyclic receptor, this unfavourable contribution is already 
paid for as the receptor already has the desired conformation for binding. This may be the 
correct explanation for the macrocyclic effect observed with the original Hamilton receptors, 
which do not have any other substituents than diamidopyridine on the central bridging 
benzene ring.1 Other work with “Hamilton-like” receptors have demonstrated that the 
preferred conformation of similar open receptors is not the one favourable to 
complexation.13a-c However in our receptors, there is a tert-butyl group, and other work13c,d 
suggests that having a bulky substituent in this position can restrict conformational freedom 
and contribute to the pre-organization of the uncyclised receptor for binding barbital. 
On the other hand, an entropic contribution to the macrocyclic effect can be 
understood if the open receptor has to lose conformational freedom in order to bind the guest, 
whereas the cyclic one does not have to lose as much conformational freedom as it is already 
restricted. This is probably the dominant effect here. The opposite changes in ∆H° may be 
understood as a case of entropy-enthalpy compensation 14  (see Chapter 1), as a linear 
relationship of the kind ∆H° = α + TC.∆S° can be verified with TC = 182 K and α = -10.2 
kcal.mol-1, but the margin of error on the data and the small number of values used for the 
regression will not allow a statistical verification of this model. 
Finally, for the complex with 17, it was difficult to obtain a good fit as reflected by the 
high margin of error in the results. This may be because the model used for fitting only 
considered the formation of the 1:1 complex and not the 2:1 complex. The difference with 18 
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is explained mostly by enthalpic reasons, as ∆H° changes in the direction of a weaker binding 
(∆(∆H°) = + 7.0 kcal.mol-1) which makes the value of ∆H° nearly two times smaller than that 
for 16. This is what would be expected if 17 binds barbital with only three hydrogen bonds 
instead of six. The absolute value of ∆S° has decreased by an even bigger factor, which makes 
that the term -T.∆S° partly compensates the variation in ∆H° (∆(−Τ.∆S°) = - 4.6 kcal.mol-1). 
Again, if we consider that barbital is bound only on one side by three hydrogen bonds instead 
of six, then it has more freedom of motion in the complex, which will add a positive 
contribution to ∆S°. 
Another positive contribution equal to R.ln(2) = 1.38 cal.K-1.mol-1 has to be added.12 
Its origin is statistical: as barbital can bind to the two binding sites, it is possible to consider 
the binding constant Ks and the thermodynamic parameters ∆X°S for each binding site, and 
compare with the values KC and ∆X°C for the 1:1 complex.  Then if we note (S) the 
concentration of free site, (B) the concentration of barbital, (R) the concentration of the 
receptor 17 and (C) the concentration of the complex, we have: 
 =
()
(). ()
 
() = 2. () ⟹   =
()
(). ()
= 2.  
∆G°S = -R.T.ln(KS) = -R.T.ln(KC) - R.T.ln(2) = ∆G°C - R.T.ln(2) 
As ∆H°C represents the binding strength of barbital to the complex, it is equal to ∆H°S for one 
of the two binding sites, however ∆S°C and ∆S°S will be different. The equation above will 
then be simplifed to ∆S°C = ∆S°S + R.ln(2), which makes the term R.ln(2) apparent. It can be 
concluded that these thermodynamic parameters are in good agreement with the formation of 
a 1:1 complex between 17 and barbital through three hydrogen bonds only, on one only of the 
two binding sites accessible to barbital. 
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2.2.3) Comparison of ab initio models, IR spectra and XRD structures 
 This work was done at the Pôle Modélisation of the Institut des Sciences Moléculaires 
(University Bordeaux I, France) by Dominique Cavagnat and Thierry Buffetau with the 
products synthesised in Birmingham, using a methodology developed by their group.15 Ab 
initio models of 17, 18, barbital and their complexes were calculated (see Figures 2.10 and 
2.11 for the models of the complexes, and Chapter 6 for experimental procedures). 
 
Figure 2.10. Ab-initio model of 17∑barbital. 
 
Figure 2.11. Ab-initio model of 18∑barbital. 
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The first observation on these models is that the general shape and conformation of 
both of 17 and 18 in the complexes are remarkably similar to what was seen on the X-ray 
structure of the receptors. However, the models of the receptors without barbital were 
different, especially the model of 18 where the same relatively large angle was observed 
between the planes of the two diamidopyridine moieties. According to the models of the 
complexes, 18 should bind barbital in a similar way to Hamilton’s receptors by forming six 
complementary H-bonds, the barbital being in the middle of the cavity and the complex nearly 
symmetrical. It can also be observed that barbital is not entirely in the same medium plane as 
the two amidopyridine units: the oxygen atom of the central C=O is between the two amide 
that bind it, in the medium plane, but the rest of the molecule is tilted out of this plane with an 
angle of 35°. This means that one of the two ethyl groups of barbital is threading in the 
receptor while the other is entirely outside. However 17 should bind barbital through three 
H-bonds only, the barbital remaining outside of the cavity. Such a complex is obviously not a 
good basis for making interlocked structures. It is also clear that one of the diamidopyridine 
binding sites is still able to bind a second molecule of barbital. Calculations of ab initio 
models for this 2:1 complex are still ongoing. 
Theoretical IR spectra of the single molecules and the complexes were then calculated 
from these models. A comparison between simulated and experimental IR spectra (see Figure 
2.12) allow us to verify whether these models are in good agreement with experimental 
observations, with a few restrictions: the C-H vibrations may be different as Fermi resonances 
are not simulated with this model,15a and the intermolecular interactions (other than inside the 
complex) are not considered as the model is one of a molecule or complex “alone”. This is 
what makes the experimental spectrum of barbital alone so different from its theoretical 
spectrum, as probably intermolecular hydrogen-bonds are forming at this concentration. The 
intensities of the C=O vibration bands are also difficult to predict because of the possible 
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hydrogen bonds to the solvent (chloroform). For the same reason, the experimental spectra of 
the 1:1 mixtures (at 5 mM) contain a very weak band at 3422 cm-1 that indicates the presence 
of a small amount of free receptor. 
 
 
Figure 2.12a. Comparison of experimental and calculated IR spectra for barbital, “reduced” 
receptor 18 and their complex. 
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Figure 2.12b. Comparison of experimental and calculated IR spectra for barbital, “reduced” 
receptor 17 and their complex. 
Knowing these restrictions, it can be observed that nevertheless for the complex of 
barbital with receptor 18, there is a very good agreement between the calculated and 
experimental spectra, confirming that the 1:1 complex is probably formed. For the complex 
with 17, the calculated and experimental spectra are also in relatively good agreement, 
however there are some features of the experimental spectrum that may indicate the presence 
of another complex. In particular, there is a shoulder at 3383 cm-1 in the spectrum of the 
complex with 17 which is absent from the theoretical and experimental spectra of 17 and 
therefore is not due to unbound receptor, but is also absent in the theoretical spectrum of the 
complex. This, combined with the lower intensity of the band at 3325 cm-1 compared to the 
complex with 18 probably indicate the presence of another 2:1 complex. The second barbital 
involved in the complex exhibits weaker hydrogen bonds with 17 since the new band appears 
at higher wavenumbers. This is consistent with the second binding constant from the UV data 
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being lower than expected from statistical considerations alone. This feature can also explain 
the lower intensity of the band observed at 1525  cm-1 (associated with the bending modes of 
the N-H groups hydrogen bonded with C=O of Barbital) for the complex with 17 (see the 
comparison of experimental spectra in Figure 2.13). 
  
Figure 2.13. Comparison of experimental spectra of 1:1 mixtures of receptors 17 or 18 with 
barbital, and changes attributed to the 2:1 complex of 17 with barbital. 
 Finally, crystals of the complex of 18 with barbital were obtained by our colleagues 
from University Bordeaux 1, allowing them to determine the solid-state structure of theses 
complexes in the solid state by X-ray crystallography. The structure obtained is complex, with 
two slightly different complexes being present in the unit cell. One of these structures is 
presented in Figure 2.14 and more details are given in Appendix 1. It is interesting to note that 
this structure is very close to the one predicted by ab-initio models, and strongly supports the 
feasibility of interlocked structures from similar complexes. 
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The different thermodynamic parameters obtained here may also lead to the 
conception of better receptors for barbiturates. It has been demonstrated that the size of the 
ring for obtaining a correct conformation for 1:1 complexes only and for obtaining an 
appropriate shape for interlocked structures is a crucial parameter. A poor binding and more 
difficult ring closing can also be related to the size of the ring. The importance of steric 
effects influencing preorganization through bulky substituents placed on the central benzene 
moiety opposite the binding site has also received a support from the interpretation of ITC 
results. Although the cis and trans isomers of the double-bonded closed receptors have not 
been separated, binding with barbital has not been shown to be noticeably different with these 
mixtures of isomers compared to single receptors. 
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3) NEW FLEXIBLE BARBITURATES 
3.1) Synthesis 
3.1.1) Design and strategy 
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Scheme 3.1. Flexible barbiturates 34, 35, 36 and 37. 
In order to form interlocked structures with “Hamilton-like” receptors, our first 
approach, which will be referred to as the “flexible barbiturate approach”, was to synthesise 
barbiturates substituted on the central carbon by two long, flexible chains terminated either by 
a stopper, or a reacting group. It was thought that if the terminal group was small enough to 
thread through a closed receptor, then a pseudo-rotaxane would be accessed, which would 
lead to a rotaxane by a stoppering reaction or a catenane by a ring-closing reaction. 
Alternatively, if its bulkiness would stop it threading through the cavity of a closed receptor, 
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then a rotaxane would be accessed either by binding it to an open receptor that could be 
closed by metathesis, or by using a “magic ring” approach.* 
The strategy adopted to synthesise the stoppered guests was to synthesise the 
stoppered chain as a bromide or iodide first, and then to use it to make a disubstituted 
malonate that would be finally converted to a barbiturate using a procedure described in the 
literature.1 The “flexible barbiturates” synthesised here are described in Scheme 3.1. In order 
to facilitate the reading of this chapter, their structures are also described on the chart folded 
at the last page of this thesis. The first barbiturates (34 and 35) were independently designed 
by C. Lincheneau and N. McClenaghan in Bordeaux,2 before we merged our projects. They 
bore tri- or tetra-ethylene glycol arms terminated by anthracenes, in order to perform a ring 
closure using anthracene dimerisation.3 The chain lengths were chosen on the basis of the 
models discussed in Chapter 1 (pp. 45-48). Another barbiturate with a tetraethylene glycol 
arm terminated by a trityl group (36) was later synthesised because of the difficulties posed by 
anthracene (see below). Finally another barbiturate with an alkane chain terminated by a free 
olefin (37) was synthesised, in order to obtain a catenane by threading through one of the 
“reduced” receptors (17 and 18) and then performing a ring closing metathesis to form the 
catenane. Its chain length is slightly shorter than that of 34, and will lead after ring-closing 
metathesis to a 19-membered ring, which is smaller than what has already been obtained for 
interlocked structures, but not theoretically impossible if the strategy adopted is clipping 
rather than threading (see discussion in Chapter 1, pp. 15-16).4 
                                                 
*
 This means an approach based on the equilibrium of open and closed forms of the receptors 
under the conditions of metathesis, cf. Chapter 1 and references therein. 
New flexible barbiturates 
88 
 
3.1.2) Malonate precursors 
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Scheme 3.2. Synthesis of the precursors 25 and 26 to the anthracene-substituted malonates 30 
and 31. 
 The synthesis of the iodo- pendant arms 25 and 26 of the anthracene-substituted 
barbiturates 34 and 35 was achieved by reacting a large excess of a diiodide, itself easily 
synthesised in two steps from tri- or tetra-ethylene glycol, with anthrone in a mixture of THF 
and water at reflux. This last reaction had to be performed in the dark (by covering the 
reacting flask with foil) in order to avoid anthracene photooxidation to anthraquinone, which 
would occur even in presence of trace amounts of oxygen. The anthracene-substituted arms 
were then isolated by column chromatography on silica gel. The yields after column 
chromatography were relatively poor and difficult to reproduce for two reasons: 
• An excess of diiodide was used to avoid forming too much of the undesired di-
anthracene substituted product, but this caused cracks in the silica and dispersion of 
the products on the column; 
• As mentioned above, anthracene derivatives are easily oxidised in air in the presence 
of light and anthraquinone as well as hydroxy-iodo-arms were obtained as byproducts. 
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Scheme 3.3. Synthesis of the precursor to malonate 32. 
 The iodo-pendant arm 29 of the trityl-substituted barbiturate 36 was synthesised in 
53% yield by reacting one equivalent of trityl chloride with tetraethylene glycol and isolating 
the mono-trityl ether from the mixture by chromatography. It was then converted to the iodide 
in two steps in a very good yield of 74%, using similar conditions to those used for the 
synthesis of diodides 22, 23 and 24. 
3.1.3) Malonates 
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Scheme 3.4. Synthesis of the disubstituted malonates 30, 31, 32 and 33. 
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 The procedure followed was similar for all four malonates, diethylmalonate was 
deprotonated with 2 equivalents of sodium hydride in THF and reacted with 2 equivalents of 
the iodide or the bromide of the arm, then the product was separated from the crude by 
chromatography on silica gel. Reasonably good isolated yields (60% and 63%) of 
disubstituted malonates 30 and 31 were obtained when reacting with anthracene terminated 
iodides 25 and 26. Some of the anthracene products were cleaved by oxidation to 
anthraquinone, which may suggest that the yield of the reaction was actually even higher. By 
comparison, the isolated yield of trityl terminated malonate 32 was very poor; the actual yield 
of the reaction may be however of the same order of magnitude, but as the trityl group is acid 
sensitive, it was probably partly hydrolysed by the silica when separating the product from the 
crude by chromatography. Finally for the olefin-terminated malonate 33, the yield of isolated 
product was also lower than for 30 and 31. This may be because commercial 
1-bromodec-9-ene was used instead of the iodide, and as the reactivity of bromides is lower 
than that of iodides in nucleophilic substitutions, the reaction was probably not complete 
when stopped. 
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3.1.4) Conversion of malonates to barbiturates 
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Scheme 3.5. Conversion of malonates to barbiturates. 
 The procedure followed was similar for all four barbiturates, they were reacted with an 
excess of sodium hydride and urea in DMSO, and then the product was separated from the 
crude by chromatography on silica gel. This time the best yield was obtained with the olefin 
terminated barbiturate 37. The lower yield observed for the other barbiturates could be due to 
product decomposition, either by photooxidation of the anthracene-tagged barbiturates 34 and 
35 or by hydrolysis of the trityl-tagged barbiturate 36. Alternatively the actual yield of the 
reaction could be lower, which may be the case as the ethylene glycol arms chains are slightly 
more rigid than the alkyl chain of 37, and this increased rigidity may increase the energy of 
the transition state in the reaction with urea through restriction of conformational freedom. 
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3.2) Photochemistry of the anthracene-tagged barbiturates 
3.2.1) Fluorescence studies 
3.2.1.1) Fluorescence spectra and quantum yields 
  
 
Figure 3.1. Absorption (top) and emission spectra (bottom) of degassed solutions of 34 (left) 
and 35 (right), 2 µ 10-5 M in dichloromethane. Excitation wavelength: 365 nm. 
 The emission spectra of solutions of 34 and 35 in degassed DCM were recorded with 
an excitation wavelength of 365 nm, close to the maximum of absorption of the anthracene 
band (369 nm) (see Figure 3.1). For 34, in addition to monomer emission, an excimer band at 
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around 530 nm was observed,* showing that the two anthracene units freely approach one 
another during the lifetime of the excited-state.  This was not observed with 35 which had 
longer flexible arms. 
  
Figure 3.2. Excimer fluorescence band of 34 (right) obtained by difference of the normalised 
emission spectra of 34 and 35 (left), in dichloromethane, excitation wavelength 365 nm. 
 By considering the whole spectrum, the fluorescence quantum yield of 34 was 
measured (cf. Chapter 6 for a description of this method): a value ΦF, 34 total = 0.184 was 
obtained. The quantum yield of fluorescence of 35 was not measured. It is important to note 
that the quantum yield of fluorescence obtained for 34 is for the complete spectrum 
containing both the monomer and the excimer bands. In other words, the total number of 
molecules that fluoresce (in the monomer and the excimer form) is divided by the total 
number of molecules of 34 in solution that have been photoexcited. It is possible to evaluate 
the quantum yield of monomer emission alone by using a method already described in the 
literature:5c If it is assumed that in the case of 35 no excimer emission is present, then the 
spectrum of 35 should have the same shape as the emission spectrum of the monomer of 34, 
in which case, by dividing those two spectra by their respective maxima and calculating the 
difference, a normalised spectrum of the excimer can be made (see Figure 3.2). The ratio 
                                                 
*
 An excimer is a complex formed between two identical molecules or molecular fragments, 
here two anthracene units, where one of the fragments is in an excited state (cf. Chapter I). 
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between the area of the surface covered by the excimer band to the surface area of the whole 
spectrum of 34 was then determined as 18.8%, so the quantum yield of the monomer, which is 
related only to the fluorescence of the monomer, corresponds to the remaining 81.2% of the 
total, that is ΦF, monomer = 0.149 and ΦF, excimer = 0.035. 
 Other information may be drawn from the spectrum of the excimer. Its maximum is 
for a wavelength of λmax ≃ 505 nm. It has been described in the literature6 that the value of 
λmax for the excimer was related to its geometry, with usually λmax ≃ 580 nm for symmetrical 
excimers with completely overlapping orbitals, and lower wavelengths when the overlap was 
only partial, usually λmax ≃ 520-540 nm. The very low value obtained here suggests that the 
two anthracene units are not completely overlapping in this excimer. 
3.2.1.2) Study of the fluorescence decay 
The lifetimes of excited states were measured by time correlated single photon 
counting, an experimental method for observing the fluorescence decay. 7  The exact data 
found experimentally are reported in the experimental section (Chapter 6), but a simplified 
overview of these results is presented here. The solutions had to be thoroughly degassed in 
order to avoid photo-oxidation. 
It was found that with 34, the fluorescence intensity, expressed in arbitrary units, at the 
wavelength of the emission at 415 nm (monomer band), was best fitted with a biexponential 
model: 
  	
 = . e

 + . e


 
with the following characteristic lifetime parameters: τA =8.6 ns and τB = 1 .4 ns and the pre-
exponential factors IA = 0.1 and IB1 =1.0 (in arbitrary units). 
At 510 nm, in the excimer band, it was also a biexponential, with one of the lifetimes, 
τB = 1 .4 ns, being the same as that at 415 nm: 
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  	
 = . e

 +  . e


 
with the following parameters: IB2 = 0.06, IE = 0.58, and τE = 14.6 ns. 
These data can be interpreted using a simplified model that is similar to what has 
already been used on a related system in the literature:5c Two “monomeric” conformers of 34 
exist in the excited state, which are noted A and B and each of them has a different lifetime (τA 
and τB), the second being shorter because it is leading to the excimer E, which lifetime has a 
lifetime of τE. These lifetimes can be related to the rate for different events, as shown in 
Scheme 3.6.  
 
Scheme 3.6. Behaviour of the excited states of 34. 
In the equations in Scheme 3.6, knr is the rate constant for non-radiative relaxation of 
the monomeric excited state of 34 and kF is the fluorescence rate constant of this monomer, 
these two rate constants being considered equal for conformers A and B. The rate constants 
for the conversion of A to B and B to A are ignored. The rate constant for the conversion of the 
monomer to the excimer is kE. The rate constant for the reversion of the excimer to the 
monomer is considered small by comparison with other rate constants and is therefore 
ignored. kFE and knrE are the rate constants for the fluorescence and non-radiative relaxation 
respectively of the excimer, and kd is the rate constant for the reaction of anthracene 
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dimerisation reaction from the excimer. As no actual dimer of the starting molecule is formed 
but an intramolecular anthracene dimer, this reaction should be strictly termed 
photocyclomerisation and the photoproduct, photocyclomer. 
This models leads directly to the rate constant for the formation of the excimer: 
 =   ! −  

 # = 6.0 µ 10
8
 s
-1
. 
As explained in Chapter 1, the quantum yield of fluorescence is given 8  by the 
following equation: 
$ = 1	%∗ ' (	
. )

*

 
  In this equation, (M*)0 is the initial concentration of molecules in the excited state, and 
iF(t) is the fluorescence intensity, which has to be distinguished from the experimental IF(t) 
introduced above which was given in arbitrary units. In our case, the concentration of the 
monomer excited state (M*)0 decomposes in the sum of the concentrations of the two 
conformers A and B: 
(M*)0 = (A*)0 + (B*)0 
As the rate constant of fluorescence kF  is assumed to be the same for A and B, the 
expression of the intensity of fluorescence is: 
(	
 =  . 	+∗. e

 +  . 	,∗. e


 
The experimental expression of the intensity of fluorescence given above was in 
arbitrary units, in other words there is a constant proportional factor K between these two 
expressions: 
(	
 =  . 	+∗. e

 +  . 	,∗. e

 = -. e

 + -. . e


 
This leads directly to  . 	+∗ = -.   and   . 	,∗ = -.  . This proportional 
factor K disappears by simplification when these expressions are reintroduced in the 
expression of ΦF, monomer : 
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$ ../ =  +  ' 0e
  + . e

1 . )

*

 
 Using the well known mathematical result of the integral of an exponential decay: 
' e. )
 = 
*

 
The expression of ΦF, monomer is equal to: 
$ ../ =  . .  + .  +   
 This last expression allows to evaluate the rate constant of fluorescence of the 
monomer kF from the experimental values, as well as the rate constant of non-radiative 
relaxation knr: 
  = $ ../.  + .  + .     and     =
1
 −   
kF = 7.3 µ 107 s-1  and  knr = 4.4 µ 107 s-1 
According to the following equation,8 the intensity of excimer emission (noted IE) and 
monomer emission (noted IM) can be related to their rate constants of fluorescence:  

5 =

 .  .   
Using the values measured or calculated before, this leads to the rate constant of 
fluorescence of the excimer: 
kFE = 
67.89
 9.69.8: =1.9 µ 10
6
 s
-1 
With 35, the excimer emission was absent from the emission spectrum. However, as 
will be described later in this chapter, photodimerisation still occurred, which means that the 
two anthracene units can also freely approach one another. It is usually assumed that 
anthracene dimerisation occurs with the formation of an intermediate excimer,3b so in the case 
of 35, an excimer probably forms but its fluorescence is not seen. This can be interpreted as 
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the rate constant of dimerisation from the excimer in this case being much larger than the rate 
constants of relaxation of the excimer, either through radiative (kFE) or non radiative (knrE) 
processes. In other words an excimer species does not need to be introduced in the kinetic 
considerations for 35 as this species is only transient and nearly completely converts to the 
photocyclomer. 
The fluorescence decay was also studied at 415 nm and 510 nm. As expected the same 
biexponential model was able to fit correctly the decay at both wavelength: 
	
 = e

 + e


 
with the following parameters: IA = 0.18, τa = 7.0 ns; IB = 0.66, τb = 3.4 ns. This indicates 
that once again two conformers of 35 are present and that each one leads to an excited state 
with a different lifetime, where the one with the shorter lifetime leads directly to the 
photocyclomer. In this case, the rate constant kd for dimerisation of 35 can be calculated as 
done previously for the rate constant for excimer formation of 34: 
 =   ! −  

 # =  1.5 µ 10
8
 s
-1
 
 The rate constants of fluorescence and non-radiative decay of 35 can not be calculated 
as the fluorescence quantum yield of 35 was not measured, but their sum can be evaluated: 
 +    =   # = 1.4 µ 10
8
 s
-1
 
 It is interesting to note that for 34, kF + knr = 1.2 µ 108 s-1, which is a very similar 
value. 
3.2.2) Photocyclomerisation and thermal return 
When a degassed solution of 34 or 35 was irradiated at the wavelength of absorption 
of the anthracene groups (at 365 nm), a photocyclomerisation reaction took place, as 
evidenced by NMR and UV-vis spectroscopy. In theory two different dimers can form, the 
head to head dimer (hh) or the head to tail dimer (ht) (see Scheme 3.7, and Chapter 6 for the 
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experimental procedure). By UV, the anthracene band centred on 369 nm disappeared (see 
Figure 3.3), and by 1H NMR, the whole spectrum of each molecule was affected (see Figure 
3.4). 
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Scheme 3.7. Photocyclomerisation of 34, with the structure of the two possible dimers, and 
some expected 1H NMR shifts by comparison with 9-methoxyanthracene dimers.9b 
Using these UV spectra, the quantum yields of dimerisation, Φd, of 34 and 35 were 
measured using Parker’s actinometry method,10 as described in Chapter 6. This involved 
fitting the experimental concentration values of remaining “monomeric” anthracene for 
different irradiation times using a model derived from the physico-chemical laws followed by 
the phenomenon (constant quantum yield, constant photonic flux, absorption described by 
Beer’s law). The determination of the constant photonic flux was made using a known 
actinometer (potassium ferrioxalate) under the same irradiation conditions. The results are 
presented in Table 3.1.  
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Figure 3.3. Changing electronic absorption spectra of a 2 µ 10-5 M solution of 34 in degassed 
DCM upon irradiation at 365 nm. 
After complete conversion (ie: when the anthracene band had disappeared in the UV 
spectrum), the solutions were left in the dark at room temperature and the absorption at 
369 nm was measured at regular intervals in order to check the reappearance of monomeric 
anthracene by thermal return. The concentrations values were fitted with a monoexponential 
model, and the rate constants kret for thermal return at room temperature are also presented in 
Table 3.1 (see Chapter 6 for the procedure), as well as the half-life of the dimers, as given by 
the formula: 
t1/2 = ln(2)/kret 
Table 3.1. Quantum yields of photocyclomerisation and times of thermal return of 34 and 35, 
measured by UV-vis. spectroscopy of solutions at 2 µ 10-5 M in DCM, monochromatic 
irradiation at 365 nm, Parker’s actinometry; thermal return at room temperature. 
Barbiturate Φd kret / s-1 t1/2 
34 0.10 3.5 µ 10-6 2.3 days 
35 0.28 7.6 µ 10-4 15 minutes 
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It can be observed that the quantum yield of photocyclomerisation for 35 is almost 
three times that of 34, whereas the thermal return rate constant is more than 200 times greater. 
In other words, the dimer is easier to form and less kinetically stable in the case of 35. The 
fact that the anthracene dimer forms fastest with 35 is consistent with the hypothesis 
expressed earlier that the dimerisation rate constant in the case of 35 is much larger than the 
fluorescence rate constant for the excimer, which explains why no excimer band was 
observed in the fluorescence spectrum of 35. This could be due to geometric reasons, with 
different relative orientations of the anthracene units. 
The quantum yields of dimerisation are of the same order of magnitude as those 
observed with similar systems.3,5,11 The thermal return rate constants may reveal the geometry 
of the dimers; according to the literature,3 the half-lives of ht dimers at room temperature are 
usually better expressed in years, whereas those of hh dimers are in hours. Here the time half-
life of 35 is clearly very short even compared to the values expected for a hh dimer, and the 
half-life of 34 is close to the longer lifetimes observed for hh dimers5c but much too short for 
a ht dimers. For this reason, it is likely that the dimers formed are head to head dimers. 
The NMR experiments (Figure 3.4a and 3.4b) confirmed that the disappearance of the 
anthracene signals in the UV spectra were associated with the formation of anthracene dimers. 
In particular, a common feature characteristic of dimerisation appeared in the spectra of the 
solutions of 34c and 35c; the singlet at 8.2 ppm corresponding to the proton opposite to the 
oxygen on the central anthracene aromatic ring (e) disappeared, and a new signal for the 
bridgehead proton (same proton, but in a new environment) appeared at 4.5 ppm (e’). The fact 
that this is only one clear singlet indicates that only one type of dimer is formed in each case. 
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Figure 3.4a. Photocyclomerisation of 34 upon irradiation using a mercury lamp and a filter 
(saturated solution of lead acetate), followed by NMR in CD2Cl2, at a concentration of 2 mM. 
Notice that the sample of 34 and/or the CD2Cl2 used was contaminated with water and other 
contaminants (unidentified peaks between 0 and 2 ppm), which did not affect the changes 
observed upon irradiation. 
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Figure 3.4b. Photocyclomerisation of 35 upon irradiation using a mercury lamp and a filter 
(saturated solution of lead acetate), followed by NMR in CD2Cl2, at a concentration of 2 mM. 
Notice that the sample of 35 and/or the CD2Cl2 used was contaminated with water and other 
contaminants (unidentified peaks between 0 and 2 ppm), which did not affect the changes 
observed upon irradiation. 
The changes in the shifts of the aromatic protons are also characteristic of the 
formation of the anthracene dimer. It is however difficult to distinguish whether a hh or ht 
dimer has formed. A comparison of the two dimers of 9-(methoxy)anthracene in the 
literature9 reveals that the signals for the aromatic protons closer to the substituent on the 
benzene ring (a’) should appear around 7.2 ppm in the hh dimer, whereas in the ht dimer both 
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this proton and the proton para to it should form a multiplet at around 7.0 ppm (see Scheme 
3.7). In both cases, the integration patterns suggest a hh dimer, although in the case of 34c, the 
spectrum is complicated by the presence of an NH signal (l’)  at 7.2 ppm. 
It can also be observed that the signals for the CH2 groups of the chain and the NH of 
the barbiturate shift upon photocyclomerisation. In particular, the NH signal (l) of 34 shifts 
from 8.7 ppm in the non-cyclised form to 7.2 ppm in the cyclised form (see Figure 3.4) and 
for 35 from 9.4 ppm to 9.2 ppm. This can be explained if in the non-cyclised form in solution, 
the NH partly binds to the polyethylene glycol chain through an intramolecular hydrogen 
bond, but not in the cyclised form. This explanation would also be consistent with the kinetic 
scheme used for explaining the results of fluorescence decay: the conformer A would be the 
conformer with the NH bond to the chain. 
3.3) Conclusion and further work 
The synthesis of these substituted barbiturates via the malonate has proved to be 
relatively easy. Different barbiturates can be designed in the same way, including different 
olefin-terminated barbiturates or trityl-phenol-stoppered barbiturates, where the stopper group 
would be less labile than the simple trityl stopper.12 
Although the study of the fluorescence decay, quantum yields of fluorescence and 
photodimerisation have given much information on the photochemistry of 34 and 35, more 
experiments are possible to get an even better understanding of their properties. The 
fluorescence quantum yield of 35 has not been measured, and variable temperature 
measurements might allow a better model to be established, in particular by measuring the 
rate of return from the excimer of 34 to the dissociated excited state.11 Nevertheless, there 
were notable differences in photochemistry between 34 and 35. In particular, it was observed 
that the internal anthracene dimer is formed more quickly with 35 than with 34, making the 
lifetime of the excimer so short in the case of 35 that it can be ignored. The photocyclomer of 
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35 is also less thermally stable than that of 34. Both of the barbiturates appear to form 
intramolecular hh dimers. 
The binding of these barbiturates to “Hamilton-like” receptors, and attempts to obtain 
mechanically interlocked structures from these complexes, either by anthracene dimerisation 
or metathesis, will be studied in Chapter 4. 
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4) APPROACH TO CATENANES WITH THE FLEXIBLE BARBITURATES 
4.1) Binding studies 
4.1.1) Titrations followed by UV-vis spectrometry 
 A first attempt at obtaining the binding constant between macrocycle 16 and guests 34 
and 35 in a similar way to what was done with barbital was unsuccessful, as the software 
Letagrop could not accurately fit the data. It appeared that this was due to absorption by the 
anthracene unit of the guests, which was leading to high absorption values when more than 3 
equivalents of barbiturate were added, and masking the slight changes in the pyridine band 
that related to complexation. Assuming that the absorption of the anthracene containing guest 
would not change upon complexation of the barbiturate moiety to the receptor, it was thought 
that its absorption could be subtracted from the spectrum, which would allow the data to fit 
with Letagrop (see Figure 4.1). 
  
Figure 4.1. Absorption of the solution during the titration of a solution of 35 (2 µ 10-5 M) by 
12 (uncyclised receptor, n = 6), from 0 to 1.2 equiv. in DCM at room temperature, before 
(left) and after (right) correction of the correction due to the anthracene moiety of 35. 
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However, as only low excesses of barbiturates were used and as the process of 
correcting the absorption due to the anthracene was also increasing the experimental error 
with the “corrected” absorption values, a relatively high margin of error in the binding 
constant resulted and sometimes a fit was difficult to obtain. The values for these binding 
constants are given in Table 4.1, along with the margin of errors given by Letagrop.1 
Table 4.1. Binding constants for guests 34, 35 and 36 obtained by titrations in DCM at room 
temperature, followed by UV, calculated with Letagrop. 
complex n log(K) margin of error 
16∑34 8 4.61 
(barbital: 5.52) 
0.04 
12∑35 6 3.73 
(barbital: 4.58) 
0.03 
15∑35 6 4.06 
(barbital: 5.09) 
0.07 
16∑35 8 3.65 
(barbital: 5.52) 
0.01 
18∑36 6 4.357 
(barbital: 5.79) 
0.001 
What can be observed first is that, notwithstanding the uncertainty over the real 
margins of error, all the binding constants seem to be lower for each receptor than those with 
barbital, which can be explained on steric grounds. In order to enable a comparison of the 
finer differences between the binding constants with different guest compounds, 36, which 
has trityl groups instead of anthracene groups, was also tested. As 36 does not absorb in the 
anthracene region, an excellent fit and margin of error was obtained for a binding constant of 
log(K) = 4.36, which is similar to the value of log(K) = 4.06 found for the titration of 15 with 
35. As 18 is the reduced form of 15 and 36 is similar to 35 where the anthracene groups have 
been replaced by trityl groups, this result is not unexpected and indicates at least that the order 
of magnitude of the binding constants found with the anthracene-tagged barbiturates is 
correct. 
The binding constant for the “open” receptor 12 with 35 has an intermediate value 
between the binding constants for the “closed” receptors 16 and 15 with 35. This is different 
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to what was observed with barbital, where the binding constant was smaller with the open 
receptors than with the closed receptors, as expected because of the macrocyclic effect. It can 
be interpreted by the role of steric effects: in the complexes with the closed receptors, the 
favourable macrocyclic effect is outweighed by larger unfavourable steric effects with the 
closed receptors than with the open receptors. 
Steric effects can again be involved to explain the differences in binding strength 
between the different complexes. A comparison between 16∑35 and 15∑35 reveals a higher 
binding constant for the smaller receptor 15, and a comparison between 16∑35 and 16∑34 
reveals a higher binding constant for the smaller barbiturate 34. These results appear to be 
influenced by the size of the ring of the receptor relative to the length of the anthracene-
terminated arms of the barbiturate. If the arms of the barbiturate are approximately as long as 
the dimension of the ring (as in 16∑35), then the binding constant is smaller because of the 
steric clash between the anthracene ends of the barbiturate and the alkyl group of the receptor. 
If they are longer (as in 15∑35) or shorter (as in 16∑34), then this steric interaction is less 
likely to take place. 
4.1.2) Titrations followed by fluorescence 
 Titrations of the anthracene-tagged barbituric acids 34 and 35 with different receptors 
were also undertaken by monitoring the emission or excitation spectra of a solution of the 
barbiturate at a concentration of 2 µ 10-5 M at room temperature in the presence of increasing 
amounts of the receptor. With 34, three titrations were made using the receptors 14, 16 and 
18, and another titration was made between 35 and 15. 
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Scheme 4.1. Possible geometric origin of the disappearance of the excimer in the complex of 
34 with the closed receptor 18. 
The disappearance of the excimer can be attributed to a blocking of the approach of 
the two terminal anthracene groups. As shown in Scheme 4.1, if the barbiturate is actually 
threading through the receptor to form an interlocked complex, the intervening macrocyclic 
ring of receptors 18 and 16 can repel the two anthracene-terminated arms and make their 
mutual approach more difficult. But if the barbiturate is actually not threading through the 
receptor and forms a “perched complex”, it is also possible that this occurs because of an 
unfavourable conformation for excimer formation as the guest is complexed. 
In the titrations of 34 with 18 and 16, excitation spectra were also recorded upon 
addition of the receptor, by recording the emission of the anthracene (λem. = 420 nm) for 
excitation wavelengths ranging from 220 to 400 nm (see Figure 4.3). As observed with the 
emission spectra, the emission obtained when irradiating in the anthracene absorption band 
(between 330 and 390 nm) increased with the amount of receptor. But the emission was also 
seen to increase for excitation at the wavelength of the pyridine band of the receptor (around 
300 nm). This can be understood as the result of an electronic energy transfer from the excited 
pyridine to the lower lying anthracene excited state, which results in subsequent anthracene 
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excess of the receptor 17, which is the “reduced” version of 14 and has the same size, it was 
seen that diminution of the excimer emission still occurred but the change was less than that 
observed with the larger receptor 18 under the same conditions (see Figure 4.4). An 
excitation spectrum of this solution also showed that some energy transfer existed between the 
pyridine of the receptor and the anthracene of the guest, which indicates close approach and 
confirms that a complex is actually forming. This energy transfer, however, is also lower than 
that with 18, as indicated by the comparison of the excitation spectra (Figure 4.4). This can 
be related to a lower binding affinity of 34 to 17 than to 18, which would mean that less 
complex is formed and thus energy transfer is less efficient.  
   
Figure 4.4. Comparison of the emission spectra (λexc. = 420 nm, left) and excitation spectra 
(λem. = 500 nm, right) of (a) 34, (b) mixture of 34 (1.8 mM) and 17 (20 mM), and (c) mixture 
of 34 and 18, same concentrations. All spectra are normalised to show the same intensity for 
the maximum of anthracene emission / resp. absorption. 
Finally, the fluorescence data obtained in the experiments described above (both 
emission and excitation spectra) were used for calculating the binding constants using the 
software Letagrop.1 The results are given in Table 4.2, where the margin of error are given by 
Letagrop. For 14∑34, the data could not be fitted by Letagrop because of the small changes 
that were observed. The values of log(K) found by this method are larger than those found by 
UV. This can be due to experimental error, because the values of fluorescence emission are 
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strictly proportional to concentration only for very low concentrations,4 but it can also be due 
to a genuine difference as it has already been described in the literature2, 5  that binding 
constants of molecules to anthracene-tagged receptors can be higher when one of the 
anthracenes is in an excited state. 
Table 4.2. Binding constants calculated from the titrations by fluorescence in DCM at room 
temperature. 
complex n log(K) margin of error 
16∑34 
By emission 
8 5.1 
(absorption: 4.61) 
0.2 
16∑34 
By excitation 
8 5.2 
 
0.2 
18∑34 
By emission 
6 5.1 0.2 
18∑34 
By excitation 
6 5.1 
 
0.3 
15∑35 
By emission 
6 4.9 
(absorption: 4.06) 
0.1 
4.1.3) Titration followed by ITC 
 The binding constant for the olefin-terminated barbiturate 37 and 18 was measured by 
ITC in DCM at 25°C (298 K). The results found were as follows: 
log(K) = 4.62 ± 0.04 (vs. 5.33 ± 0.07 for barbital) 
∆H° = -9.6 ± 0.9 kcal.mol-1 (vs. -15.0 ± 0.2 for barbital), 
∆S° = -11.0 ± 3.0 cal.K-1.mol-1 (vs. -25.8 ± 0.8 for barbital). 
In comparison to barbital, it can be seen that the value is lower, and of the same order 
of magnitude as the binding constants found for 34, 35 and 36 by UV. It can be observed that 
it is the enthalpic term ∆H° that explains the difference with barbital, with ∆H° more 
endothermic (∆(∆H°) = + 5.4 kcal.mol-1), whereas the term -T.∆S° partly compensates this 
variation (∆(−Τ∆S°) = - 4.4 kcal.mol-1). This is somewhat similar, although the differences 
are less important, to what was observed with the complex between 17 and barbital, where 
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these observations were related to the barbital binding by only 3 hydrogen bonds to the 
receptor (see Chapter 2). In this case, it may indicate again that the complex formed in this 
case is somehow structurally different from the complexes with barbital. For example, the two 
lateral chains may force the barbiturate to sit in a position which is not ideal for strong H-
bond interactions. This enthalpic contribution to a lower binding constant is partly 
compensated by a favourable entropic contribution, which can be interpreted as the result of 
increased freedom of motion, which could be a result of different types of complex being 
present in solution (e. g.  perched and threaded) in equilibrium. 
4.2) Closing of the receptors by olefin metathesis 
 As was done with barbital (cf. Chapter 2), the effect of metathesis on the complexes of 
the trityl-stoppered barbiturate 36 with the different receptors was studied by doing the 
following experiments: 1:1 mixtures of 36 with different receptors in solution in CDCl3 were 
prepared, at a concentration of 6 mM. When the receptor contained a double bond or a 
terminal olefin, a metathesis reaction was performed (addition of 10 mol% of Grubbs 1st 
generation catalyst, then reflux 30 minutes). The solutions were analysed by 1H NMR and 
mass spectrometry (ES+ and MALDI) both before and after metathesis, in order to verify that 
metathesis occurred, to check any differences in the structure of the products, and to test if 
rotaxanes could be detected. 
The NMR of the 1:1 mixture with the non-cyclic receptor 12 is presented in Figure 
4.5. Only the downfield part of the NMR spectrum is shown, which depicts the aromatic 
signals of the receptor (but not those of the trityl-barbiturate that start just on the right of this 
region) and the NH signals. It can be seen that these NH signals are significantly shifted upon 
complexation with 36 due to the expected H-bonding interactions The NH of the receptor 
closest to the benzene bridge (c)2b shifts from 7.7 to 9.6 ppm, the other NH of the receptor (g) 
shifts from 8.7 to 10.1 ppm, and the barbiturate NH (h) shifts from 9.3 to 12.3 ppm. 
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Figure 4.5. 1H NMR of 12, 36 and their 1:1 mixture in CDCl3, 6 mM. 
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Figure 4.6. 1H NMR spectra of 1:1 mixtures of 18 and 36 (top) and 15 and 36 (bottom) , in 
CDCl3, 6 mM. 
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With receptor 18, which does not possess an olefinic double bond, the top spectrum in 
Figure 4.6 was obtained. A comparison with the spectrum of 12∑36 (Figure 4.5) shows two 
differences: the downfield shift of the NH peaks (c, h & g) is greater, which is consistent with 
a stronger binding interaction, and the shape of these peaks is thinner, which may indicate that 
the relative freedom of motion of the two components is less, at least on the NMR timescale. 
With receptor 15, which only differs from 18 by the presence of an olefinic double bond, the 
bottom spectrum in Figure 4.6 was obtained. While the two spectra reveal that the shifts of 
the NH protons are similar and the peaks are approximately as sharp in both, the main 
difference is that with 15 the barbiturate NH peak and the peak for the NH protons of the 
receptor closest to the central benzene bridge are split into two peaks of approximately similar 
height. The chemical shifts observed with 15∑36 are as follows: 9.62 & 9.64 ppm for the split 
NH signal (g), 10.06 ppm for the other NH of the receptor (c), 10.60 & 12.69 ppm for the 
barbiturate NH (h). 
 
Figure 4.7. 1H NMR spectrum of 15∑35 in CD2Cl2, 2 mM. 
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It was also noted that a similar splitting of the NH signals was observed in the 
complexes of receptors 14, 15 and 16 with anthracene tagged barbiturates 34 and 35 (cf. 
Figure 4.7 and also Figures 4.9 to 4.14) but not with the “reduced” receptors 17 and 18. This 
splitting of the NH signals (c, h & g) upon complexation is therefore seen with all the flexible 
barbiturates terminated by bulky groups (but not with barbital nor with 37) and only with the 
double-bonded cyclic receptors (i. e. not with the “reduced” receptors). 
 
Figure 4.8. 1H NMR spectra of 1:1 mixtures 12 and 36 (top) and 15 and 36 (bottom) after 
metathesis, in CDCl3, 6 mM. 
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When a metathesis reaction was performed on the solution of a solution of a 1:1 
mixture of acyclic 12 and 36, the result was as shown in Figure 4.8: the peaks were the same 
as in the spectrum of 15∑36 (Figure 4.6 bottom) but the relative heights of the different peaks 
were different. The same thing was observed when performing metathesis on the complex 
15∑36: after metathesis, the height of the peaks changed to become nearly identical to what 
was obtained having done the metathesis on 12∑36. 
How can this be explained? Clearly, two different complexes are formed between 36 
and 15. It is possible to imagine two different geometries for the complex, one interlocked or 
threaded, and one non-interlocked or perched. But if this was the explanation, it would also 
be observed with 18, where the only difference is the absence of a double bond. Furthermore, 
the fact that both complexes are present in the 1:1 mixture of 15 and 36 even before 
metathesis would indicate that the perched and interlocked structures would be in 
thermodynamic equilibrium, which implies that it should not be affected by a metathesis 
experiment, where clearly it is. In other words, the fact that the ratio between the complexes is 
affected by metathesis implies that the two complexes are not in thermodynamic equilibrium 
with one another, except under the conditions of metathesis. This leads to another 
explanation, which is that the two cis and trans isomers of 15 actually bind 36 slightly 
differently, leading to different signals in the 1H NMR spectrum. It is interesting to notice that 
if this is the correct explanation, the binding of the guest can actually modify the cis-trans 
ratio after metathesis. But if this is the correct explanation, then the cis-trans ratio would be 
approximately 50/50 in the mixture used as the two signals corresponding to the two 
complexes with 15 have approximately the same integration, which contradicts the value of 
79/21 determined by 13C NMR (cf. Chapter 2). This difference could be due to the fact that 
integral heights in 13C spectra are not accurate but it is more likely to do with the fact that 15 
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was re-synthesised for this experiment: the proportion of cis and trans isomers may have been 
different in the two samples. 
The interpretation of the mass spectrometry results (see Appendix 2) is difficult as the 
two techniques used (ES+ and MALDI) can show associated adducts that in fact are not (or 
very weakly) associated under other experimental conditions.6 The results were studied in the 
positive ion mode and it is clear that some of these species are only weakly ionising to form 
cations in these conditions. In one of the experiments (14∑36 - after metathesis), a dimer of the 
receptor was observed: this was related to its aggregation (cf. Chapter 2). The mass of the 
complex was also seen in two cases (18∑36, and 14∑36 - after metathesis) but this cannot be 
considered as evidence for the formation of a rotaxane since it could simply be a perched 
complex. 
4.3) Attempts to obtain catenanes by anthracene photodimerisation 
4.3.1) Changes in photochemistry upon complexation 
The quantum yields of dimerisation and rate constants of thermal returns of the 
complexes of the anthracene-tagged barbiturates with the receptor 16 were measured using 
the same method as for the barbiturates (see Chapter 6 for the experimental procedure) by 
monitoring the disappearance of the anthracene absorption band in the UV-Vis. spectrum of 
solutions of mixtures of the complexes. The results are presented in Table 4.3. 
 Table 4.3. Quantum yields of photocyclomerisation and times of thermal return of 1:1 
mixtures of barbiturates 34 and 35 with 16, measured by UV-vis. spectroscopy, in DCM at 
room temperature 
Complex Φd kret / s-1 t1/2 
16∑34 0.0014 
(34 alone: 0.10) 
2.3.10-4 
(34 alone: 3.5.10-6) 
50 minutes 
(34 alone: 2.3 days) 
16∑35 0.026 
(35 alone: 0.28) 
2.7.10-4 
(35 alone: 7.6.10-4) 
43 minutes 
(35 alone: 15 minutes) 
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The ease of formation and the stability of the intramolecular anthracene dimers are 
clearly affected by complexation. It can be observed that the quantum yields are smaller upon 
complexation, more than 10 times for 35 and more than 70 times for 34.  The rate constant for 
thermal return is 65 times faster upon complexation for 34, but 3 times slower for 35. The 
dramatic changes observed with 34 can be interpreted in the same way as the disappearance of 
the excimer: the two anthracene groups, for geometric reasons, cannot easily approach one 
another in this complex; however it is not impossible to form an anthracene dimer, but it is 
also less stable than the dimer formed in the free form, as indicated by the higher rate constant 
for the thermal return. This is probably for steric reasons as more strain would make ring 
opening easier. With 35, the dimer is also more difficult to form in the complex than in the 
free form, but the drop in the quantum yield is less pronounced. However surprisingly the 
dimer formed is in this case slightly more stable than the one formed in the free form. 
4.3.2) Photocyclomerisation followed by NMR and mass spectrometry 
 In order to follow anthracene dimerisation in the H-bonded complexes in more detail, 
solutions of 1:1 mixtures of 34 or 35 with receptors 14, 15 and 16 at a concentration of 2 mM 
in CD2Cl2 were prepared, and a series of 1H NMR spectra were made as a function of 
irradiation time (see Chapter 6 for the experimental conditions). The results of these 
experiments are given in Figures 4.9 to 4.14,* and have to be compared with the spectra of 
the irradiation of the barbiturates 34 and 35 alone (Figure 3.4 in Chapter 3). The aim of these 
experiments was to check the feasibility of the photocyclomerisation in the complexes, which 
is a necessary preliminary to obtain catenanes by this method, and to check for any 
differences in the structures of the complexes and kinetics of the photochemical reactions.  
                                                 
*
 NB: In Figures 4.9 to 4.19, a schematic representation of the molecules is given in order to 
attribute the signals. Although interlocked structures are represented, no assumption is made 
on whether it is interlocked or perched. 
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Figure 4.9. 1H NMR of the complex 14∑34 in CD2Cl2 upon irradiation over 90 minutes. 
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Figure 4.10. 1H NMR of the complex 15∑34 in CD2Cl2 upon irradiation over 94 minutes. 
Approach to catenanes with the flexible barbiturates 
125 
 
 
Figure 4.11. 1H NMR of the complex 16∑34 in CD2Cl2 upon irradiation over 94 minutes. 
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Figure 4.12. 1H NMR of the complex 14∑35 in CD2Cl2 upon irradiation over 45 minutes. 
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Figure 4.13. 1H NMR of the complex 15∑35 in CD2Cl2 upon irradiation over 32 minutes. 
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Figure 4.14. 1H NMR of the complex 16∑35 in CD2Cl2 upon irradiation over 32 minutes. 
The appearance of an anthracene dimer is demonstrated in each case by the appearance 
of the singlet of the bridgehead proton, which appears at ca. 4.5 ppm. Quantum yields of 
dimerisation were not evaluated with precision here but as the conditions of irradiation were 
similar for every NMR tube, it can be assumed that the main differences observed in the 
irradiation time required for complete conversion to the dimer are related to differences in the 
quantum yields. With 34, the photocyclomerisation was approximately as fast in the free 
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barbiturate as it was in the complex with 14, slower with 16 and even slower with 15. This is 
consistent with what was observed with the disappearance of the excimer, showing a more 
difficult approach of the anthracenes in the complexes with 15 and 16. With 35 however, 
photocyclomerisation was faster in the complex with 16, and slower with the two other 
receptors. It is as if the approach of the two anthracenes is not hampered at all in the complex 
with 16 whereas it is in the other complexes. A tentative explanation is that these observations 
are consistent with the formation of mostly interlocked complexes in the case of 34, where the 
difficulty to form the dimer seems to be related to the distance between the macrocyclic ring 
of the receptor and the anthracenes (in between the anthracenes in the case of 16 and 15 and 
closer to the barbiturate centre in the case of 14) whereas with 35, perched complexes are 
indicated, as the difficulty to form the dimer seems to be related to the deformation imposed 
to the chains (greater with smaller receptors than with larger). It can also be observed that the 
signals corresponding to the CH2 groups of the chain of the barbiturate are more numerous in 
the complexes of 35 with 14 and 15, indicating that these two chains may not be in similar 
environments. This is consistent with the explanation above. 
Similar experiments were also undertaken with 34 and the “reduced” receptors 17 and 
18. NMR spectra of 1:1 mixtures of the receptors with 34c (photocyclised 34) were also 
recorded. Then at the end of all these experiments, an excess of barbital was added to the tube 
and a final NMR was recorded. The solutions obtained were also analysed by MALDI mass 
spectrometry, in order to verify that catenanes were obtained. The 1H NMR spectra of these 
experiments are given in Figures 4.15 to 4.18, and the MALDI spectra are presented in 
Appendix 2. 
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Figure 4.15. 1H NMR (CDCl3) of the 1:1 mixture of 17 and 34 before irradiation, after 90 min 
of irradiation and after addition of an excess of barbital (contains DCM). 
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Figure 4.16. 1H NMR (CDCl3) of the 1:1 mixture of 17 and 34c photocyclised separately and 
after addition of an excess of barbital. 
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Figure 4.17. 1H NMR  (CDCl3) of the complex 18∑34 before irradiation, after 90 min of 
irradiation and after addition of an excess of barbital. 
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Figure 4.18. 1H NMR (CDCl3) of the complex 18∑34c formed separately and after addition of 
an excess of barbital. 
In the case of 18, it was seen that two different singlet signals corresponding to the 
bridgehead proton appeared in 1H NMR, one at the same position (4.5 ppm) observed in all 
the other cases, and another at 4.8 ppm. It was thought that this could be due to a faster 
photodimerisation of 34 outside the complex than bound to the receptor. In order to prove 
that, a 5:1 mixture of receptor 18 and barbiturate 34 was made and irradiated in the same 
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conditions: this time only the singlet at 4.8 ppm appeared, showing that it was actually the 
position of the bridgehead proton of the cyclised complex (see Figure 4.19) 
 
Figure 4.19. 1H NMR of a 5:1 mixture of 18 and 34 after  90 min of irradiation 
For the case of the 1:1 mixture of 34c and 18, only the bridgehead proton at 4.5 ppm 
was seen, which clearly indicates that this bridgehead proton is in different environments 
when the photocyclomerisation is undertaken in the presence or absence of receptor 18, and 
that the 4.5 ppm value is not affected by the complexation. Therefore, probably a different 
photocyclomer, with a different structure, is forming in the complex which cannot be an 
unsymmetrical anthracene dimer as the bridgehead proton is still present in the 1H NMR 
spectrum as a singlet. Thus the 4.8 ppm signal could either indicate a head to head dimer in a 
different environment, for example an interlocked structure, or a head to tail dimer, which 
seems more likely as the shape and chemical shifts of the aromatic protons in the dimer (two 
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multiplets corresponding to v’ & y’ and w’ & x’ in Figure 4.19) are consistent with this 
structure.7 
 As explained for the experiments with 36 discussed earlier in this chapter, MALDI 
was probably not the ideal technique for following these experiments. In addition to the low 
cation formation of the barbiturates and complexes and the presence of many peaks of 
associated species, the laser used in the desorption process may heat the sample and open up 
the anthracene dimer. As in the experiments with 36, dimers of receptor were sometimes 
observed and related to aggregation. If the peaks corresponding to the complexes that were 
observed after the photocyclomerisation was performed on the complexes, were still present 
after addition of barbital, but no longer after addition of barbital to the solutions of  the 
complexes of the receptors with barbiturates photocyclomerised separately, this would be 
considered as an evidence for catenane formation. This is what was observed, but these 
experiments, all the peaks corresponding to the barbiturates or the complexes were weak and 
at the limit of the background noise, which makes this evidence dubious. 
4.4) Using olefin terminated barbiturate 
 Given that anthracene photodimerisation to form photocatenanes was proven 
problematic, a series of experiments were carried out to determine whether the olefin 
metathesis performed on the complex 17∑37 could generate any catenane: a 1 mM solution of 
a 1:1 mixture of 17 and 37 in CDCl3 was prepared, which was then heated to reflux in the 
presence of 10 mol% of Grubbs’ 1st generation catalyst. Finally an excess of barbital was 
added. After each of these steps, it was analysed by 1H NMR and mass spectrometry. For 
comparison, a mixture of 17 and 37c (cyclised 37), which can contain only perched complex, 
was also made and analysed before and after addition of barbital. The different products that 
can be detected are illustrated in Scheme 4.2. 
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Scheme 4.2. Different possible products obtained by either performing a metathesis on a 1:1 
mixture of 18 and 37, or by making a 1:1 mixture of 18 and 37c (cyclised 37), and what can 
be obtained after adding an excess of barbital to these different products. 
Approach to catenanes with the flexible barbiturates 
137 
 
 
Figure 4.20. 1H NMR spectra of a 1:1 mixture of  18 and 37, 1 mM in CDCl3, (a) before and 
(b) after metathesis with 10 mol% of Grubbs’ first generation catalyst. For comparison, (c) 
mixture of 18 and 37c (pre-metathesised 37, slight excess). (d): Same mixture as (b) after 
addition of an excess of barbital. 
The NMR spectra (Figure 4.20) reveal that the metathesis was complete after 2 hours at 
reflux, but that the spectrum of the metathesised mixture could not be distinguished by NMR 
from the mixture of the receptor with the pre-metathesised barbiturate, even after addition of 
an excess of barbital. This indicates that if some catenane has formed, then either it has done 
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so in small amounts, or it can bind barbital as suggested in the last equilibrium drawn in 
Scheme 4.2. 
The mass spectra were made first of all by MALDI by looking at the positive ions, but 
unfortunately the barbiturates and the complexes were not seen. Therefore, new spectra were 
made by electrospray in the negative ions (ES-), which allowed both the receptor and the 
barbiturate masses to be shown very clearly, as well as the complexes. The peaks for the 
complexes were relatively small but clearly distinct from the background noise. These mass 
spectra are presented in Appendix 2. 
These mass spectra can be analysed as follows: in the 1:1 mixture of the barbiturate 37 
with the receptor 18, all the peaks for the starting materials and the 1:1 complex 37∏18 can be 
clearly seen. After metathesis, we can see the peaks of the non-cyclised barbiturate 37 and its 
cyclised version 37c, the receptor 18 and the two 1:1 complexes 37∏18 and 37c∏18. There is 
also another unexplained peak which is probably an impurity in one of the starting materials 
as it was also seen in the spectrum before metathesis (though much smaller). 
After adding an excess of barbital, the 1:1 complex with the uncyclised barbiturate 
37∏18 is no longer seen as would be expected if it has been displaced by barbital. However, 
the peak for the 1:1 complex with the cyclised barbiturate 37c∏18 is still present, as would be 
expected if some of it was not displaced by barbital because of the mechanical bond. 
Therefore these results are at least consistent with the formation of a catenane. No peak 
corresponding to the mass of this complex plus barbital was seen, which indicates that the 
complex (37c∏18)∏barbital, described at the end of Scheme 4.2, was probably not formed. 
The mass spectrum of the mixture of 18 with 37c looked quite similar to the spectrum 
of the metathesised mixture, but surprisingly an additional peak was seen for a mass 
corresponding to two times 37c plus one times 18. As no peak corresponding to two times the 
mass of 37c was seen in the ES- spectrum of 37c (NB: it was seen in MALDI but this can be a 
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weakly bound dimer),6 it is unlikely that an actual “covalent dimer” of 37 was formed by 
metathesis. It is more likely that this peak corresponds to a 2:1 complex between 37 and 18. 
After addition of an excess of barbital, the peak of the complexes 18∏37c and 18∏(37c)2 both 
disappeared. This confirms that the 18∏37c peak remaining in the spectrum of the 
metathesised mixture after addition of barbital is likely to correspond to the catenane. 
As was already mentioned in Chapter III (p. 86), the ring of 37c is a 19 membered 
ring, whereas the smallest rings already known in isolated interlocked structures are 21-
membered rings.8 However, all these small-ring rotaxanes have been obtained by threading of 
the chain in the ring, whereas in our case the ring has been clipped around the chain by olefin 
metathesis. It was already pointed out in one of the seminal works of G. Schill on the limit of 
ring size in interlocked structures9 that “catenanes of small ring sizes will most likely be 
obtained by ring-contraction reactions”. However, the generally accepted theoretical limit in 
ring size predicted by molecular models with cycloalkane rings is of 20 atoms.10 
In order to explain how a catenane of this type could have been formed, models of the 
two possible cis and trans isomers of the catenane formed by 18 and 37c were calculated at 
the Pôle Modélisation of the Institut des Sciences Moléculaires (University Bordeaux I, 
France) by Dominique Cavagnat and Thierry Buffetau, using a methodology developed by 
their group.11 They were optimised starting from the crystallographic stucture of the complex 
of 18 and barbital (cf. Chapter II, pp. 81-82) and adding the closing ring. These structures are 
presented in Figure 4.21. 
It can be seen from these models that the closing double bond is positioned so that the 
hydrogen atoms bound to the sp2 carbons are not pointing in the direction of the chain around 
which the ring has been clipped. It can be argued that for this reason, there is more space for 
the interlocked alkyl chain than there would be if the ring consisted of only methylene groups. 
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4.5) Conclusion and fu
 It has been demonstra
towards “Hamilton-like” recep
effects and to the fact that b
titrations between the differen
the reasons behind these diffe
anthracene-tagged barbiturates
the results uncertain. 
These barbiturates also
variations in the different rece
differs for cis and trans rec
extremities of the barbiturate’
Approach to catenanes with the fl
   
nitio structures of the isomers cis (left) and tr
catenane formed by 18 and 37c. 
rther work 
ted that long-chained barbiturates have low
tors than barbital. This lower affinity is pro
oth threaded and perched complexes can 
t barbiturates and these receptors could give
rence in binding constants. It would also be
, a nice alternative to UV where anthracene
 seem to be more sensitive than barbital 
ptors, as shown by the shifts in the NH 1H
eptors. However this was not observed w
s side chains are not bulky. Another effect
exible barbiturates 
140 
 
ans (right) of the 
er binding affinity 
bably due to steric 
form. Further ITC 
 more insight into 
, in the case of the 
 absorption makes 
to subtle structural 
 NMR signals that 
ith 37 where the 
 of the interaction 
Approach to catenanes with the flexible barbiturates 
141 
 
between the extremities of the barbiturate’s side chains with the macrocyclic ring of the 
receptor is the control of the excimer band formation as well as the modification of the 
quantum yield of photocyclomerisation. Even without formation of interlocked structures, it 
seems that binding to these types of receptor may be a way to control the diastereoselectivity 
and kinetics of ring-closing reactions, either on the barbiturate or the receptor. 
Energy transfer from the receptor to the guest in the complexes with anthracene-
tagged barbiturates was observed and some evidence was given that it was likely to be related 
to the strength of the complexation. 
Evidence for an interlocked structure formed from a Hamilton-like receptor and a 
substituted barbiturate (18 and 37 respectively) is provided by the observation of a peak in the 
mass spectrum corresponding to the expected mass of the catenane which is still present after 
adding an excess of barbital. These experimental results are very encouraging, but definitive 
proof for the formation of a new interlocked structure would normally come with X-ray 
crystallography. If this result has been interpreted correctly, it also demonstrates the 
feasibility of accessing interlocked structures with a 19 membered ring by a clipping 
approach. In this case, the catenane observed here is the smallest in terms of ring size, and its 
structure is supported by molecular models. 
On the other hand, the formation of the photocatenanes is much less certain, as the 
method followed (detection by MALDI) was not sufficient in the time available. Re-iteration 
of these experiments, but followed by electrospray in the negative ion mode and with a 
systematic competition experiment with barbital, could eventually give better information on 
whether photocatenanes can be obtained by this method or not. 
At this stage, it is too early to state that Hamilton-like complexes are a good basis to 
make interlocked structures, because the yield of any catenane produced was poor. This may 
be because “perched” complexes are easily formed instead of threaded complexes, but any 
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evidence for this topography is indirect. In order to prove this, X-Ray diffraction of the 
products would be necessary, but for the moment, different attempts to obtain crystals of the 
complexes with long-chain appended barbiturates have been unsuccessful. As was done in 
Chapter 2, ab-initio models a comparison of calculated and experimental IR spectra could 
also be informative regarding the geometry of the complexes. However the size and great 
flexibility of these molecules would make such models difficult to perform for the complexes 
before ring closure. 
In order to avoid the formation of such perched complexes, we envisaged to synthesise 
new barbiturates with more rigid arms, which will be the subject of the next chapter. 
                                                 
1
 Havel, J. Haltafal-Spefo program; Mazaryle University: Brno, Moravia, Czech Republic. 
References: (a) Sillen, L. G.; Warnqvist, B. Arkiv för Kemi 1968, 31, 315; (b) Sillen, L. G.; 
Warnqvist, B. Arkiv för Kemi 1968, 31, 377. 
2
 (a) Molard, Y.; Bassani, D. M.; Desvergne, J.-P.; Horton, P. N.; Hursthouse, M. B.; Tucker, 
J. H. R. Angewandte Chemie International Edition 2005, 44, 1072-1075; (b) Molard, Y.; 
Bassani, D. M.; Desvergne, J.-P.; Moran, N.; Tucker, J. H. R. Journal of Organic Chemistry 
2006, 71, 8523-8531. 
3
 (a) Tecilla, P.; Dixon, R. P.; Slobodkin, G.; Alavi, D. S.; Waldeck, D. H.; Hamilton, A. D. 
Journal of the American Chemical Society 1990, 112, 9408-9410; (b) Aoki, I.; Harada, T.; 
Sakaki, T.; Kawahara, Y.; Shinkai, S. Journal of the Chemical Society, Chemical 
Communications 1992, 1341; (c) Motesharei, K.; Myles, D. C. Journal of the American 
Chemical Society 1994, 116, 7413-7414; (d) Chin, T.; Gao, Z.; Lelouche, I.; Shin, Y.-g.; 
Purandare, A.; Knapp, S.; Isied, S. S. Journal of the American Chemical Society 1997, 119, 
12849-12858; (e) Salameh, A. S.; Ghaddar, T.; Isied, S. S. Journal of Physical Organic 
Chemistry 1999, 12, 257-254. 
4
 Valeur, B. Invitation à la fluorescence moléculaire; 2004 ed.; De Boeck Université: 
Bruxelles, 2004. 
5
 Marquis, D.; Desvergne, J.-P. Chemical Physics Letters 1994, 230, 131-136. 
6
 Gross, J. H. Mass spectrometry - a textbook; Springer-Verlag: Berlin Heidelberg, 2004, p. 
433. 
Approach to catenanes with the flexible barbiturates 
143 
 
                                                                                                                                                        
7
 (a) Becker, H.-D. Chemical Reviews 1993, 93, 145-172; (b) Becker, H.-D.; Langer, V. 
Journal of Organic Chemistry 1993, 58, 4703-4708. 
8
 (a) Schill, G.; Beckmann, W.; Schweickert, N.; Fritz, H. Chemische Berichte 1986, 119, 
2647-2655; (b) Zhuang, C.; Li, S.; Zhang, J.; Zhu, K.; Li, N.; Huang, F. Organic Letters 
2007, 9, 5553-5556; (c) Hsu, C.-C.; Chen, N.-C.; Lai, C.-C.; Liu, S.-M.; Chiu, S.-H. 
Angewandte Chemie International Edition 2008, 47, 7475-7478. Indirect evidence of 
threading of an alkyl chain in a 20 membered ring have also been obtained: (e) Gibson, H. 
W.; Nagvekar, D. S.; Yamaguchi, N.; Bhattacharjee, S.; Wang, H.; Vergne, M. J.; Hercules, 
D. M. Macromolecules 2004, 37, 7514-7529. 
9
 Schill, G. Catenanes, Rotaxanes and Knots; Organic Chemistry, A Series of Monographs, 
Vol. 22, Academic Press: New York, 1971. 
10
 Frisch, H. L.; Wasserman, E. Journal of the American Chemical Society 1961, 83, 3789-
3795. 
11
 (a) Buffeteau, T.; Ducasse, L.; Brizard, A.; Huc, I.; Oda, R. Journal of Physical Chemistry 
A 2004, 108, 4080-4086; (b) Buffeteau, T.; Cavagnat, D.; Bouchet, A. ; Brotin, T. Journal of 
Physical Chemistry A 2007, 111, 1045-1051. 
New rigid barbiturates 
144 
 
5) NEW RIGID BARBITURATES 
5.1) Synthesis 
5.1.1) Starting point and design 
 As concluded in Chapter 4, the attempts to use flexible barbiturates as components of 
interlocked structures were less than satisfactory, since the desired products were only ever 
obtained in trace amounts at best. In order to avoid the formation of “perched” complexes, the 
synthesis of new barbiturates with less flexible arms was envisaged. The synthesis of 
5,5’-bis(para-hydroxyphenyl)-barbituric acid (38) from alloxan monohydrate and phenol had 
previously been described in the literature using a classical Friedel-Crafts reaction 1  (see 
Scheme 5.1). This compound has two phenyl groups directly substituted on the central ring, 
and was seen as a good starting point to synthesise barbiturate derivatives that would be more 
rigid than those containing directly appended ethylene-glycol or alkyl chains. 
N N
O O
O
H H
HO OH
N N
O O
O
H H
HO OH
+
OH
2
AcOH
80-90 °C
2 h
H2SO4 (2 equiv)
literature:     85%
experiment: 84%
38
 
Scheme 5.1. Synthesis of 38 by Friedel-Crafts reaction.1 
By linking arms terminated by either stoppers or reacting groups on the oxygen sites 
of this barbiturate, it was thought that a threaded complex could then be formed fairly readily, 
which would then lead to an interlocked structure. For example, terminal olefin groups would 
be small enough to easily thread into a macrocyclic receptor like 17 or 18, and ring closing 
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olefin metathesis on the complex would then give a catenane. This chapter focuses on 
attempts to obtain these new olefin-terminated barbiturates, and on binding studies with a 
simpler barbiturate that has a similar structure. 
The reaction described in Scheme 5.1 was repeated successfully in a yield of 84%, 
which was almost as good as the one of 85% quoted in the literature.1 X-ray diffraction on the 
crystalline product also allowed its solid state structure to be determined (Figures 5.1, 5.2 and 
Appendix 1). 
 
Figure 5.1. X-Ray crystal structure of 38. 
It can be observed that the barbituric acid moiety is nearly planar. The two phenyl 
groups are not in the same plane perpendicular to the plane of the barbiturate, but are twisted 
with respect to one another. The angles that they make with the medium plane of the 
barbiturates are practically equal for the two phenyl rings (77° for the plane of the ring 
C(5)-C(10), and 80° for the plane of the ring C(11)-C(16)). This makes the axis defined by 
C(1), O(1) and C(3) as nearly an element of symmetry of the molecule by rotation through 
180°. The angle between the two phenyl planes is 59°. This twisting is due to the possible 
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steric interactions between the hydrogen atoms born by C(10) and C(12). The angle 
C(5)-C(3)-C(11), which governs the axes from which arms attached to the oxygen atoms 
would start, is 115° in this structure. 
As shown in Figure 5.2, there are intermolecular hydrogen bonds formed in the solid 
state between the OH, CO and NH groups. 
 
Figure 5.2. H-bonds between molecules of 38 in the solid state as determined by XRD. 
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Scheme 5.2. Direct substitution with methyl iodide. 
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First of all, direct nucleophilic substitution of 38 was attempted in order to obtain 
O-substituted products. Initially various alkyl iodides were attempted under different 
conditions, but reactivity was poor.2a However a reaction with methyl iodide proceeded 
readily and a disubstituted product was obtained. However, its IR spectrum (see Figure 5.3) 
revealed that it was not the desired product 39 as substitution had in fact occurred on the N 
site, leading to 40 (see Scheme 5.2). When the reaction was repeated using DBU 
(1,8-Diazabicyclo[5.4.0]undec-7-ene, an hindered base) instead of potassium carbonate, the 
same product was obtained.2a 
 
Figure 5.3. IR spectra of 38, 39 and 40. 
In order to confirm that the product obtained by this reaction was indeed 40, 39 was 
synthesised from alloxan monohydrate and anisole using a similar procedure1 as that for 38, 
leading to 39 in 25% yield. A comparison of the IR spectra (see Figure 5.3) of 39 and 40 
confirms this difference, as the ν(O-H) stretching band at 3341 cm-1 in the spectrum of 40 is 
not seen in the spectrum of 39, whereas the ν(N-H) stretching band at 3217 cm-1 in the 
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spectrum of 39 is not seen in the spectrum of 40. The spectrum of 38, by contrast, contains 
these two bands. This difference is also visible by 1H NMR; the chemical shifts for the OH 
protons in 39 and for the NH protons in 40 vary in different spectra with concentration and 
therefore cannot be used easily to confirm the structure. However the signal for the N-Me 
group in 40 arises at 3.27 ppm and that for the O-Me group in 39 arises at 3.79 ppm. 
It was thought that the reason for the substitution at the NH position instead of the OH 
position was because of the higher acidity of the NH group. Comparing the pKa of similar 
compounds described in the literature, the pKa of the NH3 should be close to 7.3 whereas the 
pKa of the OH3b, 4  should be close to 9.4. However it is likely that both sites can be 
deprotonated in the conditions of this reaction, or that it is the intermediate formed after a first 
step of nucleophilic substitution that is deprotonated. In this case it is the reactivity of both 
sites in the nucleophilic substitution that has to be compared. According to the theory of hard 
and soft acids and bases (HSAB),5 the deprotonated nitrogen site is a softer base than the 
deprotonated phenol site, both because the electronegativity of the nitrogen is lower than the 
electronegativity of the oxygen and because the charge of the anion will be delocalised on the 
carbonyl. For this reason, according to the HSAB principle that hard acids prefer to bond to 
hard bases and soft acids to soft bases, the alkyl halide, which can be considered as a soft 
electrophile, is more likely to bond to the nitrogen site. 
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Figure 5.4: XRD of 39. 
An X-ray structure of 39 was also obtained (see Figure 5.4), showing at the molecular 
scale and in the solid state a structure which is quite different from that of 38. In this structure, 
the position of one of the OMe groups, corresponding to O(4) and C(17), was found to be 
disordered over two positions with an occupancy ratio of 72:28. As in 38, the phenyl groups 
are not in the same plane and the main reason for this is certainly again the steric interaction 
between the hydrogen atoms born by C(10) and C(12). But this time the barbiturate ring is not 
entirely planar. If we call “plane of the barbiturate” the medium plane formed by C(4)-N(2)-
C(1)-N(1)-C(2) and O(1), which atoms are all very close to planarity, the carbon C(3) is 
slightly out of this plane, at a distance of 0.42 Å, and this plane makes an angle of 30° with 
the plane defined by the atoms C(2)-C(3)-C(4). O(2) and O(3) are also slightly out of the 
plane of the barbiturate but on the other side: the medium plane of C(2)-O(2) and C(4)-O(3) 
forms an angle of 29° with the plane of the barbiturate, and the two oxygen atoms are at an 
average distance of 0.31 Å of this plane. This position of C(3) out of the medium plane allows 
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both phenyl rings to have particularly distinct orientations. One of them (C(5)-C(10)) makes 
an angle of 89° with the plane of the barbiturate, whereas the other (C(11)-C(16)) makes an 
angle of 86° with the other phenyl group, and of 90° with the plane of the barbiturate. In other 
words the medium planes of the three rings are nearly all perpendicular to each other. The two 
phenyl rings are also distinct in the sense that the medium plane of C(5)-C(10) is nearly a 
plane of symmetry of the molecule. This means that C(6) and C(7) on one side and C(10) and 
C(9) on the other side of this ring are in different environments, whereas the ring C(11)-C(16) 
is divided in two by this plane of symmetry, which means that C(12) and C(13) on one side 
and C(16) and C(15) on the other side of this ring have nearly symmetrical environments. 
 
Figure 5.5. H-bonds between molecules of 39 in the solid state as determined by XRD. 
Figure 5.5 shows only the minor OMe position, but the way that hydrogen bonds are 
formed between molecules in the solid state are similar. It can be observed that contrary to 
what was observed with 38, the hydrogen bonds form only between the terminal CO and the 
NH of the barbituric acid moieties whereas the oxygens of the OMe groups and the other CO 
of the barbiturate are not involved. 
New rigid barbiturates 
151 
 
5.1.3) Malonate strategy 
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Scheme 5.3. New rigid malonates obtained by Friedel-Crafts reaction. 
As the direct substitution of 38 was difficult, a strategy similar to the one described in 
Chapter 3 was then adopted. Diethyl bis-(para-hydroxyphenyl) malonate (41) was obtained 
from diethyl ketomalonate and phenol by a Friedel-Crafts reaction in similar conditions to 
those used for 38, in 43% yield. The methyl-substituted barbiturate 42 was also obtained by 
the same method, using anisole instead of phenol, in 14% yield (see Scheme 5.3). The bis-
substitution of this malonate on the oxygen site by different alkyl iodide and bromides was 
then realised, as illustrated in Scheme 5.4: 
EtO
O
OEt
O
NaH, THF
reflux overnight
R X 2.3 equiv.
Br
42       60 %
44        50 %
HO OH
EtO
O
OEt
O
RO OR
43       43 %Br
Me I
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Scheme 5.4. Substitution on the O site of 41. 
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  The yields of these reactions were moderate but slightly better with methyl iodide, 
which is probably due to iodide being a better leaving group than bromide. In each case the 
mono-substituted products were also isolated by chromatography at the end of the reaction. 
EtO
O
OEt
O
46     0  %44
(excess)
HN NH
O
O O
H2N NH2
O
NaH     DMSO, rt
RO OR
RO ORR:
45     0  %43
Me 42 39     19 %
 
Scheme 5.5. Conversion of rigid malonates to rigid barbiturates. 
The conversion of these malonates to the barbiturates was then studied, at first using 
the same conditions described in Chapter 3 (using sodium hydride in dimethylsulfoxide), as 
described in Scheme 5.5. Unfortunately, except for the conversion of 42 which gave 39 in 
19% yield, none of the target barbiturates were identified at the end of these reactions. This 
may be due to the difficult reproducibility of the reactions in DMSO. This solvent is 
hygroscopic and traces of decarboxylated hydrolysed starting material were observed by mass 
spectrometry. More interestingly, products of oxidation of these byproducts were also 
observed (see Scheme 5.6). The only oxidant in the reaction mixture is DMSO, so it is likely 
that this side reaction has a similar mechanism to Swern oxidation6 where DMSO is the actual 
oxidant. 
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Scheme 5.6. Products of side reactions observed in mass spectrometry in attempts to convert 
43 and 44 to 45 and 46. 
 Different conditions were then tried for the conversions of 43 to 45. The reaction was 
repeated using sodium hydride in DMF and sodium ethoxide in ethanol. In each case, the 
yields were always zero, and while no traces of oxidation were observed, the products of 
hydrolysis and partial reaction were still present. 
5.1.4) Friedel-Crafts reactions 
 As 39 was obtained by a Friedel-Crafts reaction, it was thought that this could be a 
way of directly obtaining substituted barbiturates starting from alloxan monohydrate. 
However, considering the harsh conditions of this reaction (in boiling acetic acid with two 
equivalents of H2SO4), functional groups appropriate for interlocked structure formation 
would be affected by these conditions. For example, aromatic stoppers would undergo 
competitive Friedel-Crafts reactions, and olefins would also take part in other side reactions 
including isomerisation and hydrolysis. This corresponds to what was observed (Scheme 5.7); 
the olefin-terminated phenol ether 47 was obtained in an excellent yield from phenol and 
10-bromodec-1-ene, but the Friedel-Crafts reaction with alloxan monohydrate under the same 
 conditions as used for 38 gav
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5.1.5) Protection 
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Scheme 5.8. Protection of the O-sites of 38 to give protected barbiturate 48. 
Contrary to what was observed with carbon electrophiles used in other substitutions, a 
substitution of 38 with tert-butyldimethylsilyl chloride gave a disubstituted product in 16% 
yield (Scheme 5.8) which was substituted on the O site, as can be seen by its IR spectrum 
which contains a ν(O-H) band and no ν(N-H) band (Figure 5.5). This seems to be governed 
by the principle of HSAB,5 the N site being softer than the O site and its relative softness 
being increased by charge delocalisation. 
It was thought that if 48 was deprotected in situ in the presence of an excess of a 
suitable electrophile, then the substitution could occur on the O position as this would be the 
first anion formed, but an attempt to obtain 46 by this strategy led to the N-substituted product 
49 in 69% yield (see Scheme 5.9). The fact that the substituents of 49 are situated on the N 
sites is again demonstrated by the disappearance of the ν(O-H) band and the reappearance of 
the ν(N-H) band in its IR spectrum (see Figure 5.6). This is more evidence that the 
regioselectivity of these substitution reactions is governed by HSAB,5 but it also demonstrates 
that there is no need for another base other than tert-butylamonium fluoride to perform this 
reaction from a TBDMS protected product. 
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Scheme 5.9. One pot deprotection of 48 and substitution on the N site to give 49. 
 
Figure 5.6. IR spectra of 48 and 49. 
5.2) Binding studies 
5.2.1) 1H NMR of a complex 
 As far as we are aware, barbiturate derivatives with two bulky aromatic groups 
directly substituted on the central carbon such as 39 have not previously been used as guest 
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molecules for “Hamilton-like” hosts. It was therefore important to establish that the extra 
steric bulk did not adversely affect their binding properties. 
A 1H NMR spectrum of a 1:1 mixture of 39 with 15 was made (5 mM in CDCl3). It 
was compared with spectra if 15 alone and 1:1 mixture of 15 with barbital (Figure 5.7). As 
with barbital and other barbiturates, the NH both of the receptor and the barbiturate shifted 
downfield, which indicated that a complex is forming. It was also interesting to notice that the 
signal of the olefinic proton of 15 was split in two signals of different integrations upon 
binding. This was interpreted as further evidence that two different isomers of 15, cis and 
trans, were present, as discussed in previous chapters. 
 
Figure 5.7. Detail of the 1H NMR spectra of 15, 1:1 mixture of 15 and barbital, and 1:1 
mixture of 15 with 39, all in CDCl3 at a concentration of 5 mM. 
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5.2.2) Titrations followed by UV-vis spectroscopy 
 In a similar way to what was done with anthracene-substituted flexible barbiturates 
(see Chapter 4) the absorption due to the phenoxy groups of 39 had to be corrected, leading to 
an increase in the margin of error and difficulty in fitting the data. The binding constants 
found by this method for 1:1 complexes are given in Table 5.2, where the error is given by 
Letagrop. As for the anthracene-substituted barbiturates, the actual error on the result may be 
higher. 
Table 5.2. Binding constants between 39 and 17 and 18 at room temperature, in 
dichloromethane, determined by UV-vis titration 
receptor n log(K) Error 
17 4 4.18 
(with barbital: 4.2) 
0.03 
18 6 4.98 
(with barbital: 5.79) 
0.06 
 The first observation that can be made is that barbiturate 39 actually binds to cyclic 
receptors 17 and 18 with similar affinities to barbital. In fact, if the binding constant with 18 is 
lower than it is with barbital, as expected because of the steric interactions, the binding 
constant with 17 is surprisingly very similar to the binding constant for 17 and barbital. 
Furthermore, contrary to what was observed with barbital, no better fit was obtained when 
assuming that a 2:1 complex could also form with 17. It is reasonable to think that this second 
complex could not form because of the potential steric interactions of the phenyl groups. 
5.2.3) Titrations followed by ITC 
The phenomenon of a negative slope at the beginning of the data that had been 
observed in titrations with barbital (cf. Chapter 2) was also observed here. Therefore titrations 
were made at a concentration of 0.05 mol.L-1 in order both to minimize this problem and 
obtain a satisfactory signal/noise ratio. Contrary to what was observed with barbital, a small 
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heat of dilution of 39 was recorded, which had to be removed from the values of heat changes 
obtained during the titrations before the fit. The results of the titrations are given in Table 5.3. 
Table 5.3. log(K), ∆H° and ∆S° of 1:1 complexation of open and closed receptors with 39  
measured by ITC in dichloromethane at room temperature, and comparison with binding 
constants of other barbiturates. 
receptor n log(K) ∆H° / kcal.mol-1 ∆S° / cal.K-1.mol-1 
12 6 4.35 ± 0.02 
(barbital: 4.43 ± 0.02) 
-21 ± 1 
(barbital: -17.0 ± 0.8) 
-51 ± 3 
(barbital: -37 ± 3) 
18 6 4.82 ± 0.03 
(barbital: 5.33 ± 0.07, 
37: 4.62 ± 0.04) 
-15.3 ± 0.5 
(barbital: -15.0 ± 0.2, 
37: -9.6 ± 0.9) 
-29 ± 2 
(barbital: -25.8 ± 0.8, 
37: -11 ± 3) 
 The binding of 39 to “open” receptor 12 gives rise to surprisingly big variations of 
∆H° and ∆S° compared to the binding of barbital. However the large unfavourable ∆S° is 
nearly completely compensated by a large favourable value of ∆H°, leading only to a small 
diminution of the binding constant. The large variation of ∆S° can be attributed to an 
important loss of freedom of motion, which may be associated with C-H / pi binding 
interaction that may force the pendant chain of the receptor to remain close to the barbiturate. 
This additional binding would also explain the larger value of ∆H°. 
The binding of 39 to 18 gives a ∆H° value close to the one found for the binding of 
barbital to 18 (within the margin of error), but a slightly less favourable ∆S°. The small 
difference in ∆H° indicates that either the hydrogen bonds formed are as strong as those with 
barbital, which means that 39 adopts a similar geometrical position as barbital in the complex 
(which is counter-intuitive because of the possible steric effects), or that some additional 
weak binding interactions compensate any loss in hydrogen bonds. Once again the small 
change in ∆S° can be explained by a larger loss of freedom of motion that results from the 
complexation of 39 compared with barbital. Another informative comparison can be made 
between data for the binding to 18 of 39 and 37, which are respectively “rigid” and “flexible” 
barbiturates. The lower entropic cost for the binding of the flexible barbiturate 37 may 
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indicate that this time the barbiturate 39 can adopt fewer geometrical positions than 37, which 
would be an advantage for the formation of interlocked structures if it means that it is only or 
mostly the threaded complex that is formed, and not the perched complex. 
5.2.4) Comparison of ab initio models, IR spectra and XRD structures 
 As was explained in Chapter 2, this work was done in Bordeaux by D. Cavagnat and 
T. Buffetau using a methodology developed by their group.8 Models of the complexes were 
established (see Figure 5.8) in order to calculate their theoretical IR spectra which were 
compared with their experimental spectra in solution (see Figure 5.9). 
The model of the complex of 18 and 39 is quite similar to the model of the complex of 
18 and barbital. The barbiturate is bound by six complementary hydrogen bonds and is 
completely threaded. The model of the complex of 17 and 39 also bears similarities to the 
complex of 17 with barbital, as the barbiturate is bound only on one side by three hydrogen 
bonds as was observed in the model 17∑barbital. However, this time one of the two rigid 
phenoxy substituents is forced to be threaded in the macrocycle, and protrudes in front of the 
other amidopyridine unit, blocking the arrival of another barbiturate. This gives an 
explanation for why no 2:1 complex could be observed in UV-vis. measurements. This 
phenoxy group may also be involved in favourable C-H / pi interactions between the aromatic 
ring and the hydrogens bound to the aliphatic closing chain. 
 Figure 5.8.
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Figure 5.9. Comparison of experimental and calculated IR spectra for 39, “reduced” receptors 
17 (above) and 18 (below) and their complexes. 
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 Finally, crystals of the complex between 18 and 39 were obtained by our colleagues 
from University Bordeaux 1, allowing them to determine the solid-state structure of these 
complexes in the solid state by X-ray crystallography. The structure obtained is presented in 
Figure 5.10 and more details are given in Appendix 1. 
 
Figure 5.10. Structure of the 18∑39 complex determined by X-ray diffraction. 
It is interesting to note that contrary to what was observed with barbital, this structure 
is very different to the one predicted by ab-initio models. In the solid state, the complex 
formed is clearly perched and not threaded. However, it can be argued that the gas-phase 
model probably gives a better description of what happens in solution (as it is backed by 
consistent IR-spectra). In the solid state, interactions between different complexes play a more 
important role, in particular intermolecular H-bonds, which are present in this structure. 
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5.3) Conclusion and further work 
 Binding studies with 39 indicate that barbiturates directly substituted with two bulky 
groups such as aromatic rings bind efficiently to Hamilton-like sites, even with receptors that 
are too small to form six complementary hydrogen bonds with barbital. The ab-initio models 
are generally in good agreement with the experimental IR spectra, ITC and UV titrations, but 
not with the structure obtained by XRD for the complex with 18. Except for this last result 
which can be interpreted as a phenomenon occurring only in the solid state, these studies tend 
to confirm the intuition that led to their synthesis, that these rigid guests have a structure that 
is more appropriate to the formation of interlocked structures than “flexible” barbiturates such 
as barbital. For this reason, rigid barbiturates with bulky groups and long appendages are 
promising candidates for obtaining interlocked structures. 
Friedel-Crafts reactions are reliable for obtaining the basic structure of two 
para-phenoxy groups linked to the sp3 carbon of the barbiturate ring. However this only 
applies to simple and robust starting materials that do not contain other reactive groups such 
as aromatic stoppers or terminal olefins. The starting barbiturate or malonate can be made, but 
then other strategies have to be used in order to introduce the desired functions on the 
barbiturate. 
The conversion of malonates to barbiturates when the substituents of the malonate are 
bulky has also proved to be very difficult, which is probably because of steric reasons. There 
is good experimental evidence that the regioselectivity of nucleophilic substitutions on 38 is 
governed by HSAB,5 which results in a reaction on the N position rather than the O when 
using a carbon electrophile. 
The right strategy (Scheme 5.10) will then probably be to protect the O sites of 38 
with TBDMS, then the N sites with Boc, then to deprotect the O with tBAF and substitute the 
desired pendant arm on the O, then finally to deprotect the N. There is at least one example of 
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a similar strategy in the literature,9 but it is not on a barbiturate, which suggests that the last 
step (deprotection of the N-Boc) may be difficult and require acid conditions, but nevertheless 
less harsh than those used in the Friedel-Crafts reactions described above. 
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Scheme 5.10. Protection / deprotection strategy for accessing new rigid barbiturates. 
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6) EXPERIMENTAL 
6.1) Syntheses 
6.1.1) General considerations 
 All starting materials were purchased from Aldrich or Lancaster. The solvents were 
ordered from Sigma. The solvents used for reactions were dried by classical methods: 
distillation from calcium hydride for DCM (dichloromethane), hexane and acetonitrile, 
distillation from sodium wires and benzophenone for THF (tetrahydrofuran) and diethyl ether. 
Toluene, acetone and ethyl acetate were not dried. All reactions were carried out under N2. 
When the product of the reaction contained the anthracene substructure, the reaction vessels 
were covered with foil to prevent any effect of light. Unless otherwise stated, the column 
chromatographies were made with silica gel (Merck, 230-400 mesh). 
 The NMR spectra were recorded on Bruker AC300 or AV300 spectrometers (300 
MHz). The mass spectra were recorded on VG Zabspec mass spectrometer. 
6.1.2) Experimental procedures and analysis of the products 
1 (7-octenoic acid)1 
O
OH1
2
3
4
5
6
7
8
  
0.5 mL of a solution of 7-bromohept-1-ene (0.40 mL, 2.62 mmol) 
in diethyl ether (11 mL) was added to a suspension of magnesium 
powder (77.4 mg, 3.18 mmol) in diethyl ether (3 mL). The mixture was heated to reflux. 
When the solution became turbid, the heating was stopped and the rest of the solution was 
added drop wise, so that the reflux was maintained. It was left stirring without heating during 
1h, refluxed 15 min and finally cooled to 0°C. The solution was then removed with a syringe 
and added to a mixture of powdered dry ice (CO2, 5 g, 114 mmol) and diethyl ether (2 mL). 
After 30 min of stirring, water and ammonium chloride were added. This solution was filtered 
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and extracted with 20 mL of ether. The aqueous phase was acidified with concentrated HCl 
until it became turbid, then it was re-extracted with diethyl ether. This second organic phase 
was dried over MgSO4, filtered and evaporated, giving 131.5 mg of 1 as an orange liquid 
(0.925 mmol, 35%). 1H NMR (CDCl3, 300 MHz): δ = 10.06 (br. s, 1 H, OH), 5.79 (ddt, Jt = 
6.7, Jd1 = 10.3 and Jd2 = 17.1  Hz, 1 H, 7), 4.97 (m, 2 H, 8), 2.35 (t, J = 7.5 Hz, 2 H, 2), 2.05 
(q, J = 7.0 Hz, 2 H, 6), 1.64 (quint, J = 7.3 Hz, 2 H, 3), 1.38 (m, 4 H, 4 & 5). The analysis is 
in agreement with the literature data.1 
2 (8-nonenoic acid)2 
O
OH1
2
3
4
5
6
7
8
9
  
A solution of 8-bromooct-1-ene (4.9 g, 25.6 mmol) in diethyl 
ether (50 mL) was added drop wise to a suspension of 
magnesium powder (670 mg, 27.6 mmol) in diethyl ether (75 mL) at reflux. After 1h30 min 
of reflux, it was cooled to 0°C and powdered dry ice (CO2, 30 g, 682 mmol) was added. After 
breaking the solids by vigorous stirring, a solution of sodium hydroxide (1.7 g) in water 
(100 mL) was added. The mixture was filtered and the organic phase was extracted with 
20 mL of diethyl ether. The aqueous phase was acidified with concentrated HCl until pH < 2, 
then it was re-extracted with 2 µ 30 mL of diethyl ether. This second organic phase was dried 
with MgSO4, filtered and evaporated, giving 2.18 g of 2 as an colorless liquid (14.0 mmol, 
54.5% yield). 1H NMR (CDCl3, 300 MHz): δ = 10.85 (br. s, 1 H, OH), 5.79 (ddt, Jt = 6.7, 
Jd1 = 10 and Jd2 = 17 Hz, 1 H, 8), 4.96 (m, 2 H, 9), 2.34 (t, J = 7.5 Hz, 2 H, 2), 2.05 (q, 
J = 6.7 Hz, 2 H, 7), 1.69 (quint, J = 7.4 Hz, 2 H, 3), 1.34 (m, 6 H, 4, 5 & 6). Mass spectrum 
(EI+): m/z = 156 {M●+}, 138 (loss of water), 114 (Mc Lafferty). The analysis is in agreement 
with the literature data.2 
6-heptenoyl chloride (n = 4) 
O
Cl1
2
3
4
5
6
7
 
Oxalyl chloride (10 mL, 115 mmol) was added drop wise to a solution 
of 6-heptenoic acid (3.35 g, 26.3 mmol) and DMF (0.1 mL) in DCM 
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 (100 mL) at 0°C. The solution was left stirring overnight at room temperature, and the 
solvent was evaporated under reduced pressure. 3.42 g of orange oil and black solid were 
obtained. It was proved by NMR that the oil was the pure desired product whereas the solid 
contained impurities. The oil was used for the next step without further purification. 1H NMR 
(CDCl3, 300 MHz): δ = 5.77 (ddt, Jt = 6.9, Jd1 = 11.1 and Jd2 = 16.2 Hz, 1 H, 6), 5.00  (m, 
2 H, 7), 2.90 (t, J = 7.16 Hz, 2 H, 2), 2.08 (q, J = 7.11 Hz, 2 H, 5), 1.72 (quint, J = 7.4 Hz, 
2 H, 3), 1.45 (quint, J = 7.5 Hz, 2 H, 4). 
3 (7-octenoyl chloride) 
O
Cl1
2
3
4
5
6
7
8
 
Oxalyl chloride (3 mL, 34.4 mmol) was added drop wise at 0°C to 
a solution of 1 (131 mg, 0.92 mmol) and DMF (0.1 mL) in DCM 
(10 mL). After 20h of stirring at room temperature, the solvents and excess oxalyl chloride 
were evaporated to afford 150 mg of solid which was used for the next step without further 
purification. (CDCl3, 300 MHz): δ = 5.75 (m, 1 H, 7), 4.99 (m, 2 H, 8), 2.88 (t, J = 7.3 Hz, 
2 H, 2), 2.05 (q, J = 6.5 Hz, 2 H, 6), 1.71 (quint, J = 7.3 Hz, 2 H, 3), 1.38 (m, 4 H, 4 & 5), + 
oxalic acid (11.4 ppm) and DMF (2 s near 3.0 ppm). 
4 (8-nonenoyl chloride) 
O
Cl1
2
3
4
5
6
7
8
9
 
Oxalyl chloride (1.2 mL, 13.7 mmol) was added drop wise at 
0°C to a solution of 2 (470 mg, 3.0 mmol) and DMF (20 µL) in 
DCM (20 mL). After 20h of stirring at room temperature, the solvents and excess oxalyl 
chloride were evaporated to afford 530 mg of solid which was used for the next step without 
further purification. 1H NMR (CDCl3, 300 MHz): δ = 5.79 (ddt, Jt = 6.7, Jd1 = 10 and 
Jd2 = 17 Hz, 1 H, 8), 4.98 (m, 2 H, 9), 2.88 (t, J = 7.3 Hz, 2 H, 2), 2.04 (q, J = 6.9 Hz, 2 H, 7), 
1.71 (quint, J = 7.2 Hz, 2 H, 3), 1.36 (m, 6 H, 4, 5 & 6), + oxalic acid (11.0 ppm) and DMF 
(8.21, 3.09 and 2.96 ppm). 
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5 (dodecanedioyl chloride) 
O
O
Cl
Cl
  
Dodecanedioic acid (229 mg, 1.0 mmol) was 
dissolved in a mixture of DCM (100 mL) and THF 
 (20 mL). One drop of DMF was added. To this stirred suspension, oxalyl chloride (660 µL, 
7.8 mmol) was added at 0°C. The mixture was left stirring at room temperature overnight, 
then the volatiles were evaporated, giving 364 mg of 5 as an oily solid which was used for the 
next step without further purification. 
6 (hexadecanedioyl chloride) 
O
O
Cl
Cl
  
Oxalyl chloride (660 µL, 4.73 mmol) was 
added at 0°C to a solution of 
hexadecanedioic acid (286 mg, 1 mmol) and DMF (one drop) in THF (100 mL). The mixture 
was left stirring at room temperature overnight, then the volatiles were evaporated, giving 6 as 
a crude (green liquid and black solid) which was used for the next step without further 
purification. 
7 (5-tert-Butyl isophthaloyl dichloride)3 
O O
Cl Cl
1
2
3
4
6
5
7
 
Oxalyl chloride (17 g, 0.134 mol) was added to a solution of 5-tert-
butyl isophthaloic acid (5 g, 22.5 mmol) in DCM (60 mL). One drop of 
DMF  (approx. 0.05 mL)  was added:  a gas release was observed.  The 
solution was left stirring 20h at room temperature. Then the solvent was evaporated, affording 
7.0 g of a yellow solution which crystallised partly in a yellow oily solid and partly in a white 
crystalline solid. By analysis, the white solid is pure 7 and the yellow solid is the same with 
traces of DMF and water (quantitative yield). 1H NMR (CDCl3, 300 MHz): δ = 8.67 (t, 
J = 1.7 Hz, 2 H, 3), 8.40 (d, J = 1.6 Hz, 1 H, 1), 1.40 (s, 9 H, 6). IR (ν, cm-1): 3100 (m, 
Csp2-H), 2967 (m, Csp3-H), 1758 (s, conjugated carbonyl chloride C=O), 1588 (w, conjugated 
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aromatic C=C), 1474 & 1437 (w, aromatic C=C), 1368 (w, Csp3-H), 1214 & 1149 (w, Csp3-H), 
992 (w, Csp3-H), 687 (s, C-Cl). The analysis is in agreement with the literature data.3 
8 (N,N'-Bis-(6-aminopyridin-2-yl)-5-tert-butyl isophthalamide) 
O
HN
O
NH
N
NH2
N
NH2
2
1
3
4
5
6
7
8
9
10
11
12
 
A solution of 7 (1.05 g, 4.05 mmol) in THF (50 mL) was 
added dropwise at room temperature to a solution of 2,6-
diaminopyridine (4.13 g, 37.8 mmol) and triethylamine 
(1.18 mL, 8.5 mmol) in THF (100 mL). The mixture was left 
stirring  20h   at   room  temperature,   then  the  solvent   was
evaporated and 150 mL of water were added to the crude. After 10 min of stirring, the mixture 
was filtered and the 1.4 g of grey wet solid that were obtained were separated by flash 
chromatography (eluent: DCM/THF 3:1) to give 1.39 g of desired product as a beige solid 
(3.43 mmol, 85% yield). mp 142°C. 1H NMR (CDCl3, 300 MHz): δ = 9.31 (br. s, 2 H, NH), 
8.27 (t, J = 1.6 Hz, 1 H, 1), 8.12 (d, J = 1.5 Hz, 2 H, 3), 7.63 (d, J = 7.3 Hz, 2 H, 9), 7.43 (t, 
J = 8.1, 2 H, 10), 6.24 (d, J = 7.8 Hz, 2 H, 11), 4.47 (br. s, 4 H, NH2), 1.32 (s, 9 H, 6). 
13C NMR (DMSO-d6, 300 MHz): δ = 165.07 (7), 158.52 (8), 151.31 (4), 150.35 (12), 138.91 
(10), 134.07 (2), 127.93 (3), 124.20 (1), 104.00 (9), 101.79 (11), 30.87 (6), 30.35 (5). Mass 
spectrum (ES+, exact mass): m/z = 427.1851 {M + Na+}, calculated: 427.1858. Elemental 
analysis: found: H, 6.16; C, 65.48; N, 18.35; calculated with 0.5 equiv. THF: H, 6.53; 
C, 65.47; N, 18.57. 
9 (5-tert-Butyl-N,N'-bis-(6-pent-4-enoylamino-pyridin-2-yl)-isophthalamide) 
A solution of pent-4-enoic anhydride (109 µL, 0.596 mmol) in THF (25 mL) was added 
slowly to a solution of 8 (100 mg, 0.247 mmol) and triethylamine (88 µL, 0.631 mmol) in 
THF (40 mL). The mixture was heated and left stirring at reflux overnight. Then the solvent 
was evaporated and the crude was re- NaHCO3, dried over MgSO4, filtered and evaporated. 
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The yellow solid obtained washed with hexane, to give 
77.6 mg of 9 as a white solid (0.136 mmol, 
23% yield).dissolved in dichloromethane, washed with 
aqueous 5% 1H NMR (CDCl3, 300 MHz): δ = 9.10 
(br. s, 2 H, NH between 7 and 8), 8.36 (br. s, 2 H, 3), 
8.28 (br. s, 1 H, 1), 8.17 (br. s, 2 H, NH between 12 and 
13), 8.02 (d, J = 7.0 Hz, 2 H, 11), 7.90 (d, J = 6.3 Hz, 
2 H, 9), 7.73 (t, J = 8.1 Hz, 2 H, 10), 5.84 (m, 2 H, 16),5.08 (br. d, J = 17.4 Hz, 2 H, 17a), 
5.01 (br. d, J = 11.5 Hz, 2 H, 17b), 2.54 (m, 8 H, 14 & 15), 1.38 (s, 9 H, 6).Mass spectrum 
(ES+): m/z = 607 {M + K+}, 591 {M + Na+}, 569 {M + H+}. Elemental analysis: found: 
H, 6.73; C, 68.82; N, 13.03; calculated with 0.5 equiv. hexane: H, 7.08; C, 68.72; N, 13.74. 
10 (5-tert-Butyl-N,N'-bis-(6-hept-6-enoylamino-pyridin-2-yl)-isophthalamide) 
O
HN
O
NH
N
NHO
N
HN O
1
2
3
4
5
6
7
8
9
10
11
12
13
14 15
1617
1819
 
A solution of 6-heptenoyl chloride (788 mg, 
5.37 mmol) in THF (40 mL) was added slowly to a 
solution of 8 (891 mg, 2.20 mmol) and triethylamine 
(0.85 mL, 6.1 mmol) in THF (120 mL). The mixture was 
left stirring at room temperature overnight, then the 
solvent was evaporated and the crude was re-disolved in 
dichloromethane, washed with 4 µ 50 mL of aqueous 
NaHCO3 (5%) + NaCl solution, dried over MgSO4, filtered and evaporated. The solid 
obtained was washed with 2 µ 150 mL hexane, to give 764 mg of 10 as a yellowish solid 
(55.5%). mp 182°C. 1H NMR (CDCl3, 300 MHz): δ = 8.48 (br. s, 2 H, NH between 7 and 8), 
8.23 (m, 1 H, 1), 8.14 (d, J = 1.5 Hz, 2 H, 3), 8.05 (d, J = 8.1 Hz, 2 H, 11), 7.97 (d, 
J = 8.0 Hz, 2 H, 9), 7.77 (t and s, Jt = 8.0 Hz, 4 H, 10 & NH between 12 and 13), 5.80 (ddt, 
Jt = 6.7, Jd1 = 10.2 and Jd2 = 17.0 Hz, 2 H, 18), 5.00 (m, 4 H, 19), 2.41 (t, J = 7.5 Hz, 4 H, 
14), 2.10 (q, J = 7.1 Hz, 4 H, 17), 1.76 (quint., J = 7.7 Hz, 4 H, 15), 1.49 (quint., J = 7.6 Hz, 
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4 H, 16), 1.40 (s, 9 H, 6). 13C NMR (CDCl3, 300 MHz): δ 171.84 (13), 165.24 (7), 153.29 (8), 
149.79 (12), 149.49 (4), 140.87 (10), 138.19 (18), 134.37 (2), 128.47 (3), 122.60 (1), 114.82 
(19), 110.04 (9), 109.76 (11), 37.42 (14), 35.17 (5), 33.36 (17), 31.06 (6), 28.34 (16), 24.71 
(15). Mass spectrum (ES+, exact mass): m/z = 647.3337 {M + Na+}, calculated : 647.3322. 
Elemental analysis: found: C, 67.77; H, 7.31; N, 13.65; calculated with 0.66 equiv. of water: 
C, 67.90; H, 7.18; N, 13.20. 
11 (5-tert-Butyl-N,N'-bis-(6-oct-7-enoylamino-pyridin-2-yl)-isophthalamide) 
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A solution of 3 as obtained at the last step (containing 
DMF and oxalic acid) (150 mg) in THF (20 mL) and 
DCM (20 mL) was added slowly to a solution of 8 
(155 mg, 0.383 mmol) and triethylamine (1.2 mL, 
8.61 mmol) in THF (60 mL). The mixture was left 
stirring at room temperature overnight, then the solvent 
was evaporated and the crude was re-dissolved in DCM 
 (15 mL), washed with aqueous 5% NaHCO3, dried over MgSO4, filtered and evaporated, to 
give 207.3 mg of red viscous oil. It was separated by flash chromatography (silica gel, eluent 
DCM / ethyl acetate 30 / 70) to give 17.1 mg of 11 as a yellow solid (6.8% yield). 1H NMR 
(CDCl3, 300 MHz): δ = 8.33 (s, 2 H, NH between 7 and 8), 8.18 (m, 5 H, 1, 3 & 11), 8.10 (m, 
4 H, 9 & NH between 12 and 13), 7.72 (t, J = 7.9 Hz, 2 H, 10), 5.78 (m, 2 H, 19), 4.95 (m, 
4 H, 20), 2.40 (t, J = 7.53 Hz, 4 H, 14), 2.03 (m, 4 H, 18), 1.72 (m, 4 H, 15), 1.63 (m, 17 H, 6, 
16 & 17) + traces of monosubstituted product (6.3 ppm, d, J = 7.9 Hz, free NH2). 
12 (5-tert-Butyl-N,N'-bis-(6-non-8-enoylamino-pyridin-2-yl)-isophthalamide) 
A solution of 4 (530 mg, 3.0 mmol) in THF (100 mL) was added slowly to a solution of 8 
(500 mg, 1.24 mmol) and triethylamine (0.5 mL, 3.6 mmol) in THF (150 mL). The mixture 
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was left stirring at room temperature overnight, then the 
solvent was evaporated and the crude was re-dissolved 
in DCM (200 mL), washed with an aqueous solution of 
NaHCO3 (5%) and NaCl (5%), dried with MgSO4, 
filtered and evaporated. The yellow solid obtained was 
re-dissolved in 10 mL of DCM and methanol, and 
250 mL of hexane were added, causing the 
precipitation of a solid which was filtered, re-dissolved 
in DCM and methanol and evaporated, to afford 787 mg of 12 as a white solid (93% yield). 
mp 175°C. 1H NMR (CDCl3, 300 MHz): δ = 8.67 (m, 2 H, NH between 7 and 8), 8.18 (m, 
3 H, 1 and 3), 7.99 (m,4 H, 11 & 9), 7.73 (m, 4 H, 10 & NH between 12 and 13), 5.78 (m, 2 H, 
20), 4.94 (m, 4 H, 21), 2.38 (m, 4 H, 14), 2.01 (m, 4 H, 19), 1.70 (m, 4 H, 15), 1.63 (m, 21 H, 
6, 16, 17 & 18). 13C NMR (CDCl3, 300 MHz): δ = 171.76 (13), 164.91 (7), 153.41 (8), 149.73 
(12), 149.32 (4), 140.95 (10), 138.87 (20), 134.49 (5), 128.31 (3), 122.60 (6), 114.34 (21), 
110.07 (9), 109.68 (11), 37.70 (14), 35.21 (2),  33.64 (19), 31.12 (1), 29.01 (18), 28.77 (17), 
28.65 (16), 25.25 (17). Mass spectrum (ES+, exact mass): m/z = 703.3953 {M + Na+}, 
calculated : 703.3948. Elemental analysis: found: C, 70.28; H, 7.78; N, 12.28; calculated: C, 
70.56; H, 7.70; N, 12.34. 
13 (5-tert-Butyl-N,N'-bis-(6-undec-10-enoylamino-pyridin-2-yl)-isophthalamide) 
A solution of 10-undecenoyl chloride (0.26 mL, 0.25 g, 1.2 mmol) in THF (15 mL) was 
added to a solution of 8 (202 mg, 0.50 mmol) and triethylamine (0.17 mL, 1.2 mmol) in THF 
(85 mL)  at 0°C. The mixture was left stirring overnight at room temperature, then the solvent 
was evaporated and the crude was re-dissolved in dichloromethane, washed with 4 µ 25 mL 
of aqueous 5% NaHCO3, dried with MgSO4, filtered and evaporated. The yellow solid 
obtained was washed with 2 µ 50 mL of hexane, to give 243 mg of 13 as a yellow solid 
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(66% yield). mp 130°C. 1H NMR (CDCl3, 300 MHz): 
δ = 8.38 (s, 2 H, NH between 7 and 8), 8.21 (s, 1 H, 1), 
8.13 (s, 2 H, 3), 8.06 (d, J = 8.1 Hz, 2 H, 11), 7.98 (d, 
J = 8.0 Hz, 2 H, 9), 7.78 (t, J = 8.0 Hz, 2 H, 10), 7.67 
(s, 2 H, NH between 12 and 13), 5.80 (ddt, Jt = 6.8, 
Jd1 = 10.2, Jd2 = 16.9 Hz, 2 H, 22), 4.96 (m, 4 H, 23), 
2.40 (t, J = 7.4 Hz, 4 H, 14), 2.03 (q, J = 7.0 Hz, 4 H, 
21), 1.74 (quint., J = 7.2 Hz, 4 H, 15), 1.42 (s, 9 H, 6), 
1.32 (m, 20 H, 16, 17, 18, 19, 20). 13C NMR (CDCl3, 
300 MHz): δ = 171.76 (13), 164.94 (7), 153.39 (8), 149.73 (12), 149.37 (4), 140.99 (10), 
139.09 (22),  134.49 (2), 128.33 (3), 122.65 (1), 114.16 (23),110.04 (9), 109.70 (11), 37.76 
(14), 35.22 (5), 33.73 (21), 31.14 (6), 29.28 (18 or 19), 29.26 (19 or 18), 29.17 (20), 29.03 
(17), 28.85 (16), 25.30 (15). Mass spectrum (ES+, exact mass): m/z = 759.4586 {M + Na+}, 
calculated: 759.4574. Elemental analysis: found: C, 70.48; H, 8.30; N, 10.99; calculated with 
0.5 equiv. ethyl acetate: C, 70.74; H, 8.26; N, 10.76. 
Ring closure metathesis experiment on 9
 
A solution of Grubbs’ 1st generation catalyst (bis(tricyclohexylphosphine)benzylidene 
ruthenium(IV) dichloride) (6 mg) in DCM (2 mL) was added drop wise to a solution of 9 
(40 mg) in DCM (8 mL) under reflux. The mixture was left stirring at reflux overnight. Then 
the solvent was evaporated to give 48.9 mg of green solid which was analysed by mass 
spectrometry, 1H and 31P NMR: it is a mixture of starting material, Grubbs’ catalyst and 
products of decomposition of the catalyst. 
  
Experimental 
176 
 
14 (ring closure metathesis experiment on 10) 
O O
HNNH
NN
NH HNO O
1
2
34
5
6
7
8
9
10
11
12
13
14
15
16
17
18
 
A solution of Grubbs’ 1st generation catalyst (66.6 mg, 
80.9 µmol) in DCM (50 mL) was added drop wise to a 
solution of 10 (500 mg, 801 µmol) in DCM (10 mL) at 
reflux. The mixture was heated to reflux and left stirring 
for 5 hours, then the solvent was evaporated to give 
62.1 mg of green solid which was washed with hexane to  
give a yellow oil. Flash chromatography on silica (eluent: DCM / ethyl acetate with increasing 
ratio of ethyl acetate) finally gave 209.2 mg of 14 (351 µmol, 44% yield) as a brown solid, 
mixture of cis and trans isomers (approx. 68% cis ± 6% according to 13C NMR). mp 298°C. 
1H NMR (CDCl3, 300 MHz): δ = 8.38 (m, 5 H, 1, 3 & NH between 7 and 8), 8.13 (d, J = 8.3, 
2 H, 9), 7.97 (d, J = 8.1, 2 H, 11), 7.82 (t, J = 8.3 Hz, 2 H, 10), 7.69 (br. s., 2 H, NH between 
12 and 13), 5.40 (m, 2 H, 18), 2.43 (m, 4 H, 14), 2.08 (m, 4 H; 17), 1.79 (m, 4 H, 15), 1.50 (m, 
4 H, 16), 1.42 (s, 9 H, 6). 13C NMR (CDCl3, 300 MHz): δ = 172.50 (13), 165.15 (7 trans), 
164.88 (7 cis), 153.60 (8 cis), 153.53 (8 trans), 149.99 (6 cis), 149.96 (6 trans), 149.92 (4 cis), 
149.86 (4 trans), 140.81 (10 cis), 140.69 (10 trans), 133.68 (2 trans), 133.49 (2 cis), 129.63 
(18 cis), 129.80 (3), 130.04 (18 trans), 120.86 (1), 109.59 (9), 109.45 (11 trans), 109.35 (11 
cis), 37.45 (14 trans), 37.19 (14 cis), 35.16 (5), 31.59 (17 trans), 31.00 (6 cis), 30.98 (6 trans), 
28.75 (16 cis), 28.30 (16 trans), 26.37 (17 cis), 24.84 (15 cis), 24.38 (15 trans). Mass 
spectrum (ES+, exact mass): m/z = 619.3009{M + Na+}, calculated: 619.3006. Elemental 
analysis: found: C, 65.37; H, 6.79; N, 13.02; calculated with 0.4 equiv. dichloromethane: 
C, 65.51; H, 6.52; N, 13.33. 
15 (ring closure metathesis experiment on 12) 
A solution of Grubbs’ 1st generation catalyst (48.5 mg, 59.0 µmol) in DCM (40 mL) was 
added drop wise to a solution of 12 (404 mg, 593 µmol) in DCM (150 mL) at reflux. The 
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mixture was heated to reflux and left stirring during 4 
hours, then the solvent was evaporated to give a green 
solid which was separated by flash chromatography on 
silica (eluent: DCM / ethyl acetate with increasing ratio 
of ethyl acetate), to give finally 151.2 mg of 15 
(231.6 µmol, 39% yield) as a mixture of cis and trans 
isomers (approx. 79% cis ± 5% according to 13C NMR).  
mp > 300°C. 1H NMR (CDCl3, 300 MHz): δ = 8.32 (m, 3 H, 1 & 3), 8.11 (m, 2 H, 9), 8.00 (d, 
J = 8.6, 2 H, 11), 7.81 (m, 4 H, 10 & NH between 7 and 8), 7.62 (m, 2 H, NH between 12 and 
13), 5.35 (m, 2 H, 20), 2.39 (m, 4 H, 14), 1.98 (m, 4 H, 19), 1.75 (m, 4 H, 15), 1.41 (s, 9 H, 6), 
1.36 (m, 12 H, 16, 17 & 18). 13C NMR (CDCl3 + 5% MeOH, 300 MHz): δ = 172.30 (13), 
165.41 (7), 153.62 (8), 149.86 (12), 149.84 (4), 140.84 (10 cis), 140.73 (10 trans), 134.04 (2), 
130.29 (20 trans), 129.89 (3 cis), 129.80 (20 cis), 129.76 (3 trans), 120.46 (1), 109.70 (9), 
109.62 (11 trans), 109.59 (11 cis), 39.80 (5 cis), 37.79 (14 trans), 37.60 (5 trans), 35.15 (14 
cis), 31.91 (19 trans), 30.98 (6), 29.11 (18 cis), 28.76 (18 trans), 28.68 (17 cis), 28.38 (19 cis), 
27.93 (17 trans), 26.65 (16), 25.42 (15 trans), 25.21 (15 cis). Mass spectrum (ES+, exact 
mass): m/z = 675.3651{M + Na+}, calculated: 675.3635. Elemental analysis: found: C, 70.02; 
H, 7.79; N, 11.88; calculated with 0.25 equiv. hexane and 0.25 equiv. ethyl acetate: C, 69.85; 
H, 7.74; N, 12.07. 
16 (ring closure metathesis experiment on 13) 
A solution of Grubbs’ 1st generation catalyst (14 mg, 17.0 µmol) in DCM (5 mL) was added 
drop wise to a solution of 13 (99 mg, 134 µmol) in DCM (20 mL). The mixture was heated to 
reflux and left stirring during 2 hours, then the solvent was evaporated to give 93 mg of green 
solid. A flash chromatography (eluent: pentane / ethyl acetate with increasing ratio of ethyl 
acetate), finally gave 70 mg of isolated 16 as a mixture of cis and trans isomers (approx. 
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66% cis ± 6% according to 13C NMR) (98.7 mmol, 
73.5% yield). mp > 300°C 1H NMR (CDCl3, 300 MHz): 
δ = 8.54 (s, 2 H, NH between 7 and 8), 8.28 and 8.25 (m, 
3 H, 1 & 3), 8.05 (br. s, 2 H, NH between 12 and 13), 
7.98 (m, 2 H, 9), 7.78 (m, 4 H, 10 & 11), 5.33 (t, J = 3.7 
Hz, 2 H, 22), 2.38 (t, J = 7.3 Hz, 4 H, 14), 1.98 (m, 4 H, 
21), 1.73 (quint., J = 7.2 Hz, 4 H, 15), 1.38 (s, 9 H, 6), 
1.28 (m, 20 H, 16, 17, 18, 19 & 20). 13C NMR (CDCl3, 
 300 MHz): δ = 171.97 (13), 165.29 (7), 153.91 (8), 149.79 (12), 149.63 (4), 140.96 (10 trans), 
140.87 (10 cis), 134.20 (2 trans), 134.03 (2 cis), 130.47 (22 trans), 129.95 (22 cis), 129.74 (3 
trans), 128.67 (3 cis), 114.20 (1), 110.31 (9 cis), 110.09 (9 trans), 109.83 (11), 37.80 (14), 
35.24 (5), 32.14 (21 trans), 31.03 (6), 29.45 (18 cis), 29.28 (19 cis), 29.15 (18 trans), 29.11 
(19 trans), 29.06 (17 & 20), 28.81 (16 cis) 28.27 (16 trans), 26.90 (21 cis), 25.50 (15 trans), 
25.34 (15 cis). Mass spectrum (ES+, exact mass): m/z = 731.4289 {M + Na+}, calculated: 
731.4261. Elemental analysis: found: C, 71.10; H, 7.93; N, 11.68; calculated: C, 71.16; H, 
7.96; N, 11.85. 
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A solution of dodecanedioyl chloride (1 mmol, 364 mg 
as obtained) in a mixture of THF (90 mL) and DCM 
(15 mL), and a solution of 8 (400 mg, 0.989 mmol) and 
triethylamine (660 µL, 4.73 mmol) in a mixture of THF 
(90 mL) and DCM (10 mL), were added simultaneously to 
THF (40 mL) over one hour. The mixture was left stirring 
overnight at room temperature. Then the solvents and volatiles were evaporated. The crude 
obtained was re-dissolved in DCM (100 mL), washed with 1 M NaOH solution (50 mL), then 
with 5% NaHCO3 solution (3 µ 50 mL), dried with MgSO4, filtered and evaporated. The 
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mixture obtained was separated by flash chromatography (eluent: DCM / ethyl acetate with 
increasing ratio of ethyl acetate), giving 17 as a beige solid (217 mg,36.6% yield). 
mp > 300°C. 1H NMR (CDCl3, 300 MHz): δ = 8.36 (d, J = 1.8 Hz, 2 H, 3), 8.34 (s, 2 H, NH 
between 7 and 8), 8.14 (d, J = 8.1 Hz, 2 H, 9), 8.00 (d, J = 8.2 Hz, 2 H, 11), 7.83 (br. s, 1 H, 
1), 7.82 (tr, J = 8.0 Hz, 2 H, 10), 7.67 (s, 1 H, NH between 12 and 13), 2.42 (t, J = 7.5 Hz, 
4 H, 14), 1.78 (quint, J = 7.1 Hz, 4 H, 15), 1.42 (s, 9 H, 6), 1.32 (m, 12 H, 16, 17 & 18). 
13C NMR (CDCl3, 300 MHz): δ = 171.80 (13), 164.62 (7), 154.07 (8), 149.71 (12), 149.64 (4), 
141.14 (10), 133.87 (2), 130.20 (3), 119.76 (1), 109.85 (9), 109.59 (11), 37.63 (14), 35.29 (5), 
31.07 (6), 28.39 (18), 28.27 (17), 28.03 (16), 25.08 (15). Mass spectrum (ES+): 
m/z = 621.3172 {M + H+}, calculated : 621.3165. Elemental analysis: found: C, 64.84; 
H, 7.22; N, 13.04; calculated with 2 equiv. water: C, 64.33; H, 7.30; N, 13.24. Crystals of the 
product have been obtained in DCM and in acetone. The resulting crystal structures, as 
determined by X-ray diffraction, contain respectively one molecule of DCM and one of 
acetone. They are presented in Appendix 1. 
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A solution of hexadecanedioyl chloride (1 mmol, as 
obtained) in THF (100 mL), and a solution of 8 (400 mg, 
0.989 mmol) and triethylamine (660 µL, 4.73 mmol) in 
THF (100 mL), were added simultaneously to THF 
(50 mL) over 1 hour. The mixture was left 
stirringovernight at room temperature, then the solvents 
and volatiles were evaporated. The crude obtained was 
re--dissolved in DCM (250 mL) and 1% NaOH solution 
(50 mL) was added. The solid that precipitated was filtered, and the organic phase was 
separated, washed with 5% NaHCO3 solution (3 µ 50 mL), dried with MgSO4, filtered and 
evaporated. The mixture obtained was separated by flash chromatography (eluent: DCM/ethyl 
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acetate with increasing ratio of ethyl acetate), giving 18 as a white solid (119 mg, 
18.3% yield). mp > 300°C. 1H NMR (CDCl3, 300 MHz): δ = 8.35 (s, 2 H, N-H between 7 and 
8), 8.30 (d, J = 1.4 Hz, 2 H, 3), 8.10 (d, J = 8.0 Hz, 2 H, 9), 8.00 (d, J = 7.7 Hz, 2 H, 11), 
7.85 (s, 1 H, 1), 7.81 (tr, J = 8.0 Hz, 2 H, 10), 7.63 (s, 2 H, N-H between 12 and 13), 2.39 (t, 
J = 7.6 Hz, 4 H, 14), 1.75 (quint, J = 7.0 Hz, 4 H, 15), 1.41 (s, 9 H, 6), 1.26 (m, 20 H, 16, 17, 
18, 19 & 20). 13C NMR (CDCl3 + 2% MeOH, 300 MHz): δ = 172.25 (13), 165.37 (7), 153.67 
(8), 149.87 (12), 149.82 (4), 140.90 (10), 134.04 (2), 129.86 (3), 120.36 (1), 109.82 (9), 
109.77 (11), 37.69 (14), 35.20 (5), 31.02 (6), 28.65 (18), 28.45 (19 & 20), 28.27 (17), 28.18 
(16), 25.20 (15). Mass spectrum (ES+): m/z = 677.3789 {M + H+}, calculated : 677.3791. . 
Crystals of the product, of its complex with barbital and its complex with 39 have been 
obtained. The resulting crystal structure, as determined by X-ray diffraction, are presented in 
Appendix 1. 
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Sodium hydroxide (20 g, 500 mmol) and water 
(100 mL) were added at 0°C to a solution of 
diethylene glycol (20 mL, 170 mmol) in THF (200 mL). To this stirred mixture, a solution of 
para-toluenesulphonyl chloride (70 g, 367 mmol) in THF (250 mL) was added drop wise. The 
mixture was left stirring at room temperature during 2 days. It was then acidified with approx. 
7 mL of conc. HCl solution (37% w/w), neutralised with Na2CO3 until no bubbling was 
observed, and extracted with 3 µ 75 mL of DCM. The combined organic phase was washed 
with 75 mL of water, dried with MgSO4, filtered and evaporated, to give 73.5 g of 19 as a 
yellow oil that slowly crystallised at room temperature into a white solid (97.2% yield). 1H 
NMR (CDCl3, 300 MHz): δ = 7.77 (d, J = 8.1 Hz, 4 H, 4), 7.34 (d, J = 8.1 Hz, 4 H, 3), 
4.09-4.06 (m, 4 H, 6), 3.61-3.58 (m, 4 H, 7), 2.44 (s, 6 H, 1). The analysis is in agreement 
with the literature data.4 
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Tosyl chloride (1.25 g, 6.5 mmol) was added to a mixture 
of sodium hydroxide (0.29 g, 7.2 mmol) and diethylene 
glycol (0.60 mL, 6.3 mmol) in THF (20 mL) and water (1 mL). The mixture was left stirring 
at room temperature during 24 hours. Then the THF was evaporated, the crude redissolved in 
80 mL of water and extracted with 3 µ 35 mL of ethyl acetate. The combined organic phase 
was dried with MgSO4, filtered and evaporated. The colorless oil that was obtained was 
separated by flash chromatography (solvent: diethyl ether), affording 0.828 g of 19h 
(61% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.79 (d, J = 8.3 Hz, 2 H, 4), 7.34 (d, J = 8.3 Hz, 
2 H, 3), 4.20-4.17 (m, 2 H, 6), 3.69-3.64 (m, 4 H, 7 & 8), 3.53-3.51 (m, 2 H, 9), 2.44 (s, 3 H, 
1), 2.06 (s, 1 H, OH). The analysis is in agreement with the literature data.5 
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A solution of sodium hydroxide (20 g, 
500 mmol) in water (100 mL) was added 
to a solution of triethylene glycol (22 mL, 
171 mmol) in THF (200 mL). To this stirred mixture, a solution of para-toluenesulphonyl 
chloride (70 g, 367 mmol) in THF (250 mL) was added drop wise. The mixture was left 
stirring at room temperature for 2 days. It was then acidified with approx. 7 mL of conc. HCl 
solution (37% w/w), neutralised with Na2CO3 until no bubbling was observed, and extracted 
with 3 µ 75 mL of DCM. The combined organic phase was washed with 75 mL of water, 
dried with MgSO4, filtered and evaporated, to give 73.5 g of 20 as a yellow oil that slowly 
crystallised at room temperature into a white solid (97.2% yield). mp 78°C. 1H NMR (CDCl3, 
300 MHz): δ = 7.78 (d, J = 8.1 Hz, 4 H, 4), 7.33 (d, J = 8.1 Hz, 4 H, 3), 4.13 (t, J = 4.8 Hz , 
4 H, 6), 3.64 (t, J = 4.8 Hz , 4 H, 7), 3.51 (s, 4 H, 8), 2.43 (s, 6 H, 1). 13C NMR (CDCl3, 
300 MHz): δ = 144.81 (2), 132.93 (5), 129.80 (3), 127.90 (4), 70.63 (7), 69.15 (6), 68.69 (5), 
21.58 (1). Mass spectrum (ES+, exact mass): m/z = 481.0962 {M + Na+}, calculated: 481.0967. 
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Elemental analysis: found: C, 51.64; H, 5.56; N, 0.00; calculated with 0.25 equiv. water: 
C, 51.71; H, 5.79; N, 0.00. The analysis is in agreement with the literature data.4 
21 (Tetraethylene glycol ditosylate)4 
O
OO
S
O
O
O
1
2
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A solution of sodium hydroxide (20 g, 
500 mmol) in water (100 mL) was added 
to a solution of triethylene glycol (28.8 mL 167 mmol) in THF (200 mL). To this stirred 
mixture, a solution of para-toluenesulphonyl chloride (70 g, 367 mmol) in THF (250 mL) was 
added drop wise. The mixture was left stirring at room temperature for 2 days. It was then 
acidified with approx. 7 mL of conc. HCl solution (37% w/w), neutralised with Na2CO3 until 
no bubbling was observed, and extracted with 3 µ 75 mL of DCM. The combined organic 
phase was washed with 75 mL of water, dried with MgSO4, filtered and evaporated, to give 
62.9 g of 21 as a yellow oil (77% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.78 (d, J = 8.2 Hz, 
4 H, 4), 7.33 (d, J = 8.2 Hz, 4 H, 3), 4.14 (t, J = 4.9 Hz , 4 H, 6), 3.67 (t, J = 4.9 Hz , 4 H, 7), 
3.55 (s, 8 H, 8 & 9), 2.43 (s, 6 H, 1). The analysis is in agreement with the literature data.4 
22 (1-Iodo-2-(2-iodo-ethoxy)-ethane)4 
O
II 1
2
   Sodium iodide (56.4 g, 376 mmol) was added to a stirred solution of 
diethylene glycol ditosylate (30.0 g, 72.3 mmol) in acetone (400 mL) at 0°C. After 24 hours 
of stirring at room temperature, the mixture was filtered and the acetone solution was 
evaporated. The orange solid obtained was dissolved in ether (300 mL), washed with water 
(3 µ 100 mL), dried with MgSO4, filtered and evaporated to afford 23.87 g of a red oil, which 
contains 90% of 22 and 10% of minor impurities according to the NMR, and which was used 
for the next step without further purification. 1H NMR (CDCl3, 300 MHz): δ = 3.77 (t, 
J = 6.8 Hz, 4 H, 2),  3.26 (t, J = 6.8 Hz, 4 H, 1). The analysis is in agreement with the 
literature data.4 
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23 (1-Iodo-2-[2-(2-iodo-ethoxy)-ethoxy]-ethane)4 
O
OI
I
1
2 3
   Sodium iodide (67.3 g, 449 mmol) was added to a stirred 
solution of triethylene glycol ditosylate (40.0 g, 87.2 mmol) in acetone (500 mL) at 0°C. After 
two days of stirring at room temperature, the mixture was filtered and the acetone solution 
was evaporated. The yellow solution obtained was dissolved in ether (400 mL), washed with 
water (2 µ 100 mL), dried with MgSO4, filtered and evaporated to give 28 g of 23 as a brown 
oil (87% yield). 1H NMR (CDCl3, 300 MHz): δ = 3.78 (t, J = 6.8 Hz, 4 H, 2), 3.67 (s, 4 H, 3), 
3.27 (t, J = 6.8 Hz, 4 H, 1). The analysis is in agreement with the literature data.4 
24 (1-Iodo-2-{2-[2-(2-iodo-ethoxy)-ethoxy]-ethoxy}-ethane)4 
O
OI
O
1
2 3
I4
  Sodium iodide (67.2 g, 448 mmol) was added to a stirred 
solution of tetraethylene glycol ditosylate (40.0 g, 79.6 mmol) in acetone (500 mL) at 0°C. 
After two days of stirring at room temperature, the mixture was filtered and the acetone 
solution was evaporated. The yellow solution obtained was dissolved in ether (400 mL), 
washed with 2 µ 100 mL, dried with MgSO4 and evaporated to give 31.6 g of 24 as a dark 
orange oil (96% yield). 1H NMR (CDCl3, 300 MHz): δ = 3.75 (t, J = 6.9 Hz , 4 H, 2), 3.67 (s, 
8 H, 3 & 4), 3.26 (t, J = 6.9 Hz , 4 H, 1). The analysis is in agreement with the literature data.4 
25 (9-{2-[2-(2-Iodo-ethoxy)-ethoxy]-ethoxy}-anthracene)6 
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O
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In an apparatus protected from light by a foil cover, a 
solution of 1-Iodo-2-[2-(2-iodo-ethoxy)-ethoxy]-ethane 
(20 g, 54 mmol) in THF (200 mL, non distilled) and 
water (100 mL) was degassed by bubbling nitrogen during 10 minutes. Then potassium 
hydroxide (6.2 g, 111 mmol) was added and the bubbling of nitrogen was continued during 
10 minutes. Then anthrone (3.1 g, 16 mmol) was added and the mixture was heated to reflux 
under nitrogen, and left at reflux during three days. Then the THF was evaporated. The 
organic was extracted with 100 mL of dichloromethane, washed with 50 mL of water, dried 
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with MgSO4, filtered and evaporated. It was then separated by flash chromatography, to give 
25 as a white solid (2.96 g, 6.8 mmol, 42.5% yield).  1H NMR (CDCl3, 300 MHz): 
δ = 8.37-8.40 (m, 2 H, 3), 8.23 (s, 1 H, 8), 7.98-8.01 (m, 2 H, 6), 7.45-7.49 (m, 4 H, 4 & 5), 
4.38-4.41 (m, 2 H, 9), 4.00-4.04 (m, 2 H, 10), 3.80-3.87 (m, 6 H, 11, 12 & 13), 3.30 (t, 
J = 6.7 Hz, 2 H, 14). Mass spectrum (ES+): m/z = 459.1 {M + Na+}. The analysis results are 
consistent with those already reported.6 
26 (9-(2-{2-[2-(2-Iodo-ethoxy)-ethoxy]-ethoxy}-ethoxy)-anthracene)6 
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In an apparatus protected from light by a foil 
cover, a solution of potassium hydroxide (6.3 g, 
112 mmol) in water (50 mL) was added to a 
solution of 1-Iodo-2-{2-[2-(2-iodo-ethoxy)-ethoxy]-ethoxy}-ethane (21 g, 44 mmol) in THF 
(100 mL). The mixture was degassed by bubbling nitrogen during 20 minutes, then anthrone 
(3.1 g, 16 mmol) was added and the mixture was heated to reflux and left at reflux during 
three days. Then the THF was evaporated. The organic was extracted with 3 µ 50 mL of 
dichloromethane and 20 mL of ethyl acetate, the combined organic phase was washed with 
50 mL of brine, dried with MgSO4, filtered and evaporated. It was then separated by flash 
chromatography, to give 26 as an orange oil (2.18 g, 4.5 mmol, 28% yield). 1H NMR (CDCl3, 
300 MHz): δ = 8.37-8.41 (m, 2 H, 3), 8.23 (s, 1 H, 8), 7.98-8.01 (m, 2 H, 6), 7.44-7.51 (m, 
4 H, 2 H, 4 & 5), 4.38-4.41 (m, 2 H, 9), 3.99-4.02 (m, 2 H, 10), 3.68-3.84 (m, 10 H, 11, 12, 13, 
14 & 15), 3.25 (t, J = 7.0 Hz, 2 H, 16). The analysis results are consistent with those already 
reported.6 
27 (Tetraethylene glycol mono trityl ether) and 27d (tetraethylene glycol di trityl ether) 
A solution of trityl chloride (6.0 g, 21.5 mmol) in DCM (25 mL) was added drop wise to a 
solution of tetraethylene glycol (4.0 g, 20.6 mmol) and triethylamine (3.0 mL, 2.2 g, 
21.5 mmol) in DCM (50 mL). The mixture was left stirring overnight at room temperature. 
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Then 75 mL of DCM were added and this organic solution was washed with water 
(3 µ 120 mL), dried with MgSO4, filtered and evaporated to give a viscous oil which was 
separated by flash chromatography (eluent: dichloromethane) to give the desired product 27 
as a viscous oil (4.74 g, 52.8% yield), and 27d as a white solid (1.85 g, 13.2% yield). 27: 1H 
NMR (CDCl3, 300 MHz): δ = 7.53-7.51 (m, 6 H, 3), 7.37-7.26 (m, 9 H, 4 & 5), 3.75 (m , 
10 H, 8, 9, 10, 11, 12), 3.64 (t, J = 4.6 Hz, 2 H, 13), 3.52 (m, 2 H, 7), 3.30 (t, J = 5.1 Hz, 2 H, 
6), 2.02 (br. s, 1 H, OH). Mass spectrum (ES+): m/z = 459.3 {M + Na+}. 27d: 1H NMR: δ 
7.49-7.46 (m, 12 H, 3), 7.32-7.20 (m, 18 H, 4 & 5), 3.71-3.67 (m , 12 H, 7, 8 & 9), 3.24 (t, 
J = 4.6 Hz, 4 H, 6). Mass spectrum (ES+): m/z = 701.5 {M + Na+}. 
28 (2-{2-[2-(2-Trityloxy-ethoxy)-ethoxy]-ethoxy}-ethyl tosylate) 
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A solution of sodium hydroxide (2.08 g, 
52.0 mmol) in water (10 mL) was prepared. 
3.3 mL of this solution (containing 
17.2 mmol of NaOH) were added to a solution of 27 (4.74 g, 10.9 mmol) and tosyl chloride 
(2.30 g, 12.1 mmol) in THF (20 mL). The mixture was left stirring overnight at room 
temperature. Then it was acidified with conc. HCl and neutralised with NaHCO3. The organic 
phase was extracted with DCM (4 µ 100 mL), dried with MgSO4, filtered and evaporated, to 
give 28 as a yellow oil (5.18 g, 80.7% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.79 (d, 
J = 8.0 Hz, 2 H, 15), 7.47 (m, 6 H, 3), 7.34-7.21 (m, 11 H, 4, 5 & 16), 4.14 (t, J = 4.8 Hz, 2 H, 
13), 3.76-3.60 (m, 12 H, 7, 8, 9, 10, 11 & 12), 3.24 (t, J = 4.8 Hz, 2 H, 6), 2.43 (s, 3 H, 18). 
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29 (2-{2-[2-(2-Iodo-ethoxy)-ethoxy]-ethoxy}-ethanol trityl ether) 
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Sodium iodide (3.29 g, 21.9 mmol) was added to 
a solution of 28 (5.18 g, 9.49 mmol) in acetone 
(30 mL). The reaction was slightly exothermic 
and a white solid formed after the rapid dissolution of sodium iodide. It was left stirring at 
room temperature overnight, then it was filtered and evaporated, giving a yellow solid 
(7.46 g), insoluble in ether and little soluble in chloroform, but soluble in ethyl acetate when 
water was added. Thus it was dissolved in ethyl acetate (100 mL) and water (100 mL). The 
organic phase was separated and washed with water (100 mL again) and brine (100 mL), 
dried with MgSO4, filtered and evaporated, giving 29 as a yellow solid (4.39 g, 91.7% yield). 
1H NMR (CDCl3, 300 MHz): δ = 7.46 (d, J = 7.1 Hz, 6 H, 3), 7.32-7.20 (m, 9 H, 4 & 5), 
3.76-3.67 (m, 12 H, 7, 8, 9, 10, 11 & 12), 3.26-3.20 (m, 4 H, 6 & 13). 
30 (2,2-Bis-(2-{2-[2-(anthracen-9-yloxy)-ethoxy]-ethoxy}-ethyl)-malonic acid diethyl ester)6 
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To a suspension of sodium hydride (61 mg, 2.54 mmol) 
in THF (40 mL), diethyl malonate (190 mg, 1.19 mmol) 
was added drop wise. After a few minutes, a solution of 
25 (1.00 g, 2.29 mmol) in THF (10 mL) was added. The 
mixture heated to reflux and left stirring 24 hours, then it  
was cooled to room temperature and 100 mL of water were added. The organic phase was 
extracted with 4 µ 50 mL of ether, dried with MgSO4, filtered and evaporated to give an 
orange oil, which was separated by flash chromatography on silica gel to give finally 588 mg 
of 30 as an orange oil (66% yield). 1H NMR (CDCl3, 300 MHz): δ = 8.34-8.41 (m, 4 H, 13), 
8.23 (s, 2 H, 18), 7.95-8.00 (m, 4 H, 16), 7.44-7.50 (m, 8 H, 14 & 15), 4.35-4.38 (m, 4 H, 10), 
4.13-4.18 (m, 4 H, 3), 3.99-4.10 (m, 4 H, 9), 3.70-3.79 (m, 8 H, 7 & 8), 3.52-3.61 (m, 4 H, 6), 
2.03 (t, J = 4.8 Hz, 4 H, 5), 1.24 (t, J = 7.4 Hz, 6 H, 4). The analysis results are consistent 
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with those already reported but they also contain additional data since some hydrogens in the 
1H NMR spectrum had previously not been assigned.6 
31 (2,2-Bis-[2-(2-{2-[2-(anthracen-9-yloxy)-ethoxy]-ethoxy}-ethoxy)-ethyl]-malonic acid 
diethyl ester)6 
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To a suspension of sodium hydride (73 mg, 
3.04 mmol) in THF (50 mL), diethyl 
malonate (221 mg, 1.38 mmol) was added 
drop wise. After a few minutes, a solution of 
26 (1.33 g, 2.77 mmol) in THF (10 mL) was 
added. The mixture heated to reflux and left 
stirring at reflux during 24 hours, then it was 
cooled to room temperature and 100 mL of water were added. The organic phase was 
extracted with 4 µ 50 mL of ether, dried with MgSO4, filtered and evaporated to give an 
orange oil, which was separated by flash chromatography on silica gel to give finally 752 mg 
of 31 as an orange oil (63% yield). 1H NMR (CDCl3, 300 MHz): δ = 8.36-8.39 (m, 4 H, 15), 
8.22 (s, 2 H, 20), 7.96-7.99 (m, 4 H, 18),7.44-7.48 (m, 8 H, 16 & 17), 4.35-4.39 (m, 4 H, 12), 
4.09-4.18 (m, 4 H, 3), 3.96-3.99 (m,4 H, 11), 3.75-3.81 (m, 8 H, 9 & 10), 3.64-3.67 (m, 4 H, 
8), 3.47-3.56 (m, 8 H, 6 & 7),  2.26 (t, J = 6.6 Hz, 5), 1.19-1.28 (m, 6 H, 4). The analysis 
results are consistent with those already reported but they also contain additional data since 
some hydrogens in the 1H NMR spectrum had previously not been assigned.6 
32 (2,2-Bis-(2-{2-[2-(2-trityloxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-malonic acid diethyl ester) 
Sodium hydride (250 mg of 60% w/w dispersion in mineral oil, 6.25 mmol) was washed with 
dry hexane and suspended in THF (60 mL). Diethyl malonate (0.48 mL, 0.51 g, 3.16 mmol) 
was added. After 5 min. of stirring, a solution of 29 (3.0 g, 5.49 mmol) in THF (30 mL) was 
added. The reaction mixture was left stirring overnight at room temperature. The THF was 
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evaporated and the crude re-dissolved in ether 
(100 mL) and brine (200 mL). The organic 
phase was separated and the aqueous extracted 
again with ether(3 x 50 mL). The organic 
phases were combined, dried with MgSO4, 
filtered and evaporated. The crude 
obtained was separated by flash chromatography, giving 32 as a yellow solid (265 mg, 
9.3% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.46 (d, J = 7.0 Hz, 12 H, 15), 7.31-7.19 (m, 
18 H, 16 & 17), 4.13 (q, J = 7.1 Hz, 4 H, 3), 3.69-3.58 (m, 16 H, 7, 8, 9 & 10), 3.50 (t, 
J = 5.2 Hz, 4 H, 11), 3.46 (t, J = 6.8 Hz, 4 H, 6), 3.23 (t, J = 5.2 Hz, 4 H, 12), 2.23 (t, 
J = 6.8 Hz, 4 H, 5), 1.19 (t, J = 7.1 Hz, 6 H, 4). Mass spectrum (ES+): m/z = 1019.5{M + Na+}, 
501.2 {loss of 2 EtOH and one CO2, + Na+}. 
33 (2,2-Bis-dec-9-enyl-malonic acid diethyl ester) 
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Diethyl malonate (380 µL, 2.5 mmol) and 
1-bromodec-9-ene (1.38 mL, 6.9 mmol) 
were  added to a suspension of sodium 
hydride (260 mg of a 60% w/w dispersion 
in mineral oil, 6.5 mmol) in THF (100 mL). The mixture was heated to reflux and left stirring 
at reflux during 2 days, then 2 mL of ethanol were added, and the volatiles were evaporated. 
The crude was re-dissolved in ethyl acetate (50 mL) and brine + water (50 mL). The two 
phases were separated and the aqueous was extracted with ethyl acetate (3 µ 20 mL). The 
combined organic phases were dried with magnesium sulphate, filtered and evaporated to 
afford an colourless oil which was separated by flash chromatography (eluent: hexane / DCM) 
(176 mg, 16% yield). 1H NMR (CDCl3, 300 MHz): δ = 5.86-5.73 (m, 2 H, 13), 5.01-4.90 (m, 
4 H, 14), 4.16 (q, J = 7.1 Hz, 4 H, 3), 2.02 (q, J = 7.4 Hz, 4 H, 5), 1.86-1.81 (m, 4 H, 12), 
1.38-1.18 (m, 30 H, 6, 7, 8, 9, 10, 11 & 4). Mass spectrum (ES+): m/z = 459.3 {M + Na+}. 
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34 (5,5-Bis-(2-{2-[2-(anthracen-9-yloxy)-ethoxy]-ethoxy}-ethyl)-pyrimidine-2,4,6-trione) 
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To a solution of urea (1.12 g, 18.6 mmol) in dry 
DMSO (6 mL), sodium hydride (200 mg, pure, 
8.33 mmol) was added. After 30 minutes of stirring at 
room temperature, 30 (1.44 g,1.85 mmol) was added. 
The colour of the mixture turned immediately from 
yellow to red. The reaction mixture was left stirring 
overnight in the dark (flask covered with foil) at room 
temperature. Then ice (5 g) was added. The solution was allowed to warm up to room 
temperature, re-dissolved in water (150 mL) and acidified with concentrated hydrochloric 
acid until the solution became turbid. Then sodium chloride was added and the organic phase 
was extracted with ethyl acetate (150 mL), washed with 2 µ 50 mL of water, dried with 
MgSO4, filtered and evaporated, to give an orange oil which was separated by flash 
chromatography, giving finally 392 mg of 34 as an orange solid (28% yield). 1H NMR 
(CDCl3, 300 MHz): δ = 8.78 (s, 2 H, NH), 8.24-8.33 (m, 4 H, 12), 8.09 (s, 2 H, 17), 7.83-7.86 
(m, 4 H, 15), 7.32-7.41 (m, 8 H, 13 & 14), 4.15-4.16 (m, 4 H, 9), 3.59-3.62 (m, 4 H, 8), 
3.43-3.45 (m, 12 H, 5, 6 & 7), 2.27 (tr, J = 5.7 Hz, 4 H, 4). 13C NMR (CDCl3, 300 MHz): 
δ = 8174.81 (2), 173.20 (3), 149.43 (10), 132.30 (16), 128.17 (15), 125.29 (14), 125.49 (13), 
124.72 (11), 122.66 (12), 122.45 (17), 86.82 (1), 75.10 (9), 70.51 (8), 70.29 (6 & 7), 67.13 (5), 
39.39 (4). Mass spectrum (ES+): m/z = 767.2941 {M+H+}, calculated : 767.2945. 
35 (5,5-Bis-[2-(2-{2-[2-(anthracen-9-yloxy)-ethoxy]-ethoxy}-ethoxy)-ethyl]-pyrimidine-
2,4,6-trione)  
To a solution of urea (1.12 g, 18.6 mmol) in dry DMSO (7 mL), sodium hydride (200 mg, 
pure, 8.33 mmol) was added. After 30 minutes of stirring at room temperature, 31 (1.60 g, 
1.85 mmol) was added. The colour of the mixture turned immediately from yellow to red. The 
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reaction mixture was left stirring overnight 
in the dark at room temperature. Then 
ice(5 g) was added. The solution was 
allowed to warm up to room temperature, 
re- dissolved in water (150 mL) and 
acidified with concentrated hydrochloric 
acid until a persistent white turbidity 
remains visible. Then sodium chloride was added and the organic phase was extracted with 
ethyl acetate (150 mL), washed with 2 µ 50 mL of water, dried with MgSO4, filtered and 
evaporated, to give 802 mg of orange oil which was separated by flash 
chromatography, giving finally 407 mg of 35 as an orange oil (26% yield). 1H NMR (CDCl3, 
300 MHz): δ = 9.53 (s, 2 H, NH), 8.38-8.42 (m, 4 H, 14), 8.19 (s, 2 H, 19), 7.94-7.97 (m, 4 H, 
17), 7.41-7.51 (m, 8 H, 15 & 16), 4.42-4.46 (m, 4 H, 11), 4.07-4.13 (m, 4 H, 10), 3.85-3.88 
(m, 4 H, 9), 3.58-3.61 (m, 4 H, 8), 3.20-3.23 (m, 4 H, 7), 3.11-3.15 (m, 4 H, 6), 2.94-2.97 (m, 
4 H, 5), 2.16 (tr, J = 5.5 Hz, 4 H, 4). 
36 (5,5-Bis-(2-{2-[2-(2-trityloxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-pyrimidine-2,4,6-trione) 
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Sodium hydride (90 mg of 60% w/w 
dispersion in mineral oil, 2.25 mmol) was 
suspended in DMSO (0.5 mL). To this 
suspension, urea (170 mg, 2.83 mmol) and a 
solution of 32 (265 mg, 2.25 mmol) in DMSO 
(0.5 mL) were added. The colour changed 
quickly from colourless to beige. It was left  
stirring overnight at room temperature. Then the solution was dissolved in water (50 mL). 
NaHCO3 (10 g) was added. The solution was acidified until an important bubbling was 
observed. Then it was neutralised with more NaHCO3. The organic phase was extracted with 
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ethyl acetate (3 µ 25 mL), washed with brine (2 µ 20 mL), dried with MgSO4, filtered and 
evaporated. The yellow solid obtained (152 mg) was separated by flash chromatography, 
giving 36 as a colourless viscous oil (67.1 mg, 26.1% yield). 1H NMR (CDCl3, 300 MHz): δ = 
9.34 (s, 2 H), 7.45 (d, J = 7.4 Hz, 12 H, 14), 7.30-7.18 (m, 18 H, 15 & 16), 3.80-3.74 (m, 8 H, 
8 & 9), 3.70-3.67 (m, 4 H, 7), 3.62-3.59 (m, 4 H, 6), 3.47-3.44 (m, 4 H, 10), 3.38-3.30 (m, 8 H, 
11 & 5), 2.25 (t, J = 5.4 Hz, 4 H, 4). Mass spectrum (ES+): m/z = 987.2{M + Na+}, 745.2 
{loss of 1 trityl, + Na+}. 
37 (5,5-Bis-dec-9-enyl-pyrimidine-2,4,6-trione) 
NHHN
O O
O
1
2
3
2
456
7
8 9
10 1112
5
6
7
89
1011 1213 13
4
 
To a solution of 33 (176 mg, 0.4 mmol) in 
DMSO (2 mL), sodium hydride (50 mg of 
a  60% w/w  dispersion in mineral oil)  and  
urea (50 mg) were added. It was left stirring at room temperature during 20 hours, then a 
saturated aqueous solution of NaHCO3 (50 mL) was added. The organic phase was extracted 
with ethyl acetate (2 µ 40 mL), dried with MgSO4, filtered and evaporated, affording an 
orange oil which partly crystallized to a white solid. This solid was washed with hexane, 
affording 37 (66.7 mg, 41% yield). mp 80°C. 1H NMR (CDCl3, 300 MHz): δ = 7.96 (br. s, 
2 H, N-H), 5.80 (ddt, Jt = 6.8 Hz, Jd1 = 10.2 Hz, Jd2 = 17.0 Hz, 2 H, 12), 5.02-4.91 (m, 4 H, 
13), 2.06-1.94 (m, 8 H, 4 & 11), 1.47-1.02 (m, 24 H, 5, 6, 7, 8, 9 & 10). 13C NMR (CDCl3, 
300 MHz): δ 172.57 (2), 148.64 (1), 139.96 (12), 114.17 (13), 56.72 (3), 39.17 (11), 33.73, 
29.29, 29.24, 29.07 , 28.96, 28.81 (4, 6, 7, 8, 9 & 10), 25.04 (5). Mass spectrum (ES-, exact 
mass): m/z = 403.2950 {M - H+}, calculated: 403.2961. Elemental analysis: found: C, 71.24; 
H, 10.12; N, 6.95; calculated: C, 71.25; H, 9.97; N, 6.92. 
38 (5,5-Bis-(4-hydroxy-phenyl)-pyrimidine-2,4,6-trione)7 
Alloxan monohydrate (1.60 g, 10.0 mmol) and phenol (1.90 g, 20.2 mmol) were suspended 
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acid (98%, 1.2 mL, 20 mmol) was added, The mixture was heated 
to 85°C and left stirring in acetic acid (10 mL). Sulfuric at this 
temperature 2 hours under nitrogen. Then 50 mL of water were 
added. The organic phase was extracted with chloroform  
(3 µ 50 mL), and the aqueous phase was neutralised with Na2CO3 until pH º 7.5 according to 
pH paper.Then it was extracted with ethyl acetate (3 µ 50 mL), dried with MgSO4, filtered 
and evaporated, to afford 2.61 g of 38 as a white solid (83.6% yield). mp 267°C (lit. 292°C). 
1H NMR (d6-acetone, 300 MHz): δ = 10.38 (br. s, 2 H, NH), 8.57 (s, 2 H, OH), 7.08 (d, J = 
9.0 Hz, 4 H, 5), 6.83 (d, J = 9.0 Hz, 4 H, 6). 13C NMR (d6-acetone, 300 MHz): δ = 172.96 (2), 
159.11 (1), 150.94 (7), 132.29 (5), 131.04 (4), 116.87 (6), 107.52 (3). IR (ν, cm-1): 3388 (s, 
OH H-bonded), 3198 (m, Csp2-H), 3110 (m, Csp2-H), 1746 (s, C=O), 1694 (s, C=O), 1613 (m, 
C=C aromatic), 1594 (m, C=C aromatic), 1514 (m, C=C aromatic), 1420 (m), 1340 (s), 1217 
(m), 1184 (m), 1030 (m), 1016 (m), 832 (m), 816 (m), 772 (m). Mass spectrum (EI): m/z = 
312 {M∏+}, 255, 226, 198. Mass spectrum (ES-): 311 {M - H+}, 225; exact mass determination 
on the {M - H+} peak: m/z = 311.0662, calculated: 311.0668. Elemental analysis: found: 
C, 58.85; H, 3.44; N, 8.72; calculated with 0.14 equiv. sulphuric acid: C, 58.90; H, 3.80; 
N, 8.59. The NMR spectra are in agreement with the literature data, but not the melting point,7 
which indicates that the product is not pure, as is also indicated by the mass spectra and 
elemental analysis. Crystals of the product have been obtained. The resulting crystal structure, 
as determined by X-ray diffraction, is presented in Appendix 1. 
39 (5,5-Bis-(4-methoxy-phenyl)-pyrimidine-2,4,6-trione)8a 
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Alloxan monohydrate (0.40 g, 2.5 mmol) and anisole (0.55 mL, 
5.05 mmol) were suspended in acetic acid (5 mL). Sulfuric acid 
(0.28 mL, 20 mmol) was added. The mixture was heated to 85°C 
and left stirring at this temperature 2 hours under nitrogen. Then 
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water (20 mL) was added. The solution was poured into a solution of 3.2 mg of sodium 
hydroxide. Then it was neutralised with a saturated aqueous NaHCO3 solution. The organic 
phase was extracted with ethyl acetate (3 µ 50 mL), dried with MgSO4, filtered and 
evaporated, to afford a yellow oil which was separated by column chromatography (eluent: 
petroleum ether / ethyl acetate) to give 39 as a yellow solid (215 mg, 25% yield). mp 166°C. 
1H NMR (d3-acetonitrile, 300 MHz): δ = 9.23 (br. s, 2 H, NH), 7.07 (d, J = 9.3 Hz, 4 H, 5), 
6.91 (d, J = 9.3 Hz, 4 H, 6), 3.79 (s, 6 H, 8). 13C NMR (CDCl3, 300 MHz): δ  171.61 (2), 
159.79 (1), 150.82 (7), 130.13 (5), 128.65 (4), 114.19 (6), 70.20 (3), 55.34 (8). IR (ν, cm-1): 
3217 (m, NH H-bonded), 3091 (m, Csp3-H), 2841 (m, O-Me), 1709 (s, C=O), 1608 (m, C=C 
aromatic), 1584 (m, C=C aromatic), 1510 (m, C=C aromatic), 1439 (s, C-H bending), 1418 
(m), 1299 (m), 1249 (w), 1180 (m), 1028 (m), 827 (m), 795 (m), 761 (m), 734 (m). Mass 
spectrum (ES+, exact mass): m/z = 363.0952 {M + Na+}, calculated: 363.0957. Crystals of the 
product have been obtained. The resulting crystal structure, as determined by X-ray 
diffraction, is presented in Appendix 1. 
40 (5,5-Bis-(4-hydroxyphenyl)-1,3-dimethyl-pyrimidine-2,4,6-trione)8a 
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38 (200 mg, 0.64 mmol) was dissolved in acetone (20 mL). 
Potassium carbonate (0.210 g, 1.52 mmol) was added. The mixture 
was heated to reflux, then methyl iodide (0.09 mL, 1.5 mmol) was 
added. The mixture was left stirring overnight at room temperature. 
Then it was filtered and the solid was washed with acetone. The acetone solution was 
evaporated, re-dissolved in ethyl acetate (50 mL) and water (100 mL). The organic phase was 
extracted with 2 µ 50 mL of ethyl acetate, the organic phases were combined, dried with 
MgSO4, filtered and evaporated, to afford 40 as a beige solid (145 mg, 67% yield). mp 277°C. 
1H NMR (d6-acetone, 300 MHz): δ = 8.58 (br. s, 2 H, OH), 6.99 (d, J = 9.1 Hz, 4 H, 6), 6.80 
(d, J = 9.1 Hz, 4 H, 7), 3.27 (s, 6 H, 2). IR (ν, cm-1): 3527 (s, OH free), 3341 (s, OH 
H-bonded), 1690 (s, C=O), 1666 (s, C=O) 1610 (m, C=C aromatic), 1593 (m, C=C aromatic), 
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1512 (m, C=C aromatic), 1439 (s, C-H bending), 1419 (m), 1370 (s), 1270 (m), 1225 (w), 
1168 (m), 1115 (m), 1101 (m),  834 (m), 825 (m), 807 (m), 753 (m). Mass spectrum (ES+): 
m/z = 363 {M + Na+}. Mass spectrum (ES-, exact mass): m/z = 339.0990 {M - H+}, 
calculated: 339.0981. Elemental analysis: found: C, 63.56; H, 4.54; N, 8.37; calculated: C, 
63.52; H, 4.74; N, 8.23. 
Other attempts to substitute 38 on the O site with different iodides or under different 
conditions: see reference below.8a 
41 (Diethyl 2,2-Bis-(4-hydroxy-phenyl)-malonate)8b 
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Phenol (1.90 g, 20.2 mmol) was dissolved in acetic acid (10 mL). 
Diethyl ketomalonate (1.55 mL, 1.77 g, 10.1 mmol) was added. 
The yellow solution was heated to 50°C, then sulphuric acid 
 (1.12 mL) was added. It was then heated to 80°C. After two hours at reflux, the solution has 
turned red. It was cooled to 50°C and water (20 mL) was added: the solution turned pale 
green. After cooling it to room temperature, it was mixed with 50 mL of an aqueous solution 
of sodium hydroxide (9.4 g). Then sodium hydrogen carbonate was added until the reaction 
mixture was neutral. The organic phase was extracted with 3 µ 30 mL of ethyl acetate, dried 
with MgSO4, filtered and evaporated. It was then separated by flash chromatography (eluent: 
petroleum ether / ethyl acetate) and the product was re-crystallised in methanol + petroleum 
ether, to afford 41 (1.495 g, 42.7% yield) as a yellow solid. 1H NMR (CDCl3): δ 7.20 (d, 
J = 8.8 Hz, 4 H, 4), 6.70 (d, J = 8.8 Hz, 4 H, 5), 5.64 (s, 2 H, OH), 4.24 (q, J = 7.1 Hz, 4 H, 2), 
1.21 (t, J = 7.1 Hz, 6 H, 3). 
42 (Diethyl 2,2-Bis-(4-methoxy-phenyl)-malonate)8b 
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To a solution of Anisole (2.2 mL, 20.2 mmol) in acetic acid 
(10 mL), diethyl ketomalonate (1.55 mL, 10.1 mmol) was added 
followed by H2SO4 (1.2 mL). The solution was heated to 85ºC 
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for 3 hours resulting in a red/orange solution, which was then cooled to room temperature. A 
solution of KOH (9.45 g) in water (50 mL) was added to the solution. It was then neutralised 
with a saturated solution of sodium hydrogen carbonate and separated using ethyl acetate 
(3 µ 20 mL). The organic phase was dried with MgSO4, filtered and evaporated to afford a 
reddish-brown oil, which was purified by column chromatography (eluent: ethyl 
acetate:hexane 1:1) to give 42 as a yellow oil (0.539 g, 14.3% yield), which later crystallised 
and was re-crystallised in hexane and chloroform. 1H NMR (CDCl3, 300 MHz): δ = 7.3 (m, 
4 H, 4), 6.8 (m, 4 H, 5), 4.1 (q, J = 6.9 Hz, 4 H, 2), 3.8 (s, 6 H, 7), 1.3 (m, 6 H, 3). Mass 
spectrum (ES+): m/z = 395.2 {M + Na+}. The crystal structure of this compound, as 
determined by X-ray diffraction, is presented in Appendix 1. 
42 by substitution of 41.8b 
Potassium carbonate (0.706 g, 5.11 mmol) and 41 (0.474 g, 1.38 mmol) were suspended in 
acetonitrile (30 mL). After 10 minutes of stirring (all 41 was dissolved but not K2CO3), 
methyl iodide (0.26 mL, 4.2 mmol) was added and the solution was left stirring at reflux for 
35 hours. The resulting milky white solution was then allowed to cool to room temperature. 
Water (20 mL) was added, the organic phase was extracted using ethyl acetate (3 µ 15 mL), 
dried with MgSO4, filtered and evaporated to yield a yellow oil, which crystallized to give 42 
(0.3073 g, 59.9% yield). 
43 (2,2-Bis-(4-oct-7-enyloxy-phenyl)-malonic acid diethyl ester) 
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Potassium carbonate (640 mg, 4.63 mmol) 
and 41 (240 mg, 697 µmol) were 
suspended in acetonitrile (15 mL). The 
mixture was heated to reflux during 
30 min., then 8-bromo-oct-1-ene (350 µL, 2.09 mmol) was added and the mixture was left 
stirring at reflux during 2 days. Then the solvent was evaporated and the remaining oily solid 
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was dissolved in 20 mL of ethyl acetate and 30 mL of water. The two phases were separated 
and the aqueous was extracted with 2 more times 20 mL of ethyl acetate. The combined 
organic phase was dried with MgSO4, filtered and evaporated. The resulting brown oil was 
separated by flash chromatography (eluent: hexane / ethyl acetate), to give 43 as an colourless 
oil (169 mg, 42.9% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.28 (d, J = 9.1 Hz, 4 H, 6), 6.82 
(d, J = 9.1 Hz, 4 H, 7), 5.81 (ddt, Jt = 6.7, Jd1 = 10.2, Jd2 = 17.0 Hz, 2 H, 15), 5.00 (br d, 
J = 17.0 Hz, 2 H, 16a), 4.94 (br d, J = 10.2 Hz, 2 H, 16b), 4.24 (q, J = 7.1 Hz, 4 H, 3), 3.93 (t, 
J = 6.7 Hz, 4 H, 9), 2.06 (q, J = 6.9 Hz, 4 H, 14), 1.77 (quint, J = 7.0 Hz, 4 H, 10), 1.41 (m, 
12 H, 11, 12 & 13), 1.22 (t, J = 7.1 Hz, 6 H, 4). 13C NMR (CDCl3, 300 MHz): δ = 170.24 (2), 
158.29 (8), 138.95 (15), 130.63 (6), 130.62 (5), 114.25 (16), 113.70 (7), 67.80 (9), 67.04 (1), 
61.61 (3), 33.65 (14), 29.16 (10), 28.79 (12), 28.78 (13), 25.86 (11), 13.87 (4). Mass spectrum 
of the crude (before column) (ES+): m/z = 477 {mono + Na+}, 587 {M + Na+}, 603 {M + K+}. 
44 (2,2-Bis-(4-dec-9-enyloxy-phenyl)-malonic acid diethyl ester)8b 
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To a solution of 2,2-bis-(4-
hydroxyphenyl)malonate 
(0.240 g, 0.698 mmol) in 
acetonitrile (15 mL),
10-bromodec-1-ene (360 µL) was added. The solution was heated under reflux at 85ºC for 
14 hours. Then it was cooled to room temperature, acidified with HCl and neutralised with a 
saturated sodium hydrogen carbonate aqueous solution. The organic phase was extracted 
using ethyl acetate (2 µ 10 mL), the combined organic phase was dried over anhydrous 
magnesium sulphate, filtered and evaporated to give an oil, which was purified by column 
chromatography on silica (eluent: hexane), to give 44 as a brown oil (0.214 g, 49.5% yield). 
1H NMR (CDCl3, 300 MHz): δ = 7.40 (m, 4 H, 7), 6.90 (m, 4 H, 6), 5.90 (m, 2 H, 17), 5.05 
(m, 4 H, 18), 4.35 (m, 4 H, 3), 4.05 (t, J = 6.7 Hz, 4 H, 9), 2.10 (q, J = 6.9 Hz, 4 H, 16), 1.20 
(m, 30 H, 10, 11, 12, 13, 14, 15 & 4). Mass spectrum (ES+): m/z = 643.4 {M + Na+}. 
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39 by condensation of 42 with urea 
To a solution/suspension of urea (0.115 g, 1.92 mmol) and sodium hydride (60% dispersion in 
mineral oil, 0.0843 g, 1.41 mmol) in dry deuterated DMSO (0.75 mL in capsule), a solution of 
42 (0.1553 g, 0.417 mmol) in dry deuterated DMSO (0.75 mL in capsule) was added. After 
stirring for 15 hours at room temperature, water (10 mL) and saturated potassium chloride 
solution (20 mL) were added and a white precipitate formed, which dissolved after adding 
ethyl acetate (20 mL). The organic phase was extracted using ethyl acetate (2 more times 
20 mL), dried with MgSO4, filtered and evaporated, yielding an oily solid which was purified 
by flash chromatography (eluent: 1:1 hexane : ethyl acetate). 39 was obtained as a crystalline 
white solid (0.0268 g, 18.9% yield). 
First Attempt to obtain 45 from 43 using NaH in DMSO 
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Sodium hydride (55 mg of a 60% w/w dispersion in mineral oil, 1.38 mmol) was washed with 
dry hexane and added to DMSO (2 mL). After 5 minutes of stirring, urea (167 mg, 
2.78 mmol) was added. Then 5 minutes later a solution of 43 (147.0 mg, 0.26 mmol) in 
DMSO (2 mL) was added. The colour of the solution turned immediately from colourless to 
dark brown. It was left stirring at room temperature overnight, then water (30 mL) was added. 
It was mixed with 20 mL of a saturated solution of NaHCO3, then acidified with conc. HCl 
until the solution was neutral according to pH paper. The organic phase was extracted with 
4 µ 15 mL of ethyl acetate, dried and evaporated, to afford a dark red oil. After adding 2 mL 
of ethanol and cooling it to 0°C, a white solid crystallised and was filtered, affording 
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146.4 mg of product which was proved by NMR and mass spec to be identical to the starting 
material 43, recovered in 99.6% ± 0.2% yield. 
Second Attempt to obtain 45 from 43 using NaH in DMSO 
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Sodium hydride (141 mg of a 60% w/w dispersion in mineral oil, 3.53 mmol) was washed 
with dry hexane and added to DMSO (2.5 mL). After 5 minutes of stirring, urea (35 mg, 0.58 
mmol) was added. Then 5 minutes later a solution of 43 (169 mg, 0.299 mmol) in DMSO 
(3 mL) was added. The colour of the solution turned immediately from colourless to red. It 
was left stirring at room temperature overnight, then a saturated aqueous solution of 
ammonium chloride (50 mL) was added. The organic phase was extracted with 3 µ 25 mL of 
ethyl acetate, washed with 25 mL of saturated ammonium chloride solution, dried with 
magnesium sulphate and evaporated, to afford an orange oil. The components of the mixture 
were separated by chromatography on silica gel, eluent: hexane/ethyl acetate with increasing 
ratio of ethyl acetate. Three main fractions were collected : the first (10 mg of incolor oil) was 
identified to the ketone 45d (Bis-(4-oct-7-enyloxy-phenyl)-methanone). 1H NMR (CDCl3, 
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300 MHz): δ = 7.77 (d, J = 9.1 Hz, 4 H, 4), 6.94 (d, J = 8.9 Hz, 4 H, 5), 5.81 (ddt, Jt = 6.7, 
Jd1 = 10.3, Jd2 = 17.1 Hz, 2 H, 13), 5.04 (m, 4 H, 14), 4.03 (t, J = 6.7 Hz, 4 H, 7), 2.08-2.04 
(m, 4 H, 12), 1.85-1.77 (m, 4 H, 8), 1.57-1.37 (m, 12 H, 9, 10, 11). Mass spectrum (ES+): 
m/z = 457 {M + Na+}. The second fraction (30 mg of white solid) was identified to the 
carboxylic acid 45c (Bis-(4-oct-7-enyloxy-phenyl)-acetic acid). 1H NMR (CDCl3, 300 MHz): 
δ = 7.21 (d, J = 8.5 Hz, 4 H, 4), 6.84 (d, J = 8.8 Hz, 4 H, 5), 5.81 (ddt, Jt = 6.7, Jd1 = 10.3, 
Jd2 = 17.1 Hz, 2 H, 13), 5.00 (dq, Jq = 2.2, Jd = 17.2, 2 H, 14a), 4.96-4.89 (m, 3 H, 14b & 2), 
3.92 (t, J = 6.6 Hz, 4 H, 7), 2.05 (q, J = 6.6 Hz, 4 H, 12), 1.76 (quint, J = 7.0 Hz, 4 H, 8), 
1.50-1.26 (m, 12 H, 9, 10, 11). 13C NMR (CDCl3, 300 MHz): δ = 178.94 (1), 158.39 (6), 
138.98 (13), 130.18 (3), 129.59 (4), 114.54 (5), 114.26 (14), 67.91 (7), 55.34 (2), 33.67 (12), 
29.17 (8); 28.81 (10 & 11), 25.87 (9). Mass spectrum : ES+: m/z = 509 {M - H+ + 2 Na+}, ES-: 
m/z = 463 {M -H+}, 419 {M - CO2 - H+}. The third fraction (50 mg) is a complex mixture 
which contains 45a and 45b. Mass spectrum : ES+: m/z = 486 {M 45a + Na+}, 502 
{M45b + Na+}, 950, 966. 
Attempt to obtain 45 from 43 using sodium ethoxide in ethanol 
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To a solution of urea (167 mg) and sodium ethoxide (100 mg) in ethanol (2 mL), a solution of 
recuperated 43 (146.4 mg) in hot ethanol (2 mL) was added. The mixture was heated to reflux 
overnight. Then water (20 mL) was added, the ethanol was evaporated, and the remaining 
aqueous solution was mixed with 30 mL of NaHCO3 solution and acidified until neutral with 
conc. HCl. The organic phase was extracted with 2 µ 15 mL of ethyl acetate, dried with 
MgSO4, filtered and evaporated, affording an orange oil (107.3 mg) which was analysed by 
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1H NMR and mass spec, reavealing only the starting material 43 and its products of 
hydrolysis. 
Attempts to obtain 46 from 44 using NaH in DMSO, using NaH in DMF and using sodium 
ethoxide in ethanol: see reference below.8b 
47 (Dec-9-enyloxybenzene) 
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Phenol (0.33 g, 3.5 mmol) was dissolved in 
acetonitrile (40 mL). Potassium carbonate (1.0 g, 
7.2 mmol) was added. The mixture was heated to 40 °C, then 10-bromo-dec-1-ene (0.71 mL, 
3.5 mmol) was added. The mixture was heated to reflux and let stirring at reflux over 3 days, 
then the solvent was evaporated and the crude redissolved in water (50 mL) and ethyl acetate 
(15 mL). The two phases were separated and the aqueous extracted again with 2 µ 15 mL of 
ethyl acetate. The combined organic phase was washed with 15 mL of conc. NaHCO3 
aqueous solution, dried with MgSO4, filtered and evaporated. The oil obtained was separated 
by flash chromatography (eluent: hexane / DCM) to afford the desired product 43 as an 
colorless oil (807.7 mg, 99% yield). 1H NMR (CDCl3, 300 MHz): δ = 7.31-7.25 (m, 2 H, 3), 
6.96-6.89 (m, 3 H, 2 & 4), 5.82 (ddt, Jt = 6.7, Jd1 = 10.2, Jd2 = 17.1 Hz, 1 H, 13), 5.00 (br. d, 
J = 10.2 Hz, 1 H, 14b), 4.94 (br. d, J = 17.1 Hz, 1 H, 14a), 3.95 (t, J = 6.6 Hz, 2 H, 5), 2.05 
(q, J = 7.1 Hz, 2 H, 12), 1.78 (quint., J = 7.2 Hz, 2 H, 6), 1.56-1.25 (m, 10 H, 7, 8, 9, 10 & 
11). 
Attempt to obtain 46 by Friedel-Crafts reaction from 47 and alloxan 
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Alloxan monohydrate (281 mg) and 47 (807 mg) were dissolved in acetic acid (4 mL). 
Sulphuric acid (0.2 mL) was added and the mixture was heated to 90°C during 3 hours. Then 
the mixture was cooled to room temperature and a solution of sodium hydroxide (2.52 g) in 
water (50 mL) was added. A solid appeared in suspension. The mixture was cooled to 0°C, 
then mixed with a saturated solution of NaHCO3 (50 mL). The organic phase was extracted 
with 3 µ 20 mL of ethyl acetate, dried with MgSO4, filtered and evaporated. The crude solid 
was analysed by 1H NMR and mass spec (ES+), showing no sign of desired product 46. The 
terminal olefin signal, in particular, is absent from the NMR spectrum. 
48 (5,5-Bis-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-pyrimidine-2,4,6-trione)8a 
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A solution of 38 (325 mg, 1.04 mmol), tert-butyl-
dimethyl-silyl chloride (350 mg, 2.32 mmol), 4-
dimethylaminopyridine (50 mg, 0.41 mg) and 
triethylamine (330 µL, 2.37 mmol) in acetonitrile 
(50 mL) was heated to reflux overnight. Then the solvent
was evaporated, the crude dissolved in 50 mL of ethyl acetate, washed with 3 µ 50 mL of 
NaHCO3 solution, dried with magnesium sulphate, filtered and evaporated to afford a pink 
solid. It was then purified by column chromatography (neutral alumina, ethyl 
acetate / methanol) to afford 48 as a white solid (88 mg, 15.6% yield). 1H NMR (CDCl3 + 
MeOH, 300 MHz): δ = 7.99 (br. s, 2 H, NH), 7.07 (d, J = 8.9 Hz, 4 H, 5), 6.91 (d, J = 8.9 Hz, 
4 H, 6), 0.97 (s, 18 H, 9), 0.20 (s, 12 H, 8).  IR (ν, cm-1): 3215 (m, NH H-bonded), 3098 (m, 
Csp2-H), 2952 (m, Csp3-H), 2930 (m, Csp3-H), 2858 (m, Csp3-H), 1738 (s, C=O), 1709 (s, 
C=O), 1608 (m, C=C aromatic), 1509 (m, C=C aromatic), 1471 (w), 1426 (m), 1337 (s, CH 
bending), 1263 (s), 1221 (m) 1178 (m), 1114 (m), 1014 (w), 913 (m), 870 (m), 831 (m), 778 
(m). 
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49 (5,5-Bis-(4-hydroxy-phenyl)-1,3-di-oct-7-enyl-pyrimidine-2,4,6-trione) 
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8-bromooct-1-ene (80 µL, 0.48 mmol), 
was added to a solution of 48 (71.6 mg, 
0.132 mmol) in THF (2 mL) at 50°C. The 
mixture was heated to 64°C, then 
tetrabutylammonium fluoride (0.30 mL of a 1.0 M solution in THF, 0.30 mmol) was added 
drop wise. After 16 hours of stirring at reflux, the THF was evaporated. The orange oil 
obtained was dissolved in 20 mL of ethyl acetate, washed with 2 µ 20 mL of water, dried with 
magnesium sulphate, filtered and evaporated. The orange viscous ail obtained was separated 
by column chromatography (eluent: pertroleum ether / ethyl acetate) to afford 49 as an 
colourless oil (49 mg, 69% yield). 1H NMR (CDCl3, 300 MHz): δ = 6.95 (d, J = 8.7 Hz, 4 H, 
5), 6.74 (d, J = 8.7 Hz, 4 H, 6), 5.79 (ddt, Jt = 6.7, Jd1 = 10.2, Jd2 = 17.1 Hz, 2 H, 14), 5.25 (s, 
2 H, 0H), 4.98 (br. d, J = 17.3 Hz, 2 H, 15b), 4.93 (br. d, J = 10.2 Hz, 2 H, 15a), 3.91 (t, 
J = 7.3 Hz, 4 H, 8), 2.01 (q, J = 6.8 Hz, 4 H, 13), 1.69-1.51 (m, 4 H, 9), 1.38-1.15 (m, 12 H, 
10, 11 & 12). IR (ν, cm-1): 3417 (m, OH H-bonded), 2928 (m, Csp3-H), 2857 (w), 1667 (s, 
C=O), 1613 (m, C=C aromatic), 1595 (m, C=C aromatic), 1512 (s, C=C aromatic), 1437 (s, 
CH bending), 1398 (s, CH bending), 1365 (s), 1273 (m), 1217 (s), 1178 (s), 1116 (m), 1032 
(w), 1015 (w), 996 (w), 909 (m), 833 (s), 758 (m), 734 (m), 703 (w). 
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6.2) Titrations and spectrometry 
6.2.1) Titrations followed by UV-Vis. spectrometry 
The UV spectra were made on a Cary Varian 5000 UV-visible spectrometer. 
General procedure for the titrations by UV absorption of the receptors with low UV 
absorption near 300 nm: Titration of 18 with barbital. 
A solution of 16.40 mg of 18 in 10 mL analytical grade DCM was prepared. From this first 
solution, 1.00 mL was transferred to a 100 mL graduated flask and diluted to 100 mL with 
DCM (stock solution, [18] = 2.504 µ 10-5 M). A second aliquot of 1.00 mL of the first 
solution was added to another 100 mL graduated flask containing 23.0 mg of barbital, and 
diluted to 100 mL with DCM (barbital solution, [18] = 2.504 µ 10-5 M and 
[barbital] = 1.249 µ 10-2 M). Then a first UV spectrum of the stock solution was made 
between 200 and 700 nm. Before each new spectrum of the stock solution, a volume Vi was 
removed from the stock solution and the same volume Vi of barbital solution was added. The 
volumes Vi are shown Table 6.1. Then the spectra were corrected for the baseline deviation 
by withdrawing the average value of absorption between 600 and 700 nm (supposed to be 
close to zero) to the whole spectrum (cf. Figure 6.1). 
Table 6.1. Volumes for the titration of 18 with barbital by absorption. 
i Vi / µL neq barbital 
0 0 0 
1 20 0.01 
2 20 0.02 
3 20 0.03 
4 20 0.04 
5 60 0.07 
6 60 0.10 
7 100 0.15 
8 100 0.20 
9 200 0.30 
10 195 0.41 
11 405 0.61 
12 405 0.81 
13 395 1.02 
14 1020 1.53 
15 1020 2.03 
16 2070 3.05 
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Figure 6.1. Corrected absorption spectra during the titration of 18 (2.5 µ 10-5 M in DCM) 
with barbital (see Table 6.1 for the equivalents), at room temperature.  
The exact values of the starting concentration of barbital and 18 were calculated for 
each spectrum. A matrix was then created with the first two columns containing the calculated 
values of concentration, and the next fourteen columns the corrected absorption value at 14 
wavelengths between 275 and 327 nm. This matrix was submitted to the Letagrop software,9 
with a starting value for the computation chosen by trials and errors in order to minimize the 
χ² value. Result: log(K) = 5.7886 ± 0.0271; χ² = 10.07.  
A similar procedure was followed for the titrations of all other receptors with barbital, 
and for the titration of 18 with 36. Results are given in Chapter 2 and Chapter 3. The spectra 
of crude and corrected data as well as binding isotherms are given in Appendix 3. 
Second titration of 17 with barbital by UV absorption 
A solution of 2.750 mg of 17 in 10 mL DCM was prepared. From this first solution, 2.61 mL 
were transferred to a 50 mL graduated flask which was diluted with DCM to 50 mL (stock 
solution, [17] = 2.398 µ 10-5 M), and 445 µL was transferred to a second 10 mL graduated 
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flask containing 11.036 mg of barbital, which was diluted to 10 mL with DCM (barbital 
solution, [17] = 2.411 µ 10-5 M and [barbital] = 5.992 µ 10-3 M). Then a first UV spectrum of 
the stock solution was made between 200 and 700 nm. Before each new spectrum, a volume 
Vi was removed from the stock solution and the same volume Vi of barbital solution was then 
added into it. Then ca. 3 mL was taken from the stock solution and added to a cuvette to 
obtain a reading. The solution was then returned to the stock solution and the procedure 
repeated with the next Vi value. 
The volumes Vi are shown Table 6.2. The last spectrum (20) was made by mixing the 
remaining 1.4 mL of barbital solution with 2.5 mL of the stock solution. Then the spectra 
were corrected for the baseline deviation by withdrawing the average value of absorption 
between 600 and 700 nm (supposed to be close to zero) to the whole spectrum (cf. Figure 
6.2). 
 
Figure 6.2. Corrected absorption spectra during the titration of 17 (2.4 µ 10-5 M in DCM) 
with barbital (see Table 6.2 for the equivalents), at room temperature. 
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Table 6.2. Volumes for the second titration of 17 with barbital by absorption. 
i Vi / µL neq barbital 
0 0 0 
1 10 0.05 
2 10 0.10 
3 10 0.15 
4 10 0.20 
5 30 0.35 
6 30 0.50 
7 50 0.75 
8 50 1.00 
9 100 1.50 
10 100 2.00 
11 205 3.01 
12 200 4.00 
13 205 5.00 
14 410 7.01 
15 615 10.00 
16 1045 15.01 
17 1065 20.01 
18 2175 30.00 
19 2280 40.01 
20 X 115.07 
The exact values of the starting concentration of barbital and 17 were calculated for each 
spectrum. A matrix was then created with the first two columns containing the calculated 
values of concentration, and the 21 next columns the corrected absorption value at 21 
wavelengths between 291 and 331 nm. This matrix was submitted to the Letagrop software9 
for fitting with 2 complexes (1:1 and 1:2), with starting values for the computation chosen by 
trials and errors in order to minimize the χ² value. Result: log(K1) = 4.226 ± 0.213; 
log(K2) = 7.217 ± 0.288;χ² = 11.92. The spectra of crude and corrected data as well as 
binding isotherms are given in Appendix 3. 
General procedure for the titrations by UV absorption of the receptors with significant UV 
absorption near 300 nm: titration of 12 with 35. 
A solution of 1.4057 mg of 12 in 100 mL DCM (stock solution, [12] = 1.984 µ 10-5 M) and a 
solution of 8.2780 mg of 35 in 25 mL DCM ([35] = 3.975 µ 10-4 M) were prepared. Then a 
first UV spectrum of the stock solution was made between 200 and 700 nm. Before each new 
spectrum of the stock solution, a volume Vi of 35 solution was added to the stock. The 
volumes Vi are shown in Table 6.3. 
The exact values of the starting concentration of 35 and 12 were calculated for each 
step. Then the spectra were corrected for the baseline deviation by withdrawing the average 
value of absorption between 600 and 700 nm (supposed to be close to zero) to the whole 
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spectrum. The proper absorption of 35 was also corrected by withdrawing the spectrum of 35 
at its calculated initial concentration from the obtained spectrum. A matrix was then created 
with the first two columns containing the calculated values of concentration, and the eighteen 
next columns the corrected absorption at 18 wavelengths between 275 and 326 nm. This 
matrix was submitted to the Letagrop software,9 with a starting value for the computation 
chosen by trials and errors in order to minimize the χ² value. Result: 
log(K) = 3.7272 ± 0.0332; χ² = 11.50. 
Table 6.3. Volumes for the titration of 12 with 35. 
i Vi / µL neq 35 
0 0 0 
1 250 0.050 
2 250 0.100 
3 250 0.150 
4 250 0.200 
5 250 0.250 
6 245 0.300 
7 250 0.350 
8 250 0.400 
9 250 0.450 
10 250 0.500 
11 500 0.600 
12 500 0.700 
13 500 0.800 
14 500 0.901 
15 500 1.001 
16 500 1.101 
17 495 1.200 
 
 
Figure 6.3. Absorption spectra corrected by substracting the absorption due to the anthracene 
during the titration of 12 (2.0 µ 10-5 M in DCM) with 35 (see Table 6.3 for the equivalents) 
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A similar procedure was followed for the titrations of 16 with 34, 15 with 35, 16 with 
35, 17 with 39 and 18 with 39. Results are given in Chapter 3 and Chapter 5. The spectra of 
crude and corrected data as well as binding isotherms are given in Appendix 3. 
6.2.2) Fluorescence experiments 
Fluorescence quantum yield of 34 
 
Figure 6.4. Emission spectra of 34 in DCM and anthracene in ethanol for the determination of 
the quantum yield of fluorescence of 34. 
A solution of 34 in DCM and a solution of anthracene in ethanol were prepared with 
an approximate maximum absobance close to 0.2 in UV (see absorption spectrum of 
anthracene in Chapter 1, Figure 1.7). It was observed that both solutions had the same 
absorbance at 351 nm. So the fluorescence emission spectra of both solutions were recorded 
with an excitation at λexc = 351 nm (cf. Figure 6.4). The quantum yield of fluorescence Φf  
was calculated according to the following formula:10 
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where Im is the integral of the fluorescence signal of the solution of the compound m between 
λexc and +∞, Am is its absorbance at λexc, and ns is the refractive index of the solvent s. Result: 
Φf = 0.184. 
 
Fluorescence quantum yield of 16 
 
 
Figure 6.5. Emission spectra of 34 in DCM and anthracene in ethanol for the determination of 
the quantum yield of fluorescence of 34. 
It was measured by the same method as the fluorescence quantum yield of 34, but at 
an excitation wavelength of 314 nm (Figure 6.5 for the comparison with anthracene, Figure 
2.5 in Chapter 2 for a more detailed spectrum). Result: Φf = 0.00781. The unexpected shape 
of this spectrum may indicate that this result is overevaluated because of the possible 
fluorescence of an impurity in solution. 
Lifetimes of fluorescence of 34 
The lifetimes of the excited states of 34 was measured by registering the fluorescence decay 
using a 50 W miniature Arc lamp and Time-Correlated Single-Photon Counting 
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fluorometer. 11  The decay parameters were determined by a non-linear least squares 
deconvolution method using the DECAN (1.0) programme.12 The solutions used for these 
measures were at a concentration of 2 µ 10-5 M in DCM, degased by multiple freeze-pump-
thaw cycles on a high-vacuum line and sealed under vacuum in a quartz UV cuvette. 
The decay was measured at different wavelengths of emission, at 415 nm (region of the 
monomer emission) and at 510 nm (region of the excimer emission). Each time, the best 
model for the decay was found to be a biexponential model: 
IF(t) = A.exp(-t/τa) + B.exp(-t/τb)) 
The results were as follow : 
At 415 nm: A = 1.02, τa =1 .38 ns; B = 0.11, τb = 8.60 ns; χ² = 1.01. 
At 510 nm: A = 0.061, τa =1 .40 ns; B = 0.583, τb = 14.6 ns; χ² = 1.02. 
Lifetimes of fluorescence of 35 
It was also measured by the same method as 34 at 415 and 510 nm, each time with a 
biexponential model. The results were as follow: 
At 415 nm: A = 0.16, τa = 7.00 ns; B = 0.68, τb = 3.14 ns; χ² = 1.15. 
At 510 nm: A = 0.20, τa = 7.09 ns; B = 0.64, τb = 3.57 ns; χ² = 1.04. 
Titration of 34 with 18 by fluorescence excitation and emission 
Table 6.6. Volumes for the titration of 18 with 34 by fluorescence. 
I Vi / µL neq 34 
0 0 0 
1 250 0.05 
2 255 0.10 
3 250 0.15 
4 250 0.20 
5 250 0.25 
6 255 0.30 
7 250 0.35 
8 250 0.40 
9 255 0.45 
10 250 0.50 
11 505 0.60 
12 500 0.70 
13 505 0.80 
14 500 0.90 
15 505 1.00 
16 500 1.10 
17 rest 1.99 
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 Figure 6.6. Corrected emission spectra during the titration of 34 (2.0 µ 10-5 M in DCM) with 
18 (see Table 6.6 for the equivalents). 
A solution of 1.4976 mg of 34 in 100 mL DCM (stock solution, [34] = 2.011 µ 10-5 M) 
and a solution of 2.6176 mg of 18 in 10 mL DCM (solution of 18, [18] = 3.997 µ 10-4 M) 
were prepared. Then a series of spectra was made, and between each a volume Vi of the 
solution of 18 was added to the stock solution (see Table 6.6). Absorption A was measured at 
369 nm, emission spectra were recorded between 375 and 650 nm with an excitation 
wavelength of 369 nm, and excitation spectra were recorded at 420 nm with the excitation 
wavelength varying from 220 to 400 nm. Then the emission and excitation spectra were 
corrected by multiplying them by a facto A/A0, where A0 is the value of A in the spectrum of 
34 (i = 0) (cf. Figures 6.6 and 6.7). The exact values of the starting concentration of 18 and 
34 were calculated for each spectrum. A matrix was then created with the first two columns 
containing the calculated values of concentration, and the 17 next columns the corrected 
emission value at 21 wavelengths between 470 and 602 nm. This matrix was submitted to the 
Letagrop software,9 with starting value for the computation chosen by trials and errors in 
order to minimize the χ² value. Result: log(K) = 5.126 ± 0.177; χ² = 23.9. 
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Figure 6.7. Corrected excitation spectra during the titration of 34 (2.0 µ 10-5 M in DCM) with 
18 (see Table 6.6 for the equivalents). 
 Another matrix was created with again the concentration values of the 2 first lines and 
emission value at 420 nm for a range of 21 excitation wavelengths between 277 and 329 nm, 
without the values of the two last spectra were neq 34 > 1.0 (also they are shown as well on 
Figure 6.7) This matrix was submitted to the Letagrop software,9 with starting value for the 
computation chosen by trials and errors in order to minimize the χ² value. Result (average of 
many fits): log(K1) = 5.175 ± 0.202. 
 A similar procedure was followed for 16 with 34. Result: log(K1) = 5.112 ± 0.328. 
6.2.3) Titrations followed by ITC 
General considerations: 
The ITC titrations were made with a Microcal © VP-ITC machine, and the data treated with 
the ORIGIN software provided with the machine. Before each experiment, the injection 
syringe as well as the reference and sample cells were thoroughly washed with deionised 
water, then methanol, then DCM, and the reference cell was filled with DCM. After each 
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experiments, they were washed with DCM, then methanol, then deionised water and the 
reference-cell was re-filled with deionised water.  
General procedure: titration of 18 with barbital by ITC at 0.1 mM 
 A solution of 3.30 g of 18 in 50 mL DCM ([18] = 0.1 mM) was prepared. It was 
observed that the dissolution was slow and the solution had to be sonicated for 5 minutes in a 
ultrasonic bath in order to obtain a complete dissolution (this was observed with all the 
different receptors). The sample cell was then filled to its exact volume with this solution, by 
removing the excess with a syringe posed on the margin of the cell. A solution of 11.09 g of 
barbital in 20 mL DCM ([barbital] = 3.0 mM) was introduced in the addition syringe. The 
automatic injection was then started with the following parameters: the cell temperature was 
25 °C, the reference power 15 µcal/s, the initial delay 60 s, the stirring speed 307 rpm, there 
was 30 injection with a duration of 4.6 s and a spacing of 210 s, the 1st injection with a 
volume of 1 µL, the 2nd to 7th injections with a volume of 2.5 µL, and the 8th to 30th injections 
with a volume of 5 µL. 
 For the data treatment, the first two data points were systematically deleted: the first 
according to normal practice and the second due to perceived auto-association. The 
concentration of the starting solution in the cell was adjusted to allow a fit with a value of 
n = 1. Before this correction, the calculated value of n typically fell in the range 0.9-1.0, and 
the values calculated for the thermodynamic parameters did not change after correction of the 
concentration. The crude data and experimental results are presented in Appendix 3. 
6.2.4) Ab-initio models and comparison with IR in solution 
FTIR Measurements 
Infrared spectra of 17 (18), barbital (39), and their 1:1 complexes were recorded with a 
ThermoNicolet Nexus 670 FTIR spectrometer at a resolution of 4 cm-1, by co-adding 50 scans. 
Samples were held in a variable path length cell with BaF2 windows (Eurolabo). IR spectra 
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were measured in CDCl3 at a concentration of 5 mM and at a path length of 250 µm, excepted 
barbital for which CDCl3 + DMSO-d6 95:5 mixture was used. All infrared spectra were shown 
with solvent absorption subtracted out. The results are shown in Chapters 2 and 5. 
DFT calculations 
The geometry optimizations, vibrational frequencies, and absorption intensities were 
calculated by Gaussian 03 program13 on a SGI Altix XE 1300 of the Pôle Modélisation of the 
Institut des Sciences Moléculaires (University Bordeaux I). Calculations of the optimized 
geometry of 17 (18), barbital (39), their 1:1 complexes, and the two isomers cis and trans of 
the catenane formed with 18 and 37c, were performed at the density functional theory level 
using B3PW91 functional and 6-31G* basis set. Vibrational frequencies and IR intensities 
were calculated at the same level of theory. For comparison to experiment, the calculated 
frequencies were scaled by 0.964 (0.95 for calculations in the NH/CH stretching region) and 
the calculated intensities were converted to Lorentzian bands with a half-width of 7 cm-1 
(15 cm-1 for calculations in the NH/CH stretching region). A half-width of 100 cm-1 has been 
applied for NH stretching modes of barbital (39) involved in strong hydrogen bonds with 
nitrogen atom of the pyridin groups of 17 (18). Pictures of the structure found for the 
complexes and simulated IR spectra (when applicable) are shown in Chapters 2, 4 and 5. 
6.3) Metathesis experiments  
6.3.1) General considerations 
 The NMR spectra were recorded on Bruker AC300 or AV300 spectrometers 
(300 MHz). The mass spectra were recorded on VG Zabspec mass spectrometer. 
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6.3.2) Experimental procedures and spectra 
General procedure for the cyclisation of receptors with barbital: cyclisation of 10 with 
barbital: 
A solution of 10 (40 mg, 64 µmol) and barbital (13 mg, 71 µmol) in DCM (20 mL) was 
heated to reflux. Then a solution of Grubbs 1st generation catalyst (6.0 mg, 7 µmol) in DCM 
(2 mL) was added. After 2 hours of stirring at reflux, the solvent was evaporated and the 
brown solid obtained was analysed by 1H NMR and mass spectrometry (electrospray). The 
proportion of cyclised vs. non-cyclised receptor obtained was evaluated by comparing the 
integration of the signals of remaining terminal olefin (5.80 ppm, ddt, 2 H and 5.00 ppm, m, 
4 H), with the signal of the new olefinic proton (5.40 ppm, m, 2 H). In this case 10% of 
cyclised receptor 14 were observed for 90% of starting receptor 10. In mass spec., both the 
non-cyclised and the cyclised product were observed (sodium adduct), but no peak for the 
complex. 
General procedure for the cyclisation of receptors with 36: cyclisation of 12 with 36: 
A solution of 36 (8.9 mg, 9.2 µmol) and 12 (5.2 mg, 7.6 µmol) in CDCl3 (1.5 mL, previously 
passed on a short column of MgSO4 and basic alumina) was prepared, and a first 1H NMR 
was made. Then Grubbs 1st generation catalyst (0.8 mg, 1.0 µmol) was added. The reaction 
mixture was heated to reflux during 30 min. and then cooled to room temperature. A new 
1H NMR was made. Then methanol (7 µL) was added and the solution was analysed by 
1H NMR and mass spectrometry (electrospray and MALDI). The results of these analysis are 
given in Chapter 4. 
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Cyclisation of barbiturate 37 in presence and absence of 18: 
A solution of 37 (3.05 mg, 7.54 µmol) and 18 (6.33 mg, 8.90 µmol) in CDCl3 (1.5 mL) was 
analysed by 1H NMR and a few drops were submitted for mass spectrometry (ES-). Then 
Grubbs 1st generation catalyst (1 mg, 1.2 µmol) was added and the mixture was heated to 
reflux during 2 hours, and then cooled to rt. It was analysed again by 1H NMR and mass spec., 
then an excess of barbital (approx. 15 mg) was added, and it was analysed again. 
A solution of 37 (3.10 mg, 7.66 µmol) and Grubbs catalyst (0.8 mg, 1 µmol) was heated to 
reflux during 2 hours, analysed by 1H NMR and mass spec., then 18 (6 mg) was added, it was 
analysed again, and finally barbital (approx. 15 mg) was added and it was analysed again. 
The NMR spectra are presented in Chapter 4 and the mass spectra are presented in 
Appendix 2. 
6.4) Photodimerisation experiments  
6.4.1) General considerations 
 The NMR spectra were recorded on a Buker AC 250 spectrometer (250 MHz) at the 
CESAMO (University of Bordeaux, France). 
 MALDI-MS spectra were performed by the CESAMO on a Voyager mass 
spectrometer (Applied Biosystems). The instrument is equipped with a pulsed N2 laser 
(337 nm) and a time-delayed extracted ion source. Spectra were recorded in the positive-ion 
mode using the reflectron and with an accelerating voltage of 20 kV. Samples were dissolved 
in CHCl3 at 10 mg/ml. The dithranol matrix solution was prepared by dissolving 10 mg in 
1 ml of CHCl3. A MeOH solution of cationisation agent (NaI, 10 mg/ml) was also prepared. 
The solutions were combined in a 10:1:1 volume ratio of matrix to sample to cationisation 
agent. One to two microliters of the obtained solution was deposited onto the sample target 
and vacuum-dried. 
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6.4.2) Photodimerisation experiments followed by UV 
General procedure for quantum yield and thermal return rate measurements: example 
with 34 
 A solution of 34 (1.603 mg) in DCM (100 mL) was prepared: [34] = 2.152.10-5 M. 
3 mL of this solution were introduced in a fluorescence cuvette, degased by 3 
freeze/pump/thaw cycles, and sealed. Absorption spectra of of this solution were taken after 
different intervals of time of irradiation performed at 365 nm using a mercury lamp and a 
monochromator, converting “monomeric” 34 to cyclic 34c. The concentration of remaining 
34 was calculated according to Beer’s law. 
 The photonic flux P of the lamp was measured using Parker’s actinometry:14 Three 
measuring flasks of 25 mL were prepared with in all three 1.5 mL of buffer solution (prepared 
with 300 mL of sodium acetate 1N + 180 mL of H2SO4 1N + 20 mL H2O) and 2 mL of 
o-phenanthroline solution (0.1% w/w in water), then 3 mL of potassium ferrioxalate solution 
(0.006 M, kept in the dark) were irradiated during exactly 2 minutes in the same conditions as 
the solution of 34 and added to the first measuring flask, 3 mL of the ferrioxalate solution, 
non irradiated, were added to the second flask, and all three were completed to 25 mL with 
deionised water. They were stirred in the dark during one hour, then the absorbance of both 
solutions 1 and 2 at 510 nm was measured, using the 3rd solution for the baseline. The value of 
P was given by the following formula: 
 = . .  !.  . "#  
where NA is Avogadro constant, V is 25 cm3, ∆A is the difference of absorption between 
solutions 1 and 2 at 510 nm, Φf  is the quantum yield of production of ferrous ions from 
potassium ferrioxalate at 365 nm and is equal to 1.21, and εp is the molar extinction 
coefficient of the complex of ferric ions with phenanthroline at 510 nm, which is equal to 
11100. 
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Figure 6.8: Experimental values and model of the concentration of monomeric 34 as a 
function of the time of irradiation. 
A model c(t) describing the evolution of the concentration c of 34 as a function of the 
time of irradiation t was established, using only the parameters of the problem (molar 
absorption coefficient ε of 34 in DCM at 365 nm, initial concentration c0, volume V, incident 
photonic flux P determined by Parker actinometry, optical path l, and the unknown quantum 
yield Φ): 
$%&' =  
! %1 − %1 − 10+'. ,-. %− . . ". !. !%10'.  . &'
". !. ! %10'  
Then, for different values of Φ, the values of c(t) according to this model were 
compared to the experimental values of c at t obtained from the spectra by using Beer’s law. 
The best value of Φ is the one that gives a model that fits the experimental points with the 
smallest standard deviation. Result: Φ  = 0.101 (cf. Figure 6.8). 
Finally, the cuvette was left at room temperature (25°C) and the absorption  at 369 nm 
(due to “monomeric” 34 reappearing in solution by conversion of 34c) was measured. The 
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value of kret retained for the rate constant of the reaction 34c → 34 was the one that gave the 
best fit with experimental points according to the following law: 
%&' = /. %1 − ,01234.' 
where A∞ is the initial absorbance of the solution of 34 before irradiation (cf. Figure 6.9). 
Result: kret = 3.45 µ 10-6 s-1. 
Figure 6.9. Experimental values and model of the absorbance of a solution of 34c allowed to 
return to 34 at rt. as a function of time. 
A similar procedure was used to measure Φ and kret for 35 and 1:1 mixtures of 16 with 
34 or 35. Results: 35: Φ  = 0.280, kret = 7.62 µ 10-4 s-1; 34∑16: Φ  = 0.00141, 
kret = 2.30 µ 10-4 s-1; 35∑16: Φ  = 0.00260, kret = 2.70 µ 10-4 s-1. 
6.4.3) Photodimerisation experiments followed by NMR 
Irradiation of 34 and its complexes with 14, 15 and 16 in CD2Cl2 
A solution of 3.5752 mg of 34 in 1.2 mL of CD2Cl2 was prepared. 0.3 mL of this solution was 
added to 0.3 mL of CD2Cl2 and also to the following solutions: 
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• 14: 0.7156 mg in 0.3 mL CD2Cl2, 
• 15: 0.7834 mg in 0.3 mL CD2Cl2, 
• 16: 0.8501 mg in 0.3 mL CD2Cl2 
Those four solutions (concentration 2 mM) were introduced in NMR tubes that were degassed 
by 3 freeze/pump/thaw cycles and NMR were taken after different intervals of irradiation 
using a white lamp with a Pb(NO3)2 filter. 
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1H NMR of 34 before irradiation (CD2Cl2, 250 MHz): δ = 8.75 (br. s, 2 H, NH), 8.35 (m, 4 H, 
12), 8.20 (s, 2 H, 17), 7.80 (m, 4 H, 15), 7.40 (m, 8 H, 13 & 14), 4.25 (m, 4 H, 9), 3.70 (m, 
4 H, 8), 3.45 (m, 12 H, 5, 6 & 7), 2.30 (t, J = 5.7 Hz, 4 H, 4). 
1H NMR of the solution of 34 after 45 min. of irradiation (identified to 34c hh) (CD2Cl2, 
250 MHz): δ = 7.30 (m, 6 H, 12 & NH), 6.90-6.85 (m, 12 H, 13, 14 & 15), 4.50 (s, 2 H, 17), 
3.85 (br. s, 4 H, 9), 3.70 (m, 4 H, 8), 3.45 (m, 12 H, 5, 6 & 7), 2.40 (t, J = 5.7 Hz, 4 H, 4). 
Irradiation of 35 and its complexes with 14, 15 and 16 in CD2Cl2 
A solution of 4.70 mg of 34 in 1.4 mL of CD2Cl2 was prepared. 0.3 mL of this solution was 
added to 0.3 mL of CD2Cl2 and also to the following solutions : 
• 14: 0.720 mg in 0.3 mL CD2Cl2, 
• 15: 0.803 mg in 0.3 mL CD2Cl2, 
• 16: 0.852 mg in 0.3 mL CD2Cl2 
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Those four solutions (concentration 2 mM) were introduced in NMR tubes that were degassed 
by three freeze-pump-thaw cycles on a high-vacuum line and sealed under vacuum. 1H NMR 
spectra were taken after different intervals of irradiation using a 450 W mercury lamp. The 
NMR tubes were plunged in vials containing the filter solution (saturated solution of lead 
acetate), placed in a merry-go-round apparatus to ensure their uniform irradiation, and the 
entire setup was immersed in a water bath, which allowed to filter IR radiation and thermostat 
the samples.15 
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1H NMR of 35 before irradiation (CD2Cl2, 250 MHz): δ = 9.35 (s, 2 H, NH), 8.40 (m, 4 H, 
14), 8.20 (s, 2 H, 19), 8.00 (m, 4 H, 17), 7.45 (m, 8 H, 15 & 16), 4.45 (m, 4 H, 11), 4.05 (m, 
4 H, 10), 3.80 (m, 4 H, 9), 3.60 (m, 4 H, 8), 3.20 (m, 4 H, 7), 3.15 (m, 4 H, 6), 2.95 (m, 4 H, 
5), 2.10 (t, J = 5.5 Hz, 4 H, 4). 
1H NMR of 35 after 10 min. of irradiation (CD2Cl2, 250 MHz): δ = 9.10 (s, 2 H, NH), 7.25 (d, 
4 H, 14), 6.80 (m, 12 H, 15, 16 & 17), 4.45 (s, 2 H, 19), 3.95 (m, 4 H, 11), 3.85 (m, 4 H, 10), 
3.65 (m, 8 H, 9 & 8), 3.50 (m, 12 H, 5, 6 & 7), 2.30 (t, J = 5.7 Hz, 4 H, 4). 
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Test of catenation: 17 + 34 
Three solutions were prepared, each one in 0.75 mL CDCl3: 
• 17:   2.233 mg of 17 
• 34:   2.783 mg of 33 
• 17 + 34: 2.251 mg of 17 and 2.793 mg of 33 
NMR spectra of each solution was taken, as well as MALDI on a small portion of the 
solutions. To this small portion of 17 and 17 + 34, an excess of barbital was then added and 
another MALDI was performed. Then the rest of the solutions of 34 and 17 + 34 were 
degassed by freeze/pump/thaw then irradiated over a period of 90 minutes at 4 cm of a 
medium pressure Hg lamp (400 W) in the presence of a lead nitrate solution as a filter, after 
what the NMR shown that the cyclisation was complete: the signal of the H in para of the O 
on the anthracene in the NMR at 8.09 ppm has disappeared, and a new peak for the 
bridgehead proton at 4.5 ppm has appeared. 2.233 mg of 17 were then added to the tube of 
34c (irradiated), and NMR and MALDI were performed as described above, before and after 
adding an excess of barbital. 
The same procedure was followed for the test of catenation of 18 + 34. The NMR are 
reproduced in Chapter 4. The MALDI spectra are given in Appendix 2. 
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